<SEC-DOCUMENT>0001193125-13-399924.txt : 20131015
<SEC-HEADER>0001193125-13-399924.hdr.sgml : 20131014
<ACCEPTANCE-DATETIME>20131015163616
ACCESSION NUMBER:		0001193125-13-399924
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20131015
DATE AS OF CHANGE:		20131015
EFFECTIVENESS DATE:		20131015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-191730
		FILM NUMBER:		131152246

	BUSINESS ADDRESS:	
		STREET 1:		6800 BROKEN SOUND PARKWAY NW
		STREET 2:		THIRD FLOOR
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		561-961-1911

	MAIL ADDRESS:	
		STREET 1:		6800 BROKEN SOUND PARKWAY NW
		STREET 2:		THIRD FLOOR
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d611784ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML><HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on October&nbsp;15, 2013 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM S-8
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>THERAPEUTICSMD, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Nevada</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><B>87-0233535</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6800 Broken Sound Parkway NW, Third Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, FL 33487 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMHN, Inc. 2009 Long Term Incentive Compensation Plan, as amended </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. Amended and Restated 2012 Stock Incentive Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full Title of the Plan) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Daniel A. Cartwright </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Financial Officer, Vice President of Finance, and Treasurer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6800 Broken Sound Parkway NW, Third Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, FL 33487 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(561) 961-1900 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name,
Address, and Telephone Number, Including Area Code, of Agent for Service) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Copy to:
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Robert S. Kant, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Greenberg Traurig, LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2375 East Camelback Road, Suite 700 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Phoenix, Arizona 85016 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(602) 445-8000 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Indicate by
check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and
&#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. (Check one): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Large&nbsp;accelerated&nbsp;filer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Accelerated&nbsp;filer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Non-accelerated filer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;(Do not check if a smaller reporting company)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Smaller&nbsp;reporting&nbsp;company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be registered</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount&nbsp;to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registered <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering
price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per share</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering price</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registration fee</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value $0.001</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">13,276,293&nbsp;shares<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$1.06<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$14,072,870.58</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$1,812.59</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value $0.001</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">11,723,707&nbsp;shares<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$3.65<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$42,791,530.55</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$5,511.55</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value $0.001</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">1,625,000&nbsp;shares<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$2.97<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$4,826,250.00</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">$621.62</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value $0.001</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">8,375,000&nbsp;shares<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$3.65<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$30,568,750.00</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$3,937.26</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this Registration Statement shall
also cover any additional shares of the Registrant&#146;s common stock that may become issuable under the AMHN, Inc. 2009 Long Term Incentive Compensation Plan, as amended (the &#147;LTIP&#148;) and the TherapeuticsMD, Inc. Amended and Restated 2012
Stock Incentive Plan (the &#147;2012 SOP&#148;) by reason of any stock dividend, stock split, recapitalization, or any other similar transaction that results in an increase in the number of outstanding shares of common stock of the Registrant.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Represents shares of common stock reserved for issuance pursuant to awards currently outstanding under the LTIP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The proposed maximum offering price per share was computed in accordance with Rule 457(h) promulgated under the Securities Act and represents the
weighted-average price per share of outstanding awards under the LTIP and the 2012 SOP, as applicable. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Represents shares of common stock issuable under the LTIP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The proposed maximum offering price per share was calculated solely for the purpose of this offering under Rules 457(c) and 457(h) promulgated
under the Securities Act, based upon the average of the high and low sales prices of the Registrant&#146;s common stock on October&nbsp;8, 2013 as reported on the NYSE MKT. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Represents shares of common stock reserved for issuance pursuant to awards currently outstanding under the 2012 SOP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Represents shares of common stock issuable under the 2012 SOP. </P></TD></TR></TABLE>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The documents containing the information specified in Part I will be delivered to participants of the AMHN, Inc. 2009 Long
Term Incentive Compensation Plan, as amended (the &#147;LTIP&#148;) and the Therapeutics MD, Inc. Amended and Restated 2012 Stock Incentive Plan (the &#147;2012 SOP&#148;) as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended
(the &#147;Securities Act&#148;). In accordance with the rules and regulations of the Securities and Exchange Commission (the &#147;Commission&#148;) and the instructions to Form S-8, such documents are not required to be, and are not, filed with
the Commission either as part of this registration statement filed on Form S-8 (the &#147;Registration Statement&#148;) or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents and the documents
incorporated by reference in the Registration Statement pursuant to Item&nbsp;3 of Part II of this Form S-8, taken together, constitute a prospectus that meets the requirements of Section&nbsp;10(a) of the Securities Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Incorporation of Documents by Reference. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TherapeuticsMD, Inc. (the
&#147;Registrant&#148;) hereby incorporates by reference into the Registration Statement the following documents previously filed with the Commission: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Annual Report on Form 10-K for the Registrant&#146;s fiscal year ended December&nbsp;31, 2012, filed on March&nbsp;12, 2013; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Quarterly Reports on Form 10-Q for the quarters ended March&nbsp;31, 2013, filed on May&nbsp;10, 2013, and June&nbsp;30, 2013, filed on
August&nbsp;7, 2013; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Current Reports on Form 8-K, other than information furnished pursuant to Item&nbsp;2.02 or Item&nbsp;7.01 of Form 8-K, filed&nbsp;on January 25,
2013, February 6, 2013, March 15, 2013, April 23, 2013, May 16, 2013, August 22, 2013, September&nbsp;24, 2013, and September&nbsp;25, 2013 (two reports filed); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The description of the Registrant&#146;s common stock included under the heading &#147;Description of Common Stock&#148; in the prospectus forming
a part of the Registrant&#146;s Registration Statement on Form S-3 (File No.&nbsp;333-186189), as filed with the Commission on January&nbsp;25, 2013, including exhibits, which description has been incorporated by reference in Item&nbsp;1 of the
Registrant&#146;s Form 8-A (File No.&nbsp;001-00100), as filed with the Commission on April&nbsp;22, 2013, including any amendment or report filed with the Commission for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, all documents filed with the Commission pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), subsequent to the date of the Registration Statement and prior to the filing of a post-effective amendment to the Registration Statement, which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into the Registration Statement and to be a part hereof from the date of filing of such documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any statement contained in a document incorporated or deemed to be incorporated by reference in the Registration Statement
shall be deemed to be modified or superseded for purposes of the Registration Statement to the extent that a statement contained in the Registration Statement, or in any subsequently filed document which also is or is deemed to be incorporated by
reference in the Registration Statement, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of the Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Description of Securities. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Not applicable. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Interests of Named Experts and Counsel. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">None. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Indemnification of Directors and Officers. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Registrant is a Nevada
corporation and is generally governed by the Nevada Private Corporations Code, Chapter 78 of the Nevada Revised Statutes (the &#147;NRS&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;78.138 of the NRS provides that, unless the corporation&#146;s articles of incorporation provide otherwise, a
director or officer will not be individually liable unless it is proven that (i)&nbsp;the director&#146;s or officer&#146;s acts or omissions constituted a breach of his or her fiduciary duties, and (ii)&nbsp;such breach involved intentional
misconduct, fraud, or a knowing violation of the law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;78.7502 of the NRS permits a corporation to indemnify
its directors and officers against expenses, judgments, fines, and amounts paid in settlement actually and reasonably incurred in connection with a threatened, pending, or completed action, suit, or proceeding, if the officer or director (i)&nbsp;is
not liable pursuant to Section&nbsp;78.138 of the NRS, or (ii)&nbsp;acted in good faith and in a manner the officer or director reasonably believed to be in or not opposed to the best interests of the corporation and, if a criminal action or
proceeding, had no reasonable cause to believe the conduct of the officer or director was unlawful. Section&nbsp;78.7502 of the NRS also precludes indemnification by the corporation if the officer or director has been adjudged by a court of
competent jurisdiction, after exhaustion of all appeals, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court determines that in view of all the circumstances, the person
is fairly and reasonably entitled to indemnity for such expenses and requires a corporation to indemnify its officers and directors if they have been successful on the merits or otherwise in defense of any claim, issue, or matter resulting from
their service as a director or officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;78.751 of the NRS permits a Nevada corporation to indemnify its
officers and directors against expenses incurred by them in defending a civil or criminal action, suit, or proceeding as they are incurred and in advance of final disposition thereof, upon determination by the stockholders, the disinterested board
members, or by independent legal counsel. Section&nbsp;78.751 of the NRS requires a corporation to advance expenses as incurred upon receipt of an undertaking by or on behalf of the officer or director to repay the amount if it is ultimately
determined by a court of competent jurisdiction that such officer or director is not entitled to be indemnified by the corporation if so provided in the corporation&#146;s articles of incorporation, bylaws, or other agreement. Section&nbsp;78.751 of
the NRS further permits the corporation to grant its directors and officers additional rights of indemnification under its articles of incorporation, bylaws, or other agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;78.752 of the NRS provides that a Nevada corporation may purchase and maintain insurance or make other financial
arrangements on behalf of any person who is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another company, partnership, joint
venture, trust, or other enterprise, for any liability asserted against him and liability and expenses incurred by him in his capacity as a director, officer, employee, or agent, or arising out of his status as such, whether or not the corporation
has the authority to indemnify him against such liability and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Registrant&#146;s amended and restated
articles of incorporation provide that it may indemnify, to the full extent permitted by the provisions of the NRS, all directors and officers, employees, and/or agents. The Registrant&#146;s amended and restated articles of incorporation further
provide that a director or officer of the Registrant shall not be personally liable to the Registrant or any of its stockholders for damages for breach of fiduciary duty as a director or officer, except for liability for (i)&nbsp;acts or omissions
which involve intentional misconduct, fraud, or a knowing violation of the law, or (ii)&nbsp;the payment of dividends in violation of Section&nbsp;78.300 of the NRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exemption From Registration Claimed. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Not applicable. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Exhibits to this Registration Statement are listed in the
Exhibit Index and incorporated herein by reference. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Undertakings. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a)&nbsp;&nbsp; The undersigned Registrant hereby
undertakes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to the Registration Statement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) To include any prospectus required by Section&nbsp;10(a)(3)
of the Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) To reflect in the prospectus any facts or events arising after the effective
date of the Registration Statement (or the most recent post-effective amendment hereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the
&#147;Calculation of Registration Fee&#148; table in the effective Registration Statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) To
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to
be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by
reference in the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(2) That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I>
offering thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b)&nbsp;&nbsp; The undersigned
Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at the time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c)&nbsp;&nbsp; Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers, and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action,
suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Boca Raton, state of Florida, on October&nbsp;15, 2013.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>THERAPEUTICSMD, INC.</B></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Daniel A. Cartwright</I></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Daniel A. Cartwright</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Chief Financial Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, the undersigned officers and directors of TherapeuticsMD, Inc., hereby severally constitute and appoint Robert G. Finizio and Daniel A.
Cartwright, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in
any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, to sign any registration statement filed pursuant to Rule 462(b) of the Securities Act, and to file the same, with all
exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing
requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute
or substitutes, may lawfully do or cause to be done by virtue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the requirements of the Securities Act
of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:30.60pt; font-size:8pt; font-family:Times New Roman">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Position</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Robert G. Finizio</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Chief Executive Officer and Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Robert G. Finizio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ John C.K. Milligan, IV</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">President, Secretary, and Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">John C.K. Milligan, IV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Daniel A. Cartwright</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Chief Financial Officer, Vice President</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Daniel A. Cartwright</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">of Finance, and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">(Principal Financial Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Brian Bernick, M.D.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Chief Medical Officer and Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Brian Bernick, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Tommy G. Thompson</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Tommy G. Thompson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Samuel A. Greco</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Samuel A. Greco</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Cooper C. Collins</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Cooper C. Collins</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Robert V. LaPenta, Jr.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Robert V. LaPenta, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Jules A. Musing</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Jules A. Musing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Nicholas Segal</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">October 15, 2013</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Nicholas Segal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Securities Purchase Agreement (1)</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Common Stock (2)</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Greenberg Traurig, LLP*</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Rosenberg Rich Baker Berman &amp; Company, independent registered public accounting firm*</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on signature page)</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AMHN, Inc. 2009 Long Term Incentive Compensation Plan, as amended*</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">TherapeuticsMD, Inc. Amended and Restated 2012 Stock Incentive Plan (3)</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed herewith. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed as an exhibit to Form 8-K filed with the Commission on October&nbsp;2, 2012 and incorporated herein by reference. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed as an exhibit to Form S-3 filed with the Commission on January&nbsp;25, 2013 and incorporated herein by reference. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed as an exhibit to Form 8-K filed with the Commission on August&nbsp;22, 2013 and incorporated herein by reference. </P></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d611784dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g611784g27z39.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;15, 2013 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6800 Broken Sound Parkway
NW</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Third Floor</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boca Raton, FL 33487</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><B>Re:&nbsp;&nbsp;Registration Statement on Form
S-8</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">As legal counsel to TherapeuticsMD, Inc., a Nevada corporation (the
&#147;Company&#148;), we have assisted in the preparation of the Company&#146;s Registration Statement on Form S-8 (the &#147;Registration Statement&#148;) to be filed with the Securities and Exchange Commission on or about October&nbsp;15, 2013 in
connection with the registration under the Securities Act of 1933, as amended, of 13,276,293 shares of the Company&#146;s common stock, par value $0.001 per share (the &#147;Common Stock&#148;), issuable pursuant to awards outstanding under the
AMHN, Inc. 2009 Long Term Incentive Compensation Plan, as amended (the &#147;LTIP&#148;), 1,625,000 shares of Common Stock issuable pursuant to awards outstanding under the TherapeuticsMD, Inc. Amended and Restated 2012 Stock Incentive Plan (the
&#147;Amended and Restated 2012 SOP&#148; and collectively with the LTIP, the &#147;Plans&#148;), 11,723,707 shares of Common Stock available for issuance under the LTIP, and 8,375,000 shares of Common Stock available for issuance under the Amended
and Restated 2012 SOP. The shares of Common Stock issuable pursuant to the Plans are collectively referred to as the &#147;Shares.&#148; The facts, as we understand them, are set forth in the Registration Statement.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">With respect to the opinion set forth below, we have examined
originals, certified copies, or copies otherwise identified to our satisfaction as being true copies, only of the following:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">A. The Amended and Restated Articles of Incorporation of the Company, as currently in effect;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">B. The Bylaws of the Company, as currently in effect;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">C. Various resolutions of the Board of Directors of the Company
authorizing the issuance of the Shares and adopting the Plans;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">D.
The Plans; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">E. The Registration Statement.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">GREENBERG TRAURIG, LLP <FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT> ATTORNEYS AT LAW <FONT
STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT> WWW.GTLAW.COM</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">2375 East Camelback Road, Suite 700 <FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT> Phoenix,
Arizona 85016 <FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT> Tel 602.445.8000 <FONT STYLE="FONT-FAMILY:WINGDINGS">&#110;</FONT> Fax&nbsp;602.445.8100</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g611784g24k38.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;15, 2013 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the assumptions that (i)&nbsp;the documents and signatures examined by us are genuine and authentic, and (ii)&nbsp;the persons
executing the documents examined by us have the legal capacity to execute such documents, and based solely upon our review of items A through E above, and subject to the further limitations and qualifications set forth below, it is our opinion that
the Shares, when issued and sold in accordance with the Plans, will be validly issued, fully paid, and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We express no
opinion as to the applicability or effect of any laws, orders, or judgments of any state or other jurisdiction other than the existing laws of the United States of America, and of the Nevada Revised Statutes, the Nevada Constitution, and reported
judicial decisions relating thereto. Further, our opinion is based solely upon existing laws, rules, and regulations, and we undertake no obligation to advise you of any changes that may be brought to our attention after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hereby expressly consent to any reference to our firm in the Registration Statement, to the inclusion of this Opinion as an exhibit to the
Registration Statement, and to the filing of this Opinion with any other appropriate governmental agency. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Very truly yours,</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Greenberg Traurig, LLP</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GREENBERG TRAURIG, LLP </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d611784dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of our report dated March 12, 2013, with respect to the
consolidated financial statements of TherapeuticsMD, Inc. and the effectiveness of internal control over financial reporting of TherapeuticsMD, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2012. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rosenberg Rich Baker Berman &amp; Company</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rosenberg Rich Baker Berman &amp; Company</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Somerset, NJ </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 15, 2013
</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d611784dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMHN, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2009 LONG
TERM INCENTIVE COMPENSATION PLAN </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(As Amended) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>PURPOSES</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The purposes of this Long Term Incentive Compensation Plan (the &#147;Plan&#148;) are to promote the long-term success of AMHN, Inc., a Nevada
corporation (the &#147;Company&#148;) and to provide financial incentives to employees, members of the Board, and advisers and consultants of the Company to strive for long-term creation of stockholder value. The Plan provides long-term incentives
to employees, members of the Board, and advisers and consultants of the Company who are able to contribute towards the creation of or have created stockholder value by providing them stock options and other stock and cash incentives. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>DEFINITIONS</U></B> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following definitions shall be applicable throughout the Plan: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Award&#148; means an incentive award as described in Section&nbsp;5(a). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Board&#148; means the Board of Directors of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Change in Control&#148; means the occurrence of one or more of the change in control events set forth in Treasury Regulation
Section&nbsp;1.409A-3(i)(5). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Chief Executive Officer&#148; or &#147;CEO&#148; means the Chief Executive Officer of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Chief Financial Officer&#148; or &#147;CFO&#148; means the Chief Financial Officer of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Code&#148; means the Internal Revenue Code of 1986, as amended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Committee&#148; means the Compensation Committee of the Board unless another committee comprised of members of the Board is designated by the
Board to oversee and administer the Plan, <I>provided,</I> that the Committee shall consist of the CFO and two or more members of the Board as the Board may designate from time to time, each of whom shall satisfy such requirements as:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">the Securities and Exchange Commission may establish for administrators acting under plans intended to qualify for exemption under Rule 16b-3 or
its successor under the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">the rules of a stock exchange on which the securities of the Company are traded as may be established pursuant to its rule-making authority of such
stock exchange; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">the Internal Revenue Service may establish for outside directors acting under plans intended to qualify for exemption under Code
Section&nbsp;162(m). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Company&#148; means AMHN, Inc., a Nevada corporation and its subsidiaries. For purposes of the Plan, any corporation or other entity in which
the Company, directly or indirectly, owns a 50% or greater interest at the time shall be deemed a subsidiary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Covered Employee&#148; shall have the meaning given that term by Code Section&nbsp;162(m) and income tax regulations promulgated thereunder.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Disability&#148; means a physical or mental medical condition that prevents the Participant from performing the duties of his or her position
with the Company and is likely to last at least twelve months or result in death, as determined by the Committee in its sole discretion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;EVA Award&#148; means the award described in Section&nbsp;11. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Exchange Act&#148; means the federal Securities Exchange Act of 1934, as amended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Fair Market Value&#148; means, with respect to the common stock of the Company, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">the closing sale price of such common stock at 4:00 p.m. (Eastern Time) on the principal United States national stock exchange on which the common
stock of the Company is traded, as determined by the Committee, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">if the common stock shall not have been traded on such date, the closing sale price on such stock exchange on the first day prior thereto on which
the common stock was so traded, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">if the common stock is not traded on a United States national stock exchange, such other amount as may be determined by the Committee by any fair
and reasonable means. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Fair Market Value determined by the Committee in good faith shall
be final, binding and conclusive on all parties. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Incentive Stock Option&#148; means an option to purchase the stock of the Company as described in Code Section&nbsp;422.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;LTIPA&#148; means an agreement establishing the terms and conditions for an Award granted under the Plan, including any applicable
performance goals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Non-statutory Stock Option&#148; means an option to purchase the stock of the Company which is designated not to be an Incentive Stock
Option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Participant&#148; means, subject to the provisions of Section&nbsp;11 with respect to EVA Awards, a full-time employee of the Company, or a
non-employee member of the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">
Board, a member of an advisory committee, or consultants of the operating company who meets the requirements of Section&nbsp;4(b). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Performance Stock&#148; means the award described in Section&nbsp;9. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Performance Unit&#148; means the award described in Section&nbsp;10. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Plan&#148; means this AMHN, Inc. 2009 Long Term Incentive Compensation Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(u)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Restricted Stock&#148; means the award described in Section&nbsp;8. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Restricted Stock Unit&#148; means the award described in Section&nbsp;8, denominated in units, providing a Participant the right to receive
payment at a future date after the lapse of restrictions or achievement of performance criteria or other conditions determined by the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(w)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Service&#148; means that the Participant&#146;s service with the Company, whether as an employee, adviser, consultant or member of the Board,
is not interrupted or terminated. The Participant&#146;s Service shall not be deemed to have been interrupted or terminated merely because of a change in the capacity in which the Participant renders service to the Company as an employee, adviser,
consultant or member of the Board or a change in the entity for which the Participant renders such service, provided, that there otherwise is no interruption or termination of the Participant&#146;s Service. For example, a change in status from an
employee of the Company to a consultant of an affiliate or a member of the Board will not constitute an interruption of Service. The Committee, in its sole discretion, may determine whether Service shall be considered interrupted in the case of any
leave of absence approved by the Company, including sick leave, military leave or any other personal leave. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Stock Appreciation Right&#148; or &#147;SAR&#148; means the award described in Section&nbsp;7. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Stock Option&#148; means the award described in Section&nbsp;6, which may be either an Incentive Stock Option or a Non-statutory Stock
Option, as determined by the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Ten Percent Shareholder&#148; means a person who owns (or is deemed to own pursuant to Code Section&nbsp;424(d)) stock possessing more than
ten percent (10%)&nbsp;of the total combined voting power of all classes of stock of the Company (as defined in Code Section&nbsp;424). </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>POWERS AND ADMINISTRATION</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan shall be administered by the Committee. The Committee shall have the authority to construe and interpret the Plan and any Awards
granted thereunder, to establish and amend rules for Plan administration, to change the terms and conditions of options and other Awards at or after grant, and to make all other determinations which it deems necessary or advisable for the
administration of the Plan. The determinations of the Committee shall be made in accordance with its judgment as to the best interests of the Company and its stockholders and in accordance with the purposes of the Plan. The Committee may take action
by a meeting in which a quorum of the Committee is present. The meeting may be in person, by telephone or in such other manner in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
which the members of the Committee participating in the meeting may communicate directly with each other. A majority of the members of the Committee shall constitute a quorum, and all
determinations of the Committee shall be made by a majority of its members. Any determination of the Committee under the Plan may be made without notice or meeting of the Committee, in writing signed by all the Committee members. The Committee shall
have the authority to reduce (but not increase) the payouts on such Awards and the Committee shall have the authority to limit (but not waive) the actual performance-based vesting of such Awards, in both cases in its sole discretion. The Committee
may prescribe rules and procedures for the administration of the Plan and shall have the authority to delegate ministerial duties to agents for the Committee (and allocate responsibilities among the agents appointed by the Committee for the
performance of the ministerial duties) in the administration of the Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>ELIGIBILITY AND PARTICIPATION</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Eligibility</U></B>. Only employees of the Company, members of the Board, and members of advisory committees of the Company or consultants
thereto, who are designated by the Plan or selected by the Committee to participate in the Plan shall be eligible to participate in the Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Participation</U></B>. Each year the CEO shall present to the Committee a list of employees of the Company that the CEO recommends be
designated as Participants for an upcoming Performance Period (or a concurrent Performance Period with respect to a newly hired employee of the Company), proposed Awards to such employees, and proposed terms for the LTIPAs for the proposed Awards to
such employees. In addition, the CEO may present recommended amendments to any existing LTIPAs and the proposed Phase Level advancement for existing LTIPAs with respect to EVA Awards. The Committee shall consider the CEO&#146;s recommendations and
shall determine the Awards, if any, to be granted and the terms of the LTIPAs for such Awards, any amendments to existing LTIPAs (subject to the restrictions on the authority granted to the Committee in Section&nbsp;3), and Phase Level advancements.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Designation of an employee as a Participant for any Performance Period shall not require the Committee
to designate that person to be a Participant or to receive an Award in any Performance Period or to receive the same type or amount of Award as granted to the Participant in such year. Grants of Awards to Participants need not be of the same type or
amount and may have different terms. Employment with the Company prior to completion of or during a Performance Period, or service on the Board or as a member of an advisory committee of the Company and its subsidiaries or consultants thereto, does
not entitle the employee, director, consultant or adviser to participate in the Plan or vest in any interest in any Award under the Plan. The Committee shall consider all factors that it deems relevant in selecting Participants and in determining
the type and amount of their respective Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>AWARDS AVAILABLE</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Types of Awards</U></B>. The Awards available under the Plan shall consist of Stock Options, Stock Appreciation Rights, Restricted Stock,
Restricted Stock Units, Performance Stock, Performance Units, EVA Awards, and other stock or cash awards, as described below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Shares Available under the Plan</U>.</B> There is hereby reserved for issuance under the Plan an aggregate of Twenty-five Million
(25,000,000)&nbsp;shares of the Company&#146;s common stock. All shares issued under the Plan may be either authorized and unissued shares or issued shares reacquired by the Company. Shares covered by an Award granted under the Plan shall not be
counted as used unless and until they are actually issued and delivered to a Participant. Any shares covered by an SAR shall be counted as used only to the extent shares are actually issued to the Participant upon exercise of the right. In addition,
any shares of common stock exchanged by an optionee as full or partial payment to the Company of the exercise price under any Stock Option exercised under the Plan, any shares retained by the Company pursuant to a Participant&#146;s tax withholding
election, and any shares covered by a Award which is settled in cash shall be added to the shares available for Awards under the Plan. All of the available shares may, but need not be issued pursuant to the exercise of Incentive Stock Options.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Annual Limit on Total Grants of Restricted Stock, Restricted Stock Units and Performance Stock</U></B>. Notwithstanding anything else in this
Section&nbsp;5, the Restricted Stock, Restricted Stock Units and Performance Shares granted under the Plan in any one calendar year shall have annual limits to be determined by the Committee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Reversion of Shares</U></B>. If there is a lapse, expiration, termination or cancellation of any Stock Option issued under the Plan prior to
the issuance of shares thereunder or if shares of common stock are issued under the Plan and thereafter are reacquired by the Company, the shares subject to those options and the reacquired shares shall be added to the shares available for Awards
under the Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Limits on Individual Grants</U></B>. Under the Plan, no Participant may receive in any calendar year: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Stock Options relating to more than 300,000 shares, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Restricted Stock or Restricted Stock Units that are subject to the attainment of Performance Goals below hereof relating to more than 250,000
shares, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Stock Appreciation Rights relating to more than 250,000 shares, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Performance Stock relating to more than 500,000 shares, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">A cash payment under a single Performance Unit Award, a single EVA Award, or other cash bonus exceeding $100,000. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Adjustments</U></B>. The shares reserved for issuance and the limitations set forth above shall be subject to adjustment in accordance with
Sections 16 and 17 hereof. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>STOCK OPTIONS</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Grant of Stock Options</U></B>. Stock Options may be granted to Participants by the Committee at any time as determined by the Committee.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Terms of Stock Options</U></B>. The Committee shall determine the terms and conditions of each Stock Option, the number of shares subject to
the Stock Option, and whether the Stock Option is an Incentive Stock Option or a Non-statutory Stock Option. The option price for each Stock Option shall be determined by the Committee but shall not be less than 100% of the Fair Market Value of the
Company&#146;s common stock on the date the Stock Option is granted. Notwithstanding the foregoing, a Stock Option may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an
assumption or substitution for another option in a manner satisfying the provisions of Code Section&nbsp;424(a). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Term of Stock Options</U></B>. Each Stock Option shall expire at such time as the Committee shall determine at the time of grant.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Exercisability of Stock Options.</U></B> Each Stock Option shall be exercisable at such time and subject to such terms and conditions as the
Committee shall determine; provided, however, that no Stock Option shall be exercisable later than the tenth anniversary of its grant. The option price, upon exercise of any Stock Option, shall be payable to the Company in full by (i)&nbsp;cash
payment or its equivalent, (ii)&nbsp;tendering previously acquired shares (held for at least six months to the extent necessary to avoid any variable accounting on such option) or purchased on the open market and having a Fair Market Value at the
time of exercise equal to the option price, or certification of ownership of such previously-acquired shares, (iii)&nbsp;delivery of a properly executed exercise notice, together with irrevocable instructions to a broker to promptly deliver to the
Company the amount of sale proceeds from the option shares or loan proceeds to pay the exercise price and any withholding taxes due to the Company, and (iv)&nbsp;such other methods of payment as the Committee, at its discretion, deems appropriate,
provided, that payment of the Common Stock&#146;s par value shall not be made by deferred payment. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise provided in a LTIPA, in the event the Service of a Participant holding a Stock Option terminates (other
than upon the Participant&#146;s death or Disability), the Participant may exercise his or her Stock Option (to the extent that the Participant was entitled to exercise such Stock Option as of the date of termination) but only within such period of
time ending on the earlier of (i)&nbsp;the date three (3)&nbsp;months following the termination of the Participant&#146;s Service (or such longer or shorter period specified in the LTIPA for such Stock Option), or (ii)&nbsp;the expiration of the
term of the Stock Option as set forth in the LTIPA. If, after termination, the Participant does not exercise his or her Option </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
within the time specified in the LTIPA, the Stock Option shall thereafter terminate. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Vesting</U></B>. Subject to the provisions of Sections 5(f), 16 and 24, the total number of shares of Common Stock subject to a Stock Option
shall be subject to the following vesting provisions of this Subsection 6(e): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The total number of shares of Common Stock subject to a Stock Option may, but need not, vest and therefore become exercisable in periodic
installments that may, but need not, be equal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Stock Option may be subject to such other terms and conditions on the time or times when it may be exercised (which may be based on performance
or other criteria) as the Committee may deem appropriate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The vesting provisions of individual Stock Options may vary. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The provisions of this Subsection 6(e) are subject to any Stock Option provisions governing the minimum number of shares of Common Stock as to
which a Stock Option may be exercised. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Incentive Stock Option Requirements</U></B>. Stock Options granted under the Plan as Incentive Stock Options shall have such terms as
required by Code Sections 422 for an Incentive Stock Option, including, but not limited to, the following terms in this Section&nbsp;6(f). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Incentive Stock Options shall be granted only to employees of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%)&nbsp;of the Fair Market Value of the Common
Stock subject to the Option on the date the Option is granted or one hundred ten percent (110%)&nbsp;in the case of a grant of an Incentive Stock Option to a Ten Percent Shareholder. Notwithstanding the foregoing, an Incentive Stock Option may be
granted with an exercise price lower than that set forth in the preceding sentence if such option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Code Section&nbsp;424(a).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The maximum term of an Incentive Stock Option shall be ten years from the date of grant provided that the maximum term of an Incentive Stock Option
granted to a Ten Percent Shareholder shall be five years from the date of grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options
are exercisable for the first time by any Participant during any calendar year (under all plans of the Company and its affiliated corporations) exceeds one hundred thousand dollars ($100,000), the Stock Options or portions thereof which exceed such
limit (according to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">
the order in which they were granted) shall be treated as Non-statutory Stock Options. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">If any Participant shall make any disposition of shares issued pursuant to the exercise of an Incentive Stock Option under the circumstances
described in Code Section&nbsp;421(b) (relating to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10)&nbsp;calendar days thereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Reduction in Price or Reissuance</U>.</B> In no event shall the Committee, without first receiving shareholder approval, (a)&nbsp;cancel any
outstanding Stock Option for the purpose of reissuing the Stock Option to the Participant at a lower exercise price, or (b)&nbsp;reduce the exercise price of a previously issued Stock Option. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>STOCK APPRECIATION RIGHTS</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Stock Appreciation Rights may be granted to Participants at any time as determined by the Committee. An SAR may be granted in tandem with a Stock
Option granted under the Plan or on a free-standing basis. The Committee also may, in its discretion, substitute SARs which can be settled only in stock for outstanding Stock Options, at any time when the Company is subject to fair value accounting.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The grant price of a tandem or substitute SAR shall be equal to the option price of the related option. The grant price of a free-standing SAR
shall be equal to the Fair Market Value of the Company&#146;s Common Stock on the date of its grant. An SAR may be exercised upon such terms and conditions and for the term as the Committee in its sole discretion determines to apply to the SAR;
<I>provided, however</I>, that the term of the SAR shall not exceed the option term in the case of a tandem or substitute SAR or ten years in the case of a free-standing SAR, and the terms and conditions applicable to a substitute SAR shall be
substantially the same as those applicable to the Stock Option which it replaces. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Upon exercise of an SAR, the Participant shall be entitled to receive payment from the Company in an amount determined by multiplying the excess of
the Fair Market Value of a share of Common Stock of the Company on the date of exercise over the grant price of the SAR by the number of shares with respect to which the SAR is exercised. The payment may be made in cash or stock, at the discretion
of the Committee, except in the case of a substitute SAR which may be made only in stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In no event shall the Committee, without first receiving shareholder approval, (1)&nbsp;cancel any outstanding SAR for the purpose of reissuing the
SAR to the Participant at a lower exercise price, or (2)&nbsp;reduce the exercise price of a previously issued SAR. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>RESTRICTED STOCK AND RESTRICTED STOCK UNITS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Restricted Stock and Restricted Stock Units may be awarded or sold to Participants under such terms and conditions as shall be established by
the Committee. Restricted Stock and Restricted Stock Units shall be subject to such restrictions as the Committee determines, including, without limitation, any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">a prohibition against sale, assignment, transfer, pledge, hypothecation or other encumbrance for a specified period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">a requirement that the holder forfeit (or in the case of shares or units sold to the Participant resell to the Company at cost) such shares or
units in the event of termination of employment or other service during the period of restriction; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">with respect to Restricted Stock, the Award may be conditioned upon the Participant making or not making an election under Code Section&nbsp;83(b).
If the Participant makes an election pursuant to Code Section&nbsp;83(b), the Participant shall be required to file a copy of the election with the Company within ten (10)&nbsp;calendar days. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All restrictions shall expire at such times as the Committee shall specify. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except for the restrictions set forth herein and unless otherwise determined by the Committee, the Participant shall have all the rights of a
shareholder with respect to shares of Restricted Stock, including but not limited to the right to vote and the right to receive dividends, provided that the Committee, in its sole discretion, may require that any dividends paid on shares of
Restricted Stock be held in escrow until all restrictions on the shares have lapsed. With respect to Restricted Stock Units, a Participant shall have no rights of a shareholder until restrictions lapse and underlying shares, if any, are delivered;
however, the Committee may provide for the payment of dividend equivalents if so specified in the LTIPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payment of Restricted Stock
Units may be made in cash, stock, or a combination of cash and stock, in the Committee&#146;s sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the extent a Restricted
Stock Unit Award constitutes &#147;deferred compensation&#148; within the meaning of Code Section&nbsp;409A, the Committee shall establish LTIPA terms and provisions that comply with Code Section&nbsp;409A and regulations thereunder. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>PERFORMANCE STOCK</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee shall designate the Participants to whom long-term performance stock (&#147;Performance Stock&#148;) is to be awarded and
determine the number of shares, the length of the performance period and the other terms and conditions of each such award; provided the stated performance period will not be less than twelve (12)&nbsp;months. Each award of Performance Stock shall
entitle the Participant to a payment in the form of shares of Common Stock of the Company upon the attainment of performance goals and other terms and conditions specified by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding satisfaction of any performance goals, the number of shares issued under a Performance Stock Award may be adjusted by the
Committee on the basis of such further consideration as the Committee in its sole discretion shall determine. However, the Committee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
may not, in any event, increase the number of shares earned upon satisfaction of any performance goal by any Participant who is a Covered Employee. The Committee may, in its discretion, make a
cash payment equal to the Fair Market Value of shares of Common Stock otherwise required to be issued to a Participant pursuant to a Performance Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the extent a Performance Stock Award constitutes &#147;deferred compensation&#148; within the meaning of Code Section&nbsp;409A, the
Committee shall establish LTIPA terms and provisions that comply with Code Section&nbsp;409A and regulations thereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>PERFORMANCE UNITS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee shall designate the Participants to whom long-term performance units (&#147;Performance Units&#148;) are to be awarded and
determine the number of units and the terms and conditions of each such award; provided the stated performance period will not be less than twelve (12)&nbsp;months. Each Performance Unit award shall entitle the Participant to a payment in cash upon
the attainment of performance goals and other terms and conditions specified by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the satisfaction of any
performance goals, the amount to be paid under a Performance Unit Award may be adjusted by the Committee on the basis of such further consideration as the Committee in its sole discretion shall determine. However, the Committee may not, in any
event, increase the amount earned under Performance Unit Awards upon satisfaction of any performance goal by any Participant who is a Covered Employee and the maximum amount earned by a Covered Employee in any calendar year may not exceed $250,000.
The Committee may, in its discretion, substitute actual shares of Common Stock for the cash payment otherwise required to be made to a Participant pursuant to a Performance Unit Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the extent a Performance Unit Award constitutes &#147;deferred compensation&#148; within the meaning of Code Section&nbsp;409A, the
Committee shall establish LTIPA terms and provisions that comply with Code Section&nbsp;409A and regulations thereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>EVA AWARDS</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Definitions</U></B>. The following terms shall have the meanings given them below in this Section&nbsp;11 for purposes of the EVA Awards
granted under the Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Adjusted Basic Award&#148; means the Basic Award adjusted by the percentage completion of a Target Goal. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Annual Review&#148; means the annual review by the Committee of each LTIPA entered into under the Plan. The review will determine the Phase
Level attainment by the Participant, any proposed changes to the LTIPA, evaluate the Participant&#146;s performance during the Performance Period and provides the basis for the Committee&#146;s determination of an individual Award.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Basic Award&#148; means that monetary value set forth in the LTIPA that could form the basis of the Award that may be achieved upon full
attainment of the Target Goal. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;EVA&#148; means the net operating profit after taxes, as adjusted to eliminate the effect of non-economic elements of generally accepted
accounting principles (&#147;NOPAT&#148;), less the weighted average cost of capital employed during the year (&#147;Employed Capital&#148;). The Committee shall have the discretion to adjust NOPAT to include or exclude: (i)&nbsp;extraordinary,
unusual and/or non-recurring items of gain or loss, (ii)&nbsp;gains or losses on the disposition of a business, (iii)&nbsp;changes in tax or accounting regulations or laws, or (iv)&nbsp;the effect of a merger or acquisition, as identified in the
Company&#146;s quarterly and annual earnings releases. In all other respects, Performance Criteria shall be calculated in accordance with the Company&#146;s financial statements, generally accepted accounting principles, or under a methodology
established by the Committee prior to the issuance of an Award that is consistently applied and identified in the audited financial statements, including footnotes, or the Management Discussion and Analysis section of the Company&#146;s annual
report. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;EVA Unit&#148; means the designated unit of EVA identified in the LTIPA. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Payment Cycle&#148; shall mean that period of time over which an Award, if earned, may be paid. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Phase Level&#148; means the level of attainment achieved during a Performance Period towards accomplishment of a Target Goal. The Phase Level
shall be determined annually by the Committee based on recommendations from the CEO and is a factor in determining the Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Performance Period&#148; means a period of time designated in the LTIPA during which performance under the Plan will be measured and may be a
period of at least one year and up to ten years in length and which may overlap, provided that no two Performance Periods under the Plan of equal length shall coincide. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">&#147;Target Goal&#148; means the EVA objective set forth in the LTIPA. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Eligibility and Participation</U></B>. Only the following employees of the Company shall be eligible for an EVA Award. Employees employed by
the Company on the last day of the Performance Period, who: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">are specifically designated as Participants in the Plan by the Committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">have been designated to be eligible to receive an EVA Award by the Committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">have executed an LTIPA which is executed by the CEO (or, with respect to the LTIPA of the CEO, a non-employee member of the Committee);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">have achieved relevant LTIPA performance criteria; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">have participated in Annual Reviews of the LTIPA during the Performance Period. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>EVA Award</U></B>. The EVA Award is the Adjusted Basic Award multiplied by the Phase Level attained by the Participant and a factor the
numerator of which is the average of the closing price of the Common Stock of the Company (on the principal stock exchange on which the Company&#146;s Common Stock is traded, as determined by the Company) for the six months preceding the last day of
a Performance Period and the denominator is the average closing price of the Common Stock of the Company (on the principal stock exchange on which the Company&#146;s Common Stock is traded, as determined by the Committee) for the six months
preceding the execution of a Participant&#146;s LTIPA (&#147;Beginning Stock Price&#148;). The factor so determined shall not be less than one. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Adjusted Basic Award shall be determined based on the EVA Unit&#146;s and the Participant&#146;s achievement of the Target
Goal. At an achievement level of 49.99%, the Adjusted Basic Award is 0% of the Basic Award. The Adjusted Basic Award is the percent of the Target Goal achieved (at 50% or higher) multiplied by the Basic Award, not to exceed 100% of the Basic Award.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">A Participant&#146;s potential Award shall be earned after the last day of a Performance Period and upon the final approval of the Committee of the
Award. Portions of the Award are subject to forfeiture during the Payment Cycle as provided in Section&nbsp;11(d). The Participant shall have no interest in the Award until the final approval of the Committee of the Award. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The actual Award granted to a Participant hereunder shall be based upon the Company&#146;s overall performance, the EVA Unit&#146;s overall
performance and the Participant&#146;s individual performance and shall be determined by the Committee, in its sole discretion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">No Award will be granted if a Participant&#146;s individual performance is unsatisfactory, as determined by the Committee in its sole discretion,
upon the advice of the CEO. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Form and Time of Payment of EVA Award</U></B>. The form of payment shall be in stock or cash at the sole discretion of the Committee. The
amounts paid under an Award shall be paid to the Participant less applicable federal, state, local income and employment taxes, during the Payment Cycle after the date on which the Award has been approved by Committee (but in no event later than
March&nbsp;15th of the year following the year in which the Award is earned). If the Award is paid in stock, then sufficient shares shall be withheld to meet withholding obligations unless other arrangements have been made by the Participant. The
shares to be delivered in payment (including any Deferred Award Payments as provided below) shall be valued at the average price for the five (5)&nbsp;trading days prior to the date of payment to the Participant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Committee shall have the authority to approve, reduce or eliminate any potential EVA Award and portions thereof. The Payment Cycle shall
commence on the date that an EVA Award is approved by the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">
Committee and shall extend for twenty-four (24)&nbsp;months after the end of the Performance Period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">As provided in the LTIPA for the EVA Award, the Committee shall determine in its discretion what portion, if any, of one-half of the potential EVA
Award shall be paid initially to a Participant (&#147;Initial Award Payment&#148;). The amount of the Initial Award Payment to be paid shall be paid as soon as administratively practicable after approval by the Committee of the EVA Award (but in no
event later than March&nbsp;15th of the year following the year in which the EVA Award is earned). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Committee shall determine in its discretion what portion of the remaining half of the potential EVA Award shall be paid to a Participant
(&#147;Deferred Award Payment&#148;). Except as otherwise provided in the LTIPA for the EVA Award (as determined by the Committee in its sole discretion), Deferred Award Payments shall not be vested or earned until the conditions for payment set
forth below or in the LTIPA for the EVA Award under which the Deferred Award Payment would be paid. The amount of the Deferred Award Payment that may be paid to the Participant shall be subject to the following forfeiture provisions in this
Section&nbsp;11(d)(iii): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">One-half of the approved Deferred Award Payment shall be paid twelve (12)&nbsp;months after the end of the Performance Period and one-half of the
approved Deferred Award Payment shall be paid twenty-four (24)&nbsp;months after the end of the Performance Period subject to the following forfeiture provisions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">As provided in the Participant&#146;s LTIPA for the EVA Award, (A)&nbsp;failure of the EVA Unit to achieve the same level of the Target Goal as was
obtained during the Performance Period in the twelve (12)&nbsp;months following the Performance Period will result in forfeiture of one-half of the Deferred Award Payment, and (B)&nbsp;failure of the EVA Unit to achieve the Target Goal in the twelve
(12)&nbsp;months beginning twelve (12)&nbsp;months after the ending of the Performance Period and ending twenty-four (24)&nbsp;months after the end of the Performance Period will result in the forfeiture of one-half of the Deferred Award Payment.
Payment of a portion of the Deferred Award Payment, if applicable, shall be made as soon as administratively practicable following the end of the applicable twelve (12)&nbsp;month period (but in no event later than March&nbsp;15th of the year
following the year in which the applicable twelve (12)&nbsp;month period ends). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Among other conditions to be included in a Participant&#146;s LTIPA, the Committee may require a Participant who is eligible to receive a Deferred
Award Payment to remain in employment with the Company or its subsidiary through the payment date as a condition for such payment<B>.</B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Disability, Death and Other Terminations</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In the event of the termination of a Participant&#146;s employment due to his or her Disability or death, such Participant (or the
Participant&#146;s probate estate, in the event of his or her death) may receive payment of an EVA Award, consistent with the terms of the Plan, subject to the terms of the LTIPA for the EVA Award and at the sole discretion of the Committee. Any
such Award shall be determined and paid in accordance with the regular procedures of the Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In the event of the Participant&#146;s death, should an EVA Award be approved under Section&nbsp;11(e)(i), such EVA Award shall be paid in cash or
stock, less applicable federal, state, and local income and employment taxes, on the normal EVA Award payout date and subject to the terms of forfeiture, to the Participant&#146;s estate, or to the person or persons who have acquired, by will or by
the laws of descent and distribution or by other legal proceedings, the right to such Award, in the determination and discretion of the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In the event of the termination of a Participant&#146;s employment for reasons other than his or her Disability or death, such Participant&#146;s
right to receive an EVA Award, if any, shall be determined by the following terms in this Section&nbsp;11(e)(iii): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">If the Participant&#146;s employment is terminated during the Performance Period for the EVA Award, then the Participant shall not be eligible to
any payment under the EVA Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">If the Participant&#146;s employment is terminated following the Performance Period for the EVA Award and the Committee has approved the payment of
the EVA Award to the Participant, then the EVA Award shall be paid to the Participant subject to the conditions for the payment of the EVA Award (including the achievement of the Company&#146;s Target Goals during the two 12-month periods following
the Performance Period required for the payment of the Deferred Award Payments set forth in Section&nbsp;11(d)). Any payment made pursuant to this Subsection shall be made no later than March&nbsp;15th of the year following the year in which the EVA
Award or Deferred Award Payment is no longer subject to a substantial risk of forfeiture. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>No Reallocation of EVA Awards</U>.</B> In no event may the portion of the potential EVA Award allocated to a Participant be increased in any
way, including as a result of the reduction of any other Participant&#146;s allocated portion. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>CASH BONUS AWARDS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee may designate the employees of the Company who are eligible to receive a cash bonus payment in any calendar year based on an
incentive pool to be determined by the Committee. The Committee shall allocate an incentive pool percentage to each designated Participant for each calendar year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As soon as possible after the determination of the incentive pool for a calendar year, the
Committee shall calculate the Participant&#146;s allocated portion of the incentive pool based upon the percentage established at the beginning of the calendar year.&nbsp;The Participant&#146;s incentive award then shall be determined by the
Committee based on the Participant&#146;s allocated portion of the incentive pool subject to adjustment in the sole discretion of the Committee.&nbsp;Unless otherwise specified by the Committee in writing in compliance with Code Section&nbsp;409A,
incentive awards shall be paid no later than March&nbsp;15th of the year following the year in which the incentive award is earned.&nbsp;In no event may the portion of the incentive pool allocated to a Participant be increased in any way, including
as a result of the reduction of any other Participant&#146;s allocated portion. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>OTHER STOCK OR CASH AWARDS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the incentives described in Sections 6 through 12 above, the Committee may grant other incentives payable in cash or in Common
Stock under the Plan as it determines to be in the best interests of the Company and subject to such other terms and conditions as it deems appropriate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>PERFORMANCE GOALS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as provided with respect to EVA Awards, cash bonus Awards and awards of Restricted Stock, Restricted Stock Units, Performance Stock,
Performance Units and other incentives under the Plan may be made subject to the attainment of performance goals relating to any one or more business criteria within the meaning of Code Section&nbsp;162(m), including, but not limited to, cash flow;
cost; ratio of debt to debt plus equity; profit before tax; economic profit; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization; earnings per share; operating earnings; economic value added; ratio of
operating earnings to capital spending; free cash flow; net profit; net sales; sales growth; price of the Company&#146;s Common Stock; return on net assets, equity or stockholders&#146; equity; market share; or total return to stockholders
(&#147;Performance Criteria&#148;). Any one or more Performance Criteria may be used to measure the performance of the Company as a whole or any business unit of the Company and may be measured relative to a peer group or index. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any Performance Criteria may include or exclude Special Items. Special Items shall include (i)&nbsp;extraordinary, unusual and/or
non-recurring items of gain or loss, (ii)&nbsp;gains or losses on the disposition of a business, (iii)&nbsp;changes in tax or accounting regulations or laws, or (iv)&nbsp;the effect of a merger or acquisition, as identified in the Company&#146;s
quarterly and annual earnings releases. In all other respects, Performance Criteria shall be calculated in accordance with the Company&#146;s financial statements, generally accepted accounting principles, or under a methodology established by the
Committee prior to the issuance of an award that is consistently applied and identified in the audited financial statements, including footnotes, or the Management Discussion and Analysis section of the Company&#146;s annual report. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With respect to Awards subject to Performance Criteria, the Committee shall have the authority to reduce the payouts on such Awards and shall
have the authority to limit or waive the actual performance-based vesting of such Awards in its sole discretion. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>DEFERRAL OF PAYMENT ON AWARDS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the provisions of Code Section&nbsp;409A and any regulatory guidance promulgated thereunder, a Participant and the Company may enter
into an agreement under which the payment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of amounts payable under a vested Award shall be deferred on terms and conditions to be established by the Participant and the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>ADJUSTMENT PROVISIONS</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">If the Company shall at any time change the number of issued shares of Common Stock by stock dividend, stock split, spin-off, split-off, spin-out,
recapitalization, merger, consolidation, reorganization, combination, or exchange of shares, the total number of shares reserved for issuance under the Plan, the maximum number of shares that may be made subject to an Award or all Awards in any
calendar year, and the number of shares covered by each outstanding Award and the price therefor, if any, shall be equitably adjusted by the Committee, in its sole discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In the event of any merger, consolidation or reorganization of the Company with or into another corporation that results in the outstanding Common
Stock of the Company being converted into or exchanged for different securities, cash or other property, or any combination thereof, the Company shall have the authority to provide in the controlling agreement for such transaction (i)&nbsp;that
there shall be substituted, as determined by the Committee in its discretion, for each share of Common Stock then subject to an Award granted under the Plan, the number and kind of shares of stock, other securities, cash or other property to which
holders of Common Stock of the Company will be entitled pursuant to the transaction, (ii)&nbsp;that the acquiring or surviving corporation in the transaction shall assume the outstanding Awards under the Plan (which may be exercisable into the
securities of the acquiring or surviving corporation), (iii)&nbsp;that all unexercised Awards shall terminate immediately prior to such transaction unless exercised prior to the closing of the transaction, or (iv)&nbsp;a combination of the
foregoing. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>SUBSTITUTION AND ASSUMPTION OF AWARDS</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Without affecting the number of shares reserved or available hereunder, the Board or the Committee may authorize the issuance of Awards under
the Plan in connection with the assumption of, or substitution for, outstanding Awards previously granted to individuals who become employees of the Company as a result of any merger, consolidation, acquisition of property or stock, or
reorganization other than a Change in Control, upon such terms and conditions as the Committee may deem appropriate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>TRANSFERABILITY</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each Award granted under the Plan shall not be transferable otherwise than by will or the laws of descent and distribution and each Stock
Option and SAR shall be exercisable during the Participant&#146;s lifetime only by the Participant or, in the event of Disability, by the Participant&#146;s personal representative. In the event of the death of a Participant, exercise of any Award
or payment with respect to any Award shall be made only by or to the executor or administrator of the estate of the deceased Participant or the person or persons to whom the deceased Participant&#146;s rights under the Award shall pass by will or
the laws of descent and distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>TAXES</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company shall be entitled to withhold the amount of any tax attributable to any amounts payable or shares deliverable under the Plan, after
giving the person entitled to receive such payment or delivery notice and the Company may defer making payment or delivery as to any award, if any such tax is payable until indemnified to its satisfaction. A Participant may pay all or a portion of
any required withholding taxes arising in connection with the exercise of a Stock Option or SAR or the receipt or vesting of shares hereunder by electing to have the Company withhold shares of Common Stock, having a fair market value equal to the
amount required to be withheld. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>OTHER PROVISIONS</U></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The grant of any Award under the Plan may also be subject to other provisions (whether or not applicable to the Award awarded to any other
Participant) as the Committee determines appropriate, including provisions intended to comply with federal or state securities laws and stock exchange requirements, understandings or conditions as to the Participant&#146;s employment or other
service, requirements or inducements for continued ownership of Common Stock after exercise or vesting of Awards, forfeiture of awards in the event of termination of employment or other service shortly after exercise or vesting, or breach of
non-solicitation, non-disparagement, non-competition or confidentiality agreements following termination of employment or other service, or provisions permitting the deferral of the receipt of a Award for such period and upon such terms as the
Committee shall determine. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">In the event any Award under the Plan is granted to an employee, member of the Board, or adviser who is employed or providing services outside the
United States and who is not compensated from a payroll maintained in the United States, the Committee may, in its sole discretion, modify the provisions of the Plan or adopt appendices and/or sub-plans as they pertain to such individuals as may be
necessary or desirable to comply with applicable law, regulation or accounting rules to assure the viability of the benefits from Awards granted to such individuals and to meet the objective of the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Committee, in its sole discretion, may permit or require a Participant to have amounts or shares of Common Stock that otherwise would be paid
or delivered to the Participant as a result of the exercise or settlement of an award under the Plan credited to a deferred compensation or stock unit account established for the Participant by the Committee on the Company&#146;s books of account.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">As a condition for the receipt of stock Awards under the Plan, a Participant shall agree to be bound by the employment policies of the Company (or
other applicable policies) pertaining to the securities of the Company, including, but not limited to, the insider trading restrictions of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>NO RESERVE OR TRUST</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nothing contained in the Plan shall require the Company to segregate any monies from its general funds, or to create any trust or make any
special deposit in respect of any amounts payable under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Plan to or for any Participant or group of Participants. All amounts payable under the Plan shall be paid out of the general funds of the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>NO RIGHT TO ASSIGN</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No right or interest of any Participant in the Plan or in any unpaid Award shall be assignable or transferable in whole or in part, either
voluntarily or by operation of law or otherwise, or be subject to payment of debts of any Participant by execution, levy, garnishment, attachment, pledge, bankruptcy or in any other manner. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>NO EMPLOYMENT OR SIMILAR RIGHTS CONFERRED</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nothing contained in the Plan or any Award shall confer upon any employee, director or adviser any right with respect to continuation of
employment or other service with the Company in any capacity or interfere in any way with the right of the Company to terminate an employee&#146;s employment or a director&#146;s or adviser&#146;s service at any time or guarantee any right of
participation in any other employee benefit or compensation plan of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>SUCCESSORS AND MERGERS, CONSOLIDATIONS OR CHANGE IN CONTROL</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The terms and conditions of the Plan shall inure to the benefit of and bind the Company, the Participants, their successors, assignees, and
personal representatives. If a Change of Control occurs, then the Plan shall immediately terminate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise provided in an
LTIPA, upon a Change in Control of the Company, the Committee, in its sole discretion, may (but shall not be required to) make all outstanding Stock Options and SARs fully vested and exercisable, all restrictions on Restricted Stock and Restricted
Stock Units terminated, all performance goals deemed achieved at target levels and all other terms and conditions met, and deliver all Performance Stock, and pay out all Performance Units and Restricted Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee shall in its sole discretion determine the status of achievement of a particular Target Goal and shall specify an Adjusted Basic
Award based upon its determination of achievement of the performance goals under the Awards as of the Change in Control (&#147;Change in Control Award&#148;). A Change in Control Award shall be modified as outlined below and shall be paid 30 days
after the consummation of the Change in Control. Any Deferred Award payments outstanding upon a Change in Control shall be paid within 30&nbsp;days after the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of a Change in Control, all EVA Awards or cash Awards shall be paid on a pro-rated basis (as determined by the Committee) based
on the portion of the Performance Goals achieved under the EVA Awards or cash Awards as of the date of the Change in Control, subject to the discretion of the Committee to reduce the EVA Awards. Pro-rated EVA Awards or cash Awards shall be paid
within 30 days after the Change in Control. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>GOVERNING STATE LAW AND COMPLIANCE WITH SECURITIES LAWS</U></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Plan and any actions taken in connection herewith shall be governed by and construed in accordance with the laws of the state of Nevada
(without regard to applicable Nevada principles of conflict of laws). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to
grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; provided, however, that this undertaking shall not require the Company to register under the Securities Act the Plan, any stock Award or any Common
Stock issued or issuable pursuant to any such stock Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance
and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such stock Awards unless and until such authority is obtained. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>DURATION, AMENDMENT AND TERMINATION</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board or the Committee may amend, suspend, terminate or reinstate the Plan from time to time or terminate the Plan at any time. However, no
such action shall reduce the amount of any existing Award (subject to the reservation of the authority of the Committee to reduce payments on Awards) or change the terms and conditions thereof without the Participant&#146;s consent. No amendment of
the Plan shall be made without stockholder approval to the extent stockholder approval is expressly required under applicable rules and regulations of the Securities and Exchange Commission, the applicable rules of a stock exchange on which the
securities of the Company are traded as may be established pursuant to its rule-making authority of such stock exchange, and the rules and regulations of the Internal Revenue Service for plans intended to qualify for the performance-based exemption
under Code Section&nbsp;162(m). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither the Board nor the Committee may cancel an Award once the Award has been granted by the Committee,
including any Deferred Award Payments. Each year on the anniversary of the LTIPAs, the CEO shall present to the Committee any recommendations for changes in the Plan or in the LTIPAs previously approved by the Committee (subject to the restrictions
on the grant of authority to the Committee in Section&nbsp;3). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>SHORT-TERM DEFERRAL; DEFERRED COMPENSATION</U></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Short-Term Deferral</U></B>. To the extend an Award constitutes nonqualified deferred compensation subject to Code Section&nbsp;409A and it
has not been designed to comply with Code Section&nbsp;409A, in order to be exempt from Code Section&nbsp;409A pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(4), payment of the Award shall be made no later than the later of (i)&nbsp;the
date that is 2 <SUP STYLE="vertical-align:top">&nbsp;1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">2</SUB> months from the end of the Participant&#146;s first taxable year in which the amount is no longer subject to a substantial risk of
forfeiture, or (ii)&nbsp;the date that is 2 <SUP STYLE="vertical-align:top">&nbsp;1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">2</SUB> months from the end of the Company&#146;s first taxable year in which the amount is no longer subject to a
substantial risk of forfeiture. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>Deferred Compensation</U>.</B> Notwithstanding any provision in the Plan or any LTIPA to the contrary, to the extent an Award
(i)&nbsp;constitutes &#147;deferred compensation&#148; within the meaning of Code Section&nbsp;409A, (ii)&nbsp;is not exempt from the application of Code Section&nbsp;409A and (iii)&nbsp;is payable to a specified employee (as determined in
accordance with Code Section&nbsp;409A(a)(2)(B) and applicable regulations) due to separation from service (as such term is defined under Code Section&nbsp;409A), payment shall be delayed for a minimum of six (6)&nbsp;months from the date of such
separation from service. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any Award granted under the Plan is considered deferred compensation as
defined under Code Section&nbsp;409A, and if the Plan or the terms of an Award fail to meet the requirements of Code Section&nbsp;409A with respect to such Award, then such Award shall remain in effect and be subject to taxation in accordance with
Code Section&nbsp;409A. In this circumstance, the Committee may accelerate distribution or settlement of an Award in accordance with Code Section&nbsp;409A. The Company shall have no liability for any tax imposed on a Participant under Code
Section&nbsp;409A, and if any tax is imposed on a Participant, the Participant shall have no recourse against the Company for payment of any such tax. Notwithstanding the foregoing, if any modification of an Award causes the Award to be deferred
compensation under Code Section&nbsp;409A, the Committee may rescind such modification in accordance with Code Section&nbsp;409A. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>SECTION 162(m)</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan is designed and intended, and all provisions shall be construed in a manner, to comply, to the extent applicable, with Code
Section&nbsp;162(m) and the regulations thereunder. To the extent permitted by Code Section&nbsp;162(m), the Committee shall have sole discretion to reduce, eliminate or defer payment of the amount of any Award which might otherwise become payable
upon meeting Performance Criteria. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>SEVERABILITY</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any provision of the Plan is held to be invalid or unenforceable, the other provisions of the Plan shall not be affected. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B><U>EFFECTIVE DATE AND TERM OF THE PLAN</U></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan shall continue for a term of ten (10)&nbsp;years from the date of its adoption. The Plan was originally adopted by the Company&#146;s
Board of Directors on September&nbsp;25, 2009, subject to stockholder approval. On March&nbsp;28, 2010, the Company&#146;s Board of Directors and a majority of its stockholders approved a revision to the Plan to increase the number of available
shares to 1,500,000 shares. On July&nbsp;18, 2011, pursuant to an Agreement and Plan of Merger between the Company and VitaMedMD, LLC, the Company&#146;s Board of Directors and a majority of its stockholders approved a revision to the Plan to
increase the number of available shares to 25&nbsp;million shares. The effective date of the revision will be August&nbsp;29, 2011. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g611784g24k38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g611784g24k38.jpg
M_]C_X``02D9)1@`!`@$!+`$L``#_X04T17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```$L````
M`0```2P````!061O8F4@4&AO=&]S:&]P(#<N,``R,#$S.C$P.C$T(#$Y.C$U
M.C(T``````.@`0`#`````0`!``"@`@`$`````0```%R@`P`$`````0```NT`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```$!@````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``?_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(`(``$`,!(@`"$0$#$0'_W0`$``'_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`/2`YI<U[BTOAIDM<3.T?N^U6V;]OOC=WCA5&[B&@'D-
M`'JEIX;^9M5JNL,)(<YT_O$G[DE/_]#TJMMA:V-X$-AP#(^B.-WNVJTT$``F
M2!J?%5&M86`EK9V-!)J<XQ`Y>/I_11V48XVN96UIY!VP4E/_T?2&N$-`<W<&
MMT-KF]@[5C?:U6JWE[9,<Q[3(_(%7I<06DO<&!K9:2S9JUO_`%U6@01(,CQ"
M2G__TO2&MEH]HDM8`XU%W9O+Y]ZL5.:`&!I;`_=VCY*K``'&H9,N>/S6]F>U
M6*[+K-6EFT&':.GSY24__]/TECQ#`YY8T-:2=[0!#6GZ)]RM-<UPEI#@-#!G
M55:VEP:V'`%K==K2WZ+?SC[E9K8YI,NW`]H`_(DI_]3T<!A:TNV_1;,L<3]$
M?G-*LT.<X&2"T:"&ENHY^D@5O#=FHW`,`!M(!EO^C5EEU-AACVO/@T@_D24_
M_]7TNOU/3;'J1M;&WTXX'T=_N1VN).K"WS,?]]*H6N8WTY?6PFMI(>T&3Q]+
M:Y&QX!`%[`)_FV!HD^#FQNW>U)3_`/_6]%L9:[TBQUC1Z;9#-T<?R7;=RL5$
MC;-KM(EA;_T9<W?_`-)5[*2\U'W`>FT$AI/;R:4:H7S#+3M:/HN80/DYVW_J
MDE/_V?_M">A0:&]T;W-H;W`@,RXP`#A"24T$)0``````$```````````````
M```````X0DE-`^T``````!`!+`````$``0$L`````0`!.$))300F```````.
M`````````````#^````X0DE-!`T```````0````>.$))3009```````$````
M'CA"24T#\P``````"0```````````0`X0DE-!`H```````$``#A"24TG$```
M````"@`!``````````$X0DE-`_4``````$@`+V9F``$`;&9F``8```````$`
M+V9F``$`H9F:``8```````$`,@````$`6@````8```````$`-0````$`+0``
M``8```````$X0DE-`_@``````'```/____________________________\#
MZ`````#_____________________________`^@`````________________
M_____________P/H`````/____________________________\#Z```.$))
M300(```````0`````0```D````)``````#A"24T$'@``````!``````X0DE-
M!!H``````V$````&``````````````+M````7````!8`,0`Q`#$`-P`X`#0`
M(`!%`%@`(`!,`&4`9P!A`&P`7P!0`&$`9P!E`%\`,0````$`````````````
M`````````````0``````````````7````NT``````````````````````0``
M```````````````````````0`````0```````&YU;&P````"````!F)O=6YD
M<T]B:F,````!````````4F-T,0````0`````5&]P(&QO;F<``````````$QE
M9G1L;VYG``````````!"=&]M;&]N9P```NT`````4F=H=&QO;F<```!<````
M!G-L:6-E<U9L3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI
M8V5)1&QO;F<`````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M
M````#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M
M````"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0``````
M`%)C=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````
M0G1O;6QO;F<```+M`````%)G:'1L;VYG````7`````-U<FQ415A4`````0``
M`````&YU;&Q415A4`````0```````$US9V5415A4`````0``````!F%L=%1A
M9U1%6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X
M=%1%6%0````!```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI
M9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!
M;&EG;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"
M1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE
M9G1/=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR
M:6=H=$]U='-E=&QO;F<``````#A"24T$$0```````0$`.$))3004```````$
M`````3A"24T$#``````$(@````$````0````@````#```!@````$!@`8``'_
MV/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2`
M`````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04
M#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,_\``$0@`@``0`P$B``(1`0,1`?_=``0``?_$`3\```$%`0$!`0$!````
M``````,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+
M$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52
MP6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S
M1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("
M`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A
M<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%
MM)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1
M`#\`](#FES7N+2^&F2UQ,[1^[[5;9OV^^-W>.%4;N(:`>0T`>J6GAOYFU6JZ
MPPDASG3^\2?N24__T/2JVV%K8W@0V'`,CZ(XW>[:K300`"9(&I\54:UA8"6M
MG8T$FISC$#EX^G]%'91CC:YE;6GD';!24__1](:X0T!S=P:W0VN;V#M6-]K5
M:K>7MDQS'M,C\@5>EQ!:2]P8&MEI+-FK6_\`75:!!$@R/$)*?__2](:V6CVB
M2U@#C47=F\OGWJQ4YH`8&EL#]W:/DJL``<:ADRYX_-;V9[58KLNLU:6;08=H
MZ?/E)3__T_26/$,#GEC0UI)WM`$-:?HGW*TUS7"6D.`T,&=55K:7!K8<`6MU
MVM+?HM_./N5FMCFDR[<#V@#\B2G_U/1P&%K2[;]%LRQQ/T1^<TJS0YS@9(+1
MH(:6ZCGZ2!6\-V:C<`P`&T@&6_Z-6674V&&/:\^#2#^1)3__U?2Z_4]-L>I&
MUL;?3C@?1W^Y':XDZL+?,Q_WTJA:YC?3E];":VDA[09/'TMKD;'@$`7L`G^;
M8&B3X.;&[=[4E/\`_];T6QEKO2+'6-'IMD,W1Q_)=MW*Q42-LVNTB6%O_1ES
M=_\`TE7LI+S4?<!Z;02&D]O)I1JA?,,M.UH^BYA`^3G;?^J24__9.$))300A
M``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P
M````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#<`+@`P````
M`0`X0DE-!`8```````<`"`````$!`/_A$DAH='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H
M:4AZ<F53>DY48WIK8SED)S\^"CP_861O8F4M>&%P+69I;'1E<G,@97-C/2)#
M4B(_/@H\>#IX87!M971A('AM;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAA
M<'1K/2=835`@=&]O;&MI="`R+C@N,BTS,RP@9G)A;65W;W)K(#$N-2<^"CQR
M9&8Z4D1&('AM;&YS.G)D9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R
M,BUR9&8M<WEN=&%X+6YS(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA9&]B92YC
M;VTO:5@O,2XP+R<^"@H@/')D9CI$97-C<FEP=&EO;B!A8F]U=#TG=75I9#HT
M-C1F-S(W82TS-&0T+3$Q93,M.#!B9BTX9#0Q.6,W,68R,#0G"B`@>&UL;G,Z
M>&%P34T])VAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\G/@H@(#QX
M87!-33I$;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HT-C1F-S(W
M."TS-&0T+3$Q93,M.#!B9BTX9#0Q.6,W,68R,#0\+WAA<$U-.D1O8W5M96YT
M240^"B`\+W)D9CI$97-C<FEP=&EO;CX*"CPO<F1F.E)$1CX*/"]X.GAA<&UE
M=&$^"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H\/WAP86-K970@96YD/2=W)S\^_^X`#D%D;V)E`&1``````?_;`(0`
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("
M`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@"
M[0!<`P$1``(1`0,1`?_=``0`#/_$`:(````&`@,!``````````````<(!@4$
M"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+$``"`0,$`0,#
M`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,74G&!&&*1)4.A
ML?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R9(-TDX1EH[/#
MT^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8F9JDI::GJ*FJ
MM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1``(!`P($!`,%
M!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B%C,)L23!T4-R
M\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756-X2%H[/#T^/S
M*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>WQ]?G]TA8:'B(
MF*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:``P#`0`"$0,1
M`#\`W^/?NO=$)R':>Z,1V/G-S[DSV5P75>\M\8'"[/R]=FL;2[-Q=/UAOO;N
MW-P/]U_$8JG$?WS2LR\E2*N**GJH*",JSJ03[KW2>WAVS1XONW/[LQ?8%)D\
M-09KJZIQ^)PG9>7KZS+;"R.V'FW)4[9ZWAJ*C96X-N23%ZJORUEGI(J>>5)0
M\*`^Z]U(VQNCN3%9O8.#W%+O&AW9CMV[O[!R6U<SN''Y:3=NV-U==Y+=$^U9
M)<5/6P?P7"[M_C%!A8Y+O1MCJ/@*"GOW7NEKTI7[NW%-T[BZG=^X*[;6Y.IM
MH]WY:;)Y3-2[@K<[3X[#8,[?^]GECJ:;;&7R-;#F:NEED=FK(I(2GV\\D8]U
M[H[7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_T-XSH'<&;W+L?-Y#
M/Y.JRU=3]N=[X2"JJRAEBQ&W.Z=^8#!8]3&D:_;XK"XV"FB%KB*);DFY/NO=
M#0\,,D9BDBCDB/UC=%:,_P"NC`K[]U[K&M)2H59::G5EC,2E88P5B/UB4A01
M&;_I^GOW7NLVE=6O2NH"P:PU`<\7^MN3_M_?NO==A5!!"@$#2"`+@?6P_P`+
M^_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__1W=/C-_S+O</_
M`(G#Y(__``0'97OW7N@GSO?V^:S>G<.T=MM34'\,3'8_J^LK=J9MHZW,;=W3
MM':V_)/XMD*6DVUN>"?+;PCIX8:*IDFI&HYC*`>%]U[KC6=X=@Y_=NZDVS6#
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ML[=WA'MO;FBCSD,>6VK#N;^%SI'054`D,F1@*WLBR>Z]T:;J[+YW/=<;'S.Z
M)J.HW+DMKX:JW!/CH/M<?/FI*&'^*34-,9)3!1R5H<Q(68JA`N?K[]U[I>>_
M=>Z][]U[KWOW7NO>_=>Z_]+=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z&4;4VNL
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M]%14L2PTU)20QT]-3PH+)%!!$J1Q1H/HJ@`>_=>ZD^_=>Z][]U[KWOW7NO>_
M=>Z__]/=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z@/WW)DMY=Q['VY0[?DR?66"
M7*XNKK\]#,N=JL124-7O.@KL/CR^8PZ8,YBBACF=&2>6H-A:,ZO=>Z?>J^VL
MCN_&;GKMVX_#X,;9P>S]Q553BJRLJ:+^';JV91[Q?R_>T\$T;XNGJC&[<B31
MJ`6]A[KW2%V+\FCO3"[(SB[9Q]/1;BR.[Z#<3T6Y(<XNUUQD>!J=I59EPU%7
M4U7'N&FW;B35+))3_P`-^]+2,5B:_NO=*:+MS=-%B]P;MSV-VK3[6P/5N)[-
MEIZ6OR,>:DAS>+SM;1X8U-=%#B89XJG">-YF8(PF4V72??NO="%U+OT]E;!P
M>[)H<329.H.0QF?Q^"SE+N3$XS<F!R=9@]P8['YVB5:;*TE)EL?*L4Z`"6/2
MUN??NO="1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__U-W3XS?\R[W#_P")
MP^2/_P`$!V5[]U[I70=+[!IY$JHL9,N4T;WBJLX*EES>3@[#GJ*K<U-E<DJK
M49&GJ*J=)(4E++3M3P^,*(U'OW7ND\WQ[VDLV3%)N'?F.Q.<VMB=HYS;E!N7
MP8/+XK"[:&TZ)ZR$T,E:M<,*BQO+%/$79`Q%[W]U[I3'IGKL5N=JX<!!10[D
MQF1Q69Q6/8T&&K(,MB\9A,C-_#:00T\%;58O#4D+31A'TTT9O=0??NO=3'ZM
MVG)BH\+)!6RXU,+LG;TU--6R5"5N%V%D),CAL?7B=915P54DSQUH>_W<+%'X
M)]^Z]TI-N[5P6U$RD&W\?!BJ3+967-5%!1QQT]!#7U%)1TE2]'1P)'!2)4_9
M++(J`!YW>0^IR??NO=*'W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__5W=/C
M-_S+O</_`(G#Y(__``0'97OW7NE++W;LZ/=N]]EB+-29C8,FR8LPRX]5Q]3)
MOFNH:"ACQ-;+41Q5TF)ERE,U>OI-.M1';6QTCW7NI60[8Q=)N)-KT>!W!F,L
M,ME,=4PX]<0K0TV%I=K5>5RL$-9EJ6JR=/1Q;OI&:&ECFJRB3,(M*#7[KW2?
MG[SH\=7[AHLSLK=6+CVYO'#[%J*QJG:E;#59W/8G&9[&"DCHMQSU(HY</F*>
M5I94BT,S(1J4CW[KW4X=VX&KQ.W\IA<)G\K)N:BVK6XO'S+B<#5*-U0;JJ(:
M;(G<.4QD.-KL6NS:U*N*5@Z3!(TULW'NO=1\+WMM_/0X3*4.W]S)MG+3;4Q]
M3NFKCPU+BL-G-Z?:1X+!UT<F9_B-15R5>1I()):6"HIEDK8-,KJY9?=>Z@3=
M^47]QY>PJ'8>\<EMKRX%Z&K@J-H1'*8W<E<<7CLA2BIW/"M/-#D2D59151IZ
M^B,J^6%>0/=>Z=LSW5B<!/7_`,5VUN*#&8&HPN*W5GXY=NRX;;.YL_C*7)8[
M;60F&=6HGKV_B5%!)+3Q2TT<^0I@9-+LT?NO=//7_;.VNR10-M^GS$*Y#8FU
M-_I_%:)*&2GQN[:[<>-I<960&HDGI\WC*W:]3'60E?'&VG3(]S;W7NA/]^Z]
MU[W[KW7O?NO=?__6W=/C-_S+O</_`(G#Y(__``0'97OW7NFM_C1@X\EE-TX[
M<60QV^\]4[JK<_N5:9ZJDS%7G-QXC=6">JVW5Y"7$Q1[4R>V,3'"(1$]11T;
M12/>9G'NO=<=P]`9S=6(?'YOL*DJ*K.9FOS&[ZV'8U%%>LJSC::ERO79DS<^
M3Z\W-B,/BTI*:O\`N\GPS2212/H*^Z]TKMQ],4NX:C<T[[@J:4[D[%VOV%(J
M8^&44DVV-IX#:L>+0M4)Y8:R/`B=I39D:4J%(`)]U[I-YGX_"I-9-AMQXN.:
MIJMC9!,;NW9M)N_:R9':.)W-AZ^IEP`R^#>==Q1[C-2Z?<J*>OA\ZEFD<>_=
M>ZR8+H>OPE+A]OC>L-1LF+(;;W)N/;B[2I**HR>[-KUU)E<;6;?R=%E8H=J;
M<3)8G'LN+6EJU@@H4AAFC1GO[KW6"E^/U7)C]^TV;WG2UE=OB39OW61PNSJ'
M;2RC9VX9=PQ9C/8ZDRM30Y[>6;FG:*OR:+1B:)(@L"",`^Z]T];OZ4GW5D-S
M4J[JCQ^Q][Y+&;DW;M4[=AK*_([JPF.QM!B\E1;D;*4\F.Q^O;N*FJ*3[65I
MGH+)-$LTH;W7NG;KOI^AZ\W'EMPT>;K,@<QL7KK9]50STZ14ZUFPJ?.4LNX(
M&$\IAGW#!E8O/3J!&DE,9`6>60^_=>Z&/W[KW7O?NO=>]^Z]U__7W=/C-_S+
MO</_`(G#Y(__``0'97OW7NEEG^Z>L=KYFJP.?W738ROHE(J)*BARQQ:5@B2H
M.%3.18^3"3;D%)()_P"%I4-D?MOWO#X@7]^Z]T]5?96Q:#+9?!UVY<?1Y3`T
MV2K,Q3U1GIUQ]+B,;MK+Y*>HJ985I5CI<=O'&2DAS<5:`78,%]U[ICQG=O5V
M6_N^E-NRFIZK<^YY-EX;&9>@R^!S4VZ8\/4;@&$J\)G,?C\OBJV?"4QJH15P
M0">&2)HRWFAU^Z]UEJ>YNLJ+<.4VO6;KI*3+X>BS%=6_=4>4I\64V]2+7[@I
M:'/RT*8'*Y7`T3>6MHJ6IFK*5%8RQ*$:WNO=*;:6\]N[XQ\V3VY5U=13TU6]
M#5PY'#YG`9*CJUA@J1#6X;<&/Q>7HS-25,4T1E@02PRI(A9&5C[KW2I]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__0W=/C-_S+O</_`(G#Y(__``0'97OW
M7NDEV-U'V=NW;F]NN\2^PZ;:>YMUYG=$>X:^HRYW%+0YX25]7M_[*FQ87"9B
MGS]5*8<W35KRPT$<:)`)B9$]U[IKF^.&?QNYMY97:V3QO\/R0S^1VW%NS<.[
M=U5G\:GQO0LV&@W#7YM\KEIL/-G>IJI*I4JI6AHJB/PJ6+(GNO=2MX]/=N=E
M9>IW+F=P[7V+786GILQL+#[52ASJ0;KHZ[:N3IDWEN'<&ROO<K01Y'9L+)58
M^GQ]9#35DE.NI8]4ONO=2<YU#VID:T8G&YW!X[:N.RW8.;I!)DIY*3<!W=-G
M]Q87'YS;0VQ)-C\I@MV9I(9\I391GJL7`_[/EJI$B]U[H9=B[9S=%G][;SW)
M34&,S.\YMO0MA<3EILUCL?0;9Q34%+*<A48G"R5&0KJFJJ'D(@55@$"?J5B?
M=>Z$WW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__T=W3XS?\R[W#_P")P^2/
M_P`$!V5[]U[H?XYX)7ECBFBDD@(6:..1'>%FOI655):,G2;`V^GOW7NN8=#R
M&4@J'!#`W0_1OK^D_P!?I[]U[KO4M@;BS6TFXL;_`$L?S?W[KW7%98V>2-9$
M:2+1Y8U=2\>L%D\B@ZDUJ+B]KCW[KW7/W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7_TMW3XS?\R[W#_P")P^2/_P`$!V5[]U[H$8]F[OCQ.6I-C]?Y
M'!]D)F_D%%6[LR>)FP.&K:;L'?&YZ/:+9'+TQCJ=T41_C]!FA)`M4:.CQDOJ
MBE:.*7W7NL6QME[PZZJ,MLS)[0S)I:7J3<776U:K:M%N/<>UE6LW7G\_MK$T
MV:KH374U'B,+N.GH1-7")4^T9=95-1]U[K/NK;79>_-B]+X[9FV*JBS/46WL
M/NZKIM_T6Z=L4S;]VGB]OTN`HL:L%/&,[D%*Y*,+(30'R!G<^F_NO="GUMAL
MQC>WMS5L>TLI3X/+4N\LE69W<^W8,;G\-E,KNK%Y*FP]'N^BR-13;\VWN%9*
MBJHH)8?N-O4U)%2F15<0I[KW1G??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=?_3W=/C-_S+O</_`(G#Y(__``0'97OW7NC">_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__U-W3XS?\R[W#_P")
MP^2/_P`$!V5[]U[HI^YMVI2["['R6UNRMR5.^%R/R%C[!QB]C[BJJ3;F$PW8
M>Y,?MFNR>K(Y%^KY,68J"CH9*`8^5J&HF=(IUAU0^Z]T)O6?9VR=I]A55%E.
MR=G4V&K>NWKX,9C>]<]VO@*W<--NJMBG7"9S>M5!DZW<!PXIQ-100!H@Z!0W
MDN?=>Z#VLW?W*,$U%/DMU;5W+O'.4L^WZ;-9VGEKL;B?D5M3-8#;L\D=!59"
M&FCZ_P"U<</LJ9BDM'#)&ICC&D/[KW7/'=D=H;AV?197!P[\KL_1[FW%N;<&
M"BR\=%EH<)\>,!A-B9[%T=-DZ^BBJ<3O#MJAGDJ(`?/71O.K1,0ZI[KW4#/9
MS=WWG8>[:+<&Y\3A,GE?D"E'NFH[,WHV`S>.Q.S:VIVUM"+;Q#8CKEJ.&3^*
MT>7H_'4118J<(3+.$/NO='/Z-GQ-1M"K?$Y3;.6C&=K%J)MI]O;H[IQ<4XI*
M`B$[LW:L>3I:H0%&>B55AB#!UN96/OW7NAF]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7_U=W3XS?\R[W#_P")P^2/_P`$!V5[]U[H?A3TX\I$$(^X_P`_:)!YOJ/W
M?3^YPQ^M_K[]U[K$*"A73:BI!H8NEJ>$:'-KLMD]+&PY'/'OW7NI)16()521
M:Q(!(L=0L2.+$7_U_?NO=>"J#<*H//(`!Y8L>1_5B2?\3[]U[KHQQE2A1"C7
M#*54J;BQNI%C<<>_=>ZXPP04ZE((8H$)U%(8TC4L0`6*H%%R!]??NO=9??NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U_];=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z"'=
M7;7:.W-C9G>5+NBBR53E<EWCA\5MU]OX85V'EV#O7.XK;5=M\ZZ-,A$F+PHI
M*Q<B\T<M;64[^2%0R2>Z]TKLSV5V#M"FCK\K+G:*@78_8^8R5'O_``>TAN3'
MY6@GVQC=F9,-UU6Y'`)@(\K621SB1V<QUHEF>%(+'W7NH>8[BWO_``W,8.CE
M8;UVD<E'N&AP>-PU;E:R#+]@;5P'7U7C:?,5,&&HZW<NU,Y/5TT=3(D+540\
MA$2M?W7NFK=?:79>VZ_$4-NRZ6IFQVW)TAS>S>MZ^FI<KN3?F0VU1)V5D]L9
M*HQ^W=L5<=-"D57CYC)!"\LTYU1A#[KW1U??NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=?_7W=/C-_S+O</_`(G#Y(__``0'97OW7NA)'5_7`_CEMB;3
M_P!_,F0BW`#@,8RYB++UAR.6CKU:F*U$>4R!^XJ0W$\]I'U.`??NO=2:7KS8
ME%CJ[$TVS]N)B\G1Y#'Y&@;$44M)78_+)31Y2@JX)H9(ZBBR*4<0GB<&.41K
MJ!L/?NO=2:O8^S:_^/FLVIMVI;=4.-@W-)+A\>TNX(<-&(L/'F9O!Y<DN)C`
M6F\Q?P`>C3[]U[KV/V1L_%4%3C,=MC!TF/K*9Z*LI(L;2B"JHY)IZAZ2H0QG
MS4S3U,C^-KKJD8VN3[]U[I4@```<`<`?X#W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7__0W=/C-_S+O</_`(G#Y(__``0'97OW7NF:E[MW/7;AW]B:
M#'[.JSMW<:[-P6+>?>5!D?X[7[MH]IX:KW)EJC;+;>7$3/+)53C&RUU1%%H3
M1KUA?=>Z3^]/D+N_9L%%2U^(Z]HMQXV3=-'N'%97<V?IZ?<F8P%7LV/$8+KJ
MHH]NUU=D,MNZFWG2BEAJ*7RI5S)3A93ZV]U[H2=G;\[#RV]>S<'N/#;-HL'L
M.*B-)/B,EG*C-UTV9Q5-G\4E=35N-@H*58<9,T=3XY93]PHT70^_=>Z@;Y[Y
MQNQMG=7[GR<.(II^PY\)/-2Y3.TF(I<9A7P+;GW37PUM>8$K:C#XF%Q3P`!Z
MF=XT](8D>Z]TE=^_(C-[7VW493$[5Q=;DF[?W+U30PY'+5=-0>3#P9,T69K9
MJ7'U%2L=1/0KY8HT9D1CI+$`'W7NL.[N]=\[2%#@\QB]A8;=46;S>)RM94U.
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M[KW2Q]^Z]U__T=W3XS?\R[W#_P")P^2/_P`$!V5[]U[H4:K8F!J\#E=NO_$8
M:/*YFOW$U32Y&IILE09NNS;[B&2Q=?"R3T%319EA-3E#:,J`05N#[KW2>'3F
MS)</4X7)QY7.PY'`Y[`YBLS64GKLCFDW+5XVNRN4R56P1GS+56)IV@GC$8I!
M$B0+&B(J^Z]TI\3LO#X?(;FRL+5U17[OCQ"9ZHK*HS&K.%PT6"I)514CC@ED
MHH@92@4/(2UA]/?NO=!MBOCULBEI!C]PU^Z.P<;#MG(;0QN-W]E*7/T.&P.4
MAQU-7T^*IUQM$M-45%-BH(_N&UU"HA"N`S:O=>ZP9WXX;`W"E9%7UN[T@J8X
MIZ:FIMQSQ4^(W&L%-2U.]L5"89$@WAD:>D5:BKD$H=GE<())IGD]U[IQFZ-P
MII:`4.\^R<3FZ2LR]?7;NQ^Z5_O/GZG-T>)H*XYRMKL=6TE3"*7`4*11100Q
M0+21B-5`(/NO=.N6Z;VAF<6N.JY,VDR0[VIUS-/E'BS0A["AF7=40K/$R".O
MK7BK`HCTQU=+!(H'C`/NO=1*7HO8/HEW!39'?&0^USU+4Y7?%=_>&NK#N.FP
ME!D*J7[B%*.GJH\;MZEIJ<T\,"T\(D$:JTTS/[KW2>E^.FWI*0X]=]]J14,6
M4QV>QE*F[H77"Y_&U]+DHLWC)I\3-5#(U%7`[3-/),DOW$MU]8M[KW0T;<PK
M[>P])B'S.;W`U)YKY?<=7!79BK\U1+./NZJGI:*&7PB7QI:);1JH-R+GW7NG
MOW[KW7__TMW3XS?\R[W#_P")P^2/_P`$!V5[]U[I5YGN;9N!Q]5D\D];'3T.
M5WGB*M(THYJJ*?9%-F:G)2?:)6F=XZ[^"O'1@`R32S1*577Q[KW4?%=R8JMW
M+!LW*;:W1MS=$@RLD^*RT.'E^UIL;@<;N**L:MQ>8R-#4TN0HLB8HG@DE"U=
M-41/I,5V]U[J+M?NS';V>(;3VENG,1O@<%EYI0VW*/\`A]7N79M#OK"8C)05
M>?BK*9J["Y*&-:T1OC?O6-/]P9%?3[KW3'COD+09/`XW-TNP-[SRY3`Y_=\.
M$I'VE6YJ'9^V9*:FRF>GIZ;<\E/=ZZJ%-2T<<LE95S*PCC*JS+[KW2TQ';^T
ML[DY<5C/XG//'N?![928T8CI:EMQ[(7?N'S-)/),HJ<)5XC7%Y5O(M7$\;1C
M3J]^Z]T*?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__T]W3XS?\R[W#_P")
MP^2/_P`$!V5[]U[J3G?CYM#<%/D8ZH4U-79?-;ZRV1SE!A<939^H3>E/FHHZ
M1LN(VJW7!3Y2*6$R&1)&I(PZ:0`/=>Z@5O2^\:ZKCW7/V;2MV5%+5TD6Y?[C
MQ?W>I=N5F&.%EQ%)L_\`O)J2K4,U8M5+D)K5TCDQ&F*TR^Z]UGP?1!P6[.O\
MQ!NJ.JP/6N%H<+MJBJMLT`WC'0T.T3M$8:LWW25E))6;4JE=LA-CY*!B<CID
M6941(A[KW6&#HG(X3#;5H]H;\EP&<P&U<WL:OW!4;<ILNV4VOG\I'EZD4V.D
MRE)3XO/8VMA62AJRU3#$Q?S4\Z-H7W7NGZCZ5QF-SNU\SC<U64J[9W*,O'2&
MFCF%?A(=A0;+H]MU4[S!O'1U-%!D$J@IE$J/&`$FD)]U[H:_?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7__4W=/C-_S+O</_`(G#Y(__``0'97OW7NA2J^P=
MG4.U,KO>KSM-#M7"5&7I,IF##5O#2U.!S55MW+0M#'3M5224>:HI:<A(VUNG
MIU`@GW7NNI>P=H1;KHME'+^3<5?`L\%-3T&3JJ)/+25&0IJ6LS=-1RX/'9&M
MQ])+44]+45,53401M)&C(-7OW7NH.7[5Z^P.&K\_EMS4=)BL9D]RX>MG,-=+
M-#E-GT.6R>Y*$4,%++7S3XO'8*JG8)$VN*+4FH,A;W7NF&M[VZTQF%;/Y7);
MAQ&/2HJH63+;![`Q>4\-!1I7Y+*#!UVUZ?-G;^*I)%>KR0I_X?2Z@)9D8@'W
M7NE'_I0Z].3S>'7=V%?([=VEC-]YFFCJA+]GM#,FO&,S_EC5H*B@J_X9*5,3
M.P702`)8B_NO=/.U=V8'>F)7-;=JYJJA-3544JUF.R>&R%'6T4IAJJ+)8?-4
M>/R^+K8''JBJ((I-+*UM+*3[KW2C]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]7=
MT^,W_,N]P_\`B</DC_\`!`=E>_=>Z34O4G8.=VF>M,E7X[:VV7[0W5O#+;EV
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M@D\JN)(A'+[KW3)_H$[%&;J-[2[IV[E=R9/%9K:>>VMEZ*F78N8VK/LW`8"C
M5ZC%[;HMW4M=E,WLR@K:B-:QJ6B^YG^WC8QJLONO=#MU;M_=^W</F:;=^1:K
M:LW-D,CM['2Y_(;LJ=N;;GI<?%28*IW3EJ''Y//215U/4U"RSQEX8JA:?R2B
M$2-[KW0F>_=>Z][]U[KWOW7NO>_=>Z][]U[K_];=T^,W_,N]P_\`B</DC_\`
M!`=E>_=>Z,"TD:(\KNBQQJS/(S*J(J7+L[DA55`#<GZ6]^Z]UX21LH=9$9&5
M7#!E*E'_`$.&!L5?\'Z'W[KW7&.>"8R+#-%*T3^.41R(YB<?5)`I)1Q_0V/O
MW7NNXYHI422*6.6.12R/&ZNCJ/JR,I*LH_J/?NO=9`;\CD'D$?GW[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__U]W3XS?\R[W#_P")P^2/_P`$!V5[
M]U[I!TF-SU1L5=KUFU]T/%MSNS=>ZMYX.MVQ7STNZMBU_;>\\U308>2:GDQV
MY8GILC09)J6"2226FA,>AG(B;W7N@IS_`%AOJ0=BY[:6Q]RT6,RVU=OX/;.S
M_)38H#;>6[7WUELE2)B)*@TU'D=N?<4N9@I-4#TU#6/`NEV-.ONO=+Y]EUE;
MC<Q38'K?-T.1IML;SH-]F/"P[6E[`AK^P<#E?[MT.5FFQB[BK\QMW'9)(:HR
M>!!6V-1&9F]^Z]UPCV%N&3=.8WCM'9V:V_@,76;OW%L+;7\/IMNDU@VEL7#Y
MS'/@JA%3#4/8DM'D(HHI(X',ZFK(A=Q(WNO=&,ZAP&X]N[)Q-)N7,UV2J9Z#
M"5%'C,ACJ''U&T:&/;6#H!M1C0LXKVQU90S225$K-*\L[B^E5`]U[H3_`'[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__T-W3XS?\R[W#_P")P^2/_P`$!V5[
M]U[HPGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z__]'=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z#JA[2BR6Q),>V_L?45N
M%[JWABNU)X]U4U-N39/75/VUO;&T]5DI:7(093;6.AIZ*@HON7$?@Q[LP9%7
MRI[KW25K^R9-OY':N2;?68W+M;^/Y2EVKA(]RY?&;KW;B:CL(4F%S>S*B6AJ
MZ'N&HAA,V.GQ53-YI,/%%6PN6F6:;W7NEAV%OO?=#V]75N-J,[0]9X#$OUGF
MYA-C(<"=[[KVOD=T8S,P!:HYR3,T66DV]C*>98?MH?XA4AG#7`]U[I/+OK=5
M$,1MW>.X,_!@,'C>M*3L'><V6J=O(V!R6WNS,O@MUUFYDH\+38K^^6;QV'QF
M:K*,I'250EC:2.(ZQ[KW2,VWV?497?C4=3NRGH\+#M?;T>`H^Q^\<SM7<-5,
MG9?;^$J,GLS'8''2XSM6+(4V%HTHZNJF1Z^EAI/)(YF:0^Z]TL-P=NX?-;>Z
M5JL7V7U_D:>;:V1BWA59SN^NZYQ']Y(=O;3JE@S&Y=I0Y:K;<D7W-3(E!.D9
M9'FE-C&`?=>Z$'KW>ZS=PY#;']X*C=(R..W+6TLF)W7E<I#@<?C*G`BDHMY[
M.R^.B_NXD?W3Q8',T<YAW#2F2>56=D?W[KW1IO?NO=>]^Z]U[W[KW7O?NO=?
M_]+=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z'T4M,&E84\`:<%9V$4>J96OJ64Z
M;R!K\@WO[]U[K(8HSX[QH?";Q713XCI*7CX]!T,1Q;@V]^Z]UV54@@JI!-R"
M`02"""1^2"/?NO=>9$=61T5D92C(RAE9&%F1E((*D&Q'T]^Z]UB>EII61Y:>
M"1X["-WBC=DTFXT,RDK8\BWY]^Z]UC-!0E2AHJ0HS^1D-/#I,EB-9718O8VO
M]??NO=2%CC0EDC16*HA95524CU>-"0`2J:C8?07-O?NO=<_?NO=>]^Z]U[W[
MKW7O?NO=?__3W=/C-_S+O</_`(G#Y(__``0'97OW7N@LW=WEOO#)NC#X[+[<
M_O)1=H96;'Q5V*:1Z?J/#Y*HPE8XI*:I3RUPW)0B@%9*=/\`E8.DNH'OW7NN
M5;VSVIM;IG!]F_;;BW-G\E'M35M7=.%VQB(<JNX-OS564RFWVV12Y7(+BMK"
M9LS5K4WF.+QE0@L[!O?NO=+R#=._-PU=7M?&=@XG#2XNGSV2&_$VYB<E19:E
MP&U.N)Z:9J&:K&,3$9+*;SER%0\+B3[1$BAECU>8>Z]UQVCV+O3.9C:^X*C.
MX&?;VYNR]W=<2;3H\>@%+2[:PNY'I=QXC+R.F5JJS)Y+:;UYCG7P_P`(R$8$
M:R0^67W7NH>Y>PM]T]/OO>=!NG#;?Q6UMU;@V/C]DY_!T\IRTV#P\]1'DZ/*
MI/!DVSV5J]-92PF](<:FDQEW\Z^Z]U)W!NCL/9I[2W<=TUVZL!U;EJ/)Y/:4
MN!VM35&2V6=JXO<FXHL=D::GP\ZYW#TF1FGHC)-XZ@4JP2*6E,J^Z]T,>RZS
M>\U%CEW;0XYI:O$1Y:KR=#4I`E-D<G5U=4-N0XE4J&>'`T$D-.:PU#?=,ADT
M@L57W7NEW[]U[KWOW7NO>_=>Z][]U[K_U-W3XS?\R[W#_P")P^2/_P`$!V5[
M]U[H6)]A[+JIZNJJ=K8*>JKH)Z6LJI<;2O4U5+4YK^\D]+/4&,S24TN?)K#&
M3H-23);42??NO=,.T^GNLMBU,=7M/9V*PE1#$88&IA4NM-$T#TICIHJBHFAI
ME^UD:+]M5M&Q7])(]^Z]UDR/4/6&7QE#ALGL3;-=BL;7IDZ"@J<5324U+61T
M5/C=<492PBDQM)%321?YJ2GC6)U9`%]^Z]T\4^P=E4FZZC?--M?"P;OJJ-:"
M?<,5#"F2DI5AAI]!G51:1J6FBA:0`2-#$D;,415'NO=0J_K#KS*;DJMWY+9N
MWJ[<];C6Q%7FZK&T\U=/0/2R4+Q22NIO(V/E:G,MO*:9C%J\?I]^Z]THJO;N
M"KZ;/4=;B:&II=T024VXJ>:G1XLU3S8Y,1+#D486J8Y,9$L!#7!B`7Z>_=>Z
M=T18T6-%"(BJB*HLJJH`50!P``/?NO=<O?NO=>]^Z]U[W[KW7O?NO=?_U=W3
MXS?\R[W#_P")P^2/_P`$!V5[]U[IGW'\@,E@,5N.I7:=+7Y3$=HU>R:.B3,-
M3PS;9H7J#4[MJI9J/R`PKCJF$T\*2#[KQIKLQ8>Z]TC*[Y930P[XCHMIXJLR
MFV>I]O;]PF*3=E`^0W%N&IQFVLMN?;AQD,<N4QE!A:??F$CAK)H0*J::=54>
M$^_=>Z6U-\AURG=.U>L<3MF>3!;EP6(R@W/D'JL=51UN2VOO#==1C8<5-26E
M;&4&#H$G8R@I/6R1,`\#!O=>Z,S[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO_];=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z4F3Z*ZYR^0R67K<
M76297*T>3H*FO7*5J2K29?=@WI6Q4\8E^VIW?-WM*L8F^W/AUF,!1[KW4`_'
MGK%L!1X%L1.31QUE.,\*A$W154==$M/-0U^>C@2NJZ%:>&"-(G)1$I(`!^TE
MO=>ZGX[HSKW$;OPN]L;09"ES6!K=Q9"@TY:MEHA5[HJ=T565>:EJ))1)'JW=
M5I!'<1TT"PQ1*D<,:CW7NA@]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7_]?=T^,W_,N]P_\`B</DC_\`!`=E>_=>ZG9_Y![-VWA]P9C(XS<Q
M&W^PJCKB:@I:"BJJZLRM+`]9+E:1(\D8(\`M#!-,9ZB2!PL#@QARBM[KW2IS
MG:F"P.PMU]@S8S<%?CMIU&;HIL1B<<E?N',9+#923"IC<%CHJG36UV7RBK#2
M(TD?D>5=6BYM[KW4&'NC:%5(JT<6:JH9ML=?[OH:V/'JM#D<-V/FA@\*]+/-
M416JZ*>2*6LAE$;Q03QLGD)95]U[I7;5W]L7?:5TFR-Z;3WC'BY((LD^UMQ8
MC<"8^6J1Y::.N;$UE6*22HCC9D$FDN%)%['W[KW2M]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U_]#=T^,W_,N]P_\`B</DC_\`!`=E>_=>ZA[C^.M)
MN*JW%/)O3-TM-GZ;.WQ4=+`^*I,QF]W5FXCN#[7SHU5E*/%5TN+C+MH%,[.`
MKL;^Z]TXS=+97*5,V'W%O"CR77)WI-OJ#:^.V_EMO[B.77+/N'&PUN],=O(/
M/18O<+)5QB"@II&:")6?2K^3W7NL(Z`H(Z&CH:?<M93KA\GLN3`RBA\\V-V[
MLW=N5SD.VI9:O(5$V1@R.W\F,3+/*VL+3QU(!F1;>Z]T-6&VUMS;BSIM[;^$
MP*51A-4N&Q5!BUJ33HT=.9UH8(!,8(V*IJOI!(%A[]U[I[]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U__1W=/C-_S+O</_`(G#Y(__``0'97OW7NE[
MD^V^N\/C,WF<AN:GAQ^W,OG,#F9DH\G4R4>9VW1-D<SC12TM#-5U-724::PL
M,<AEN!'K8@'W7NFA.]NKEBFEK]PU>`\%5MZDD@W9MC=FT*SR[KW!3;5V^Z4.
MY\'B:R6ER6X*M*99UC,*OJ+NJH[+[KW2XJ-X[:I-NYG=E3E8H-N[?_CW\7RD
MD-4L%&-LUE;09QV0P>>:.@J\=,A:-'5_&2A8$$^Z]TAZGO7K>C3,35%?N1:7
M!Y`8FKKDZ]["FQU5E7W)3;1BQN#R,.UI*'<E?/N.K2EBAQ\E5)*VIE!1'9?=
M>ZE4'=76F3_N_P#9;AFD;<N2JL/01O@-R4\M'E*/,OMR:@W'%48>*3:%4^X8
MS0Q+EA1&>L_9BUR$+[]U[KAM_NWKG=%714F'RN7=<E7MB\9DJ_9N]<+@<ID!
M)5Q+2XS<>:V]C\!D)9Y:"58O#4N)BMHRVI;^Z]T(6%S>*W%CTRN%K(\ACI:B
MNIH:R%9%AGDQU;48ZK,#2HGFA2LI9%65;QR@:D9D*L?=>Z=??NO=>]^Z]U[W
M[KW7O?NO=?_2W=/C-_S+O</_`(G#Y(__``0'97OW7ND'V-T'O7<M!FZ;!9+`
M1IG\AV1DLM15F1RM"M35YN?.-LZLI*ZCQE3-0U\6/SDE)72!241(&B+F$:O=
M>ZR;XZ*W/V-)M:+(TV,PV$QN-W]C]PXG*;QS>]<CDZJOH,97]=YBEW%EL-_$
MHY=K;PII*I(BZK2\2PEGLJ^Z]TJ]Q]<]EUG3&&ZXQ=;M6JRF:VUE=N]C564J
MLC#`U5NC"9"/*Y_`5]-C)9:A\5N>O-2M/-2P_?4P9#)3N0P]U[IDFZ=W=D,3
M6[8FB_AU))V1B-W?W@I^S-W3>?$X[N.AW_+%BMNC'PTFU,M+A(G2-Z20>.I`
MC\GC8R#W7NHN/Z9[*VX<718#*X1)Z/=7\0/8/]XMRT6[:_"R=B5&Y\LF^\4M
M#583L.KS^TY_L98Y_M5@R'EJ(7B6H'V_NO=8L#TCNJ/I[>'5V5H*2FR%?M3-
MT&`SZ]E;OS.,BW.,C69;:F8H</48RB&T6Q&8:FK$FH09:>2!0@;2I]^Z]T:C
M"XNEPF'Q.&HH(J6CQ&-H<924T&KP4]-04L5+!!#KN_BBBB"K?FPY]^Z]TY^_
M=>Z][]U[KWOW7NO>_=>Z_]/=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z,"TD:*7
M9T55U%F9@%4("7))(`T@&_\`3W[KW6*&KI:A2]/4T\Z!@A>&:.50[$!5+(S`
M,Q(L/J??NO=9@RM]&4\L."#RITL./RIX/]#[]U[KB9HA(D1EC$L@=HXRZB1Q
M&0)"B7U,(R1JL.+\^_=>ZXQ5%//K\,\,WC<Q2>*5)-$@^L;Z&.EQ_0\^_=>Z
MR@@\@@BY'!OR"01_K@BQ]^Z]UW[]U[KWOW7NO>_=>Z][]U[KWOW7NO_4W=/C
M-_S+O</_`(G#Y(__``0'97OW7N@'[4ZXW_-MW>V+P>ULI7TF[-R]O;G84U+'
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MW=/C-_S+O</_`(G#Y(__``0'97OW7NC">_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__UMW3XS?\R[W#_P")P^2/_P`$
M!V5[]U[HOG=N\=U8J@[&KMK;YW3%VA19+L'&Y394&>K:.CP75M)LO<57AMS8
MG;T4D5-B!!%#05]/N*&.2I?)S/3>9R/M(O=>ZP9S)]LX?$[OV'M.N[$_OQ+V
M1!E-M[2Q^\8-Z[EPNW-H;"PVZ'J_[[=D5V(CSFQMW[L?'Q5=.9]2PUU311_N
MB:*+W7NEU%V3NVMR(SF`RF;K*#?V]7J]DX2K6JD:AR-%\?VW1#LR9%IQ246+
MR-2D548995'\2@J;$F10/=>Z0.7WGCDH,GC]N]BY^NP_][>MFSNY=Y=]97;F
MV)*_,83?$^<Q,N\L"V2W1UADH,UBHHJW!%((!+%3)'3PQU#E_=>Z&[<.8P<.
MT.JZ//\`8%1MOKK.8_)Q9;>NU^S\]DJ2JSL%+25.VL:G<51+1[@J*#(R+6M%
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M_=>Z][]U[K__U]W3XS?\R[W#_P")P^2/_P`$!V5[]U[HP)CC+,Q1"S($9BH+
M,BEBJ,;7*`N2!].3[]U[KEI75JL-5M.JPU:;WM?ZVO[]U[KP51P``+WL`!S_
M`%_U^/?NO=86IJ9D>-J>!DD<RR(T49220V)D=2MG<D#D\\>_=>ZYB&%8UA6*
M,1+ITQ"-1&NA@Z:4`TC2X!''!%_?NO=<M":Q)I76%*!](UA&*LRAK7"L5!(^
MA('OW7NNEBC2^B-%N[2G2BK>1[ZY#8"[M<W/U-_?NO=<K`<V%^>;?U-S_MS[
M]U[KP``L``+DV`L+DW)_UR3[]U[KOW[KW7O?NO=?_]#=T^,W_,N]P_\`B</D
MC_\`!`=E>_=>Z##MSN'L;96V-Y;[PV:Q512TV[]^=?8K:<6%I:J?"28'9VX*
M[%[BJ*J20UE=FX\UM\Y":FDTT<F(J441H\9GE]U[I3=9=E[]S':];LO,UE56
M[9IX]\&EEW#@,;@=Y"IV[C.GZC[?-X[%-%344%-5;UJ9*67P0&MI:J)PK(B2
MR^Z]T@ZWY#=D9#,]F8C;N/I*2HQV_P#8&*ZYDSVV=Q4>&S&%/<%!U=O.@;,5
MN,QU%FFRUDJ:>KQTU6*2/*QL=0B`?W7NGW`=N;WW;%V;NS$[JIXL%U_G)VQ.
M&&VZ(4VX,3!NW.X^7#9:2LCCS='F9,=B/M(C%+`\-8=4D4A4Q'W7NA!P>^MX
MG>6TY<AFL5E,!OS?G:6R(MM4F-@IIMKP[&&Z)<5E(\BDLU=75179LL&36<^+
M[G(Q>(0B+3-[KW1B_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__T=W3XS?\
MR[W#_P")P^2/_P`$!V5[]U[H2:_J_KO*YO+;CR.S-O5N=SN(J,#F,G48VGEJ
MLCBJNE^PJZ2K9E(E^[QX%/*Y'DDIE6)F,:JH]U[J/N/J;K?=N4@S>XMG8;)9
MBFJ4K(LI)`T&0%3'!24JRO5TLD$\K?;8^GC.MF#)!&IN$4#W7NGZ;9NU:B'#
M4\^W\5+#MZ2GEP<3TD3)BY:3(8[+4TE&"MH9(<GB:6H4CD30(WU4'W[KW2;D
MZ=ZNES]+NA]B[=.>H\G59JGR`H(U<9BMRD^;J<K)"NFFJ,C)FJJ2K$TB-(M2
MYE4A_5[]U[I\QVPMF8G<V5WGC-L8:AW5G(?!E<]34,,>1K8B8#*LLZK=34M2
MQ&9ETM.88S(6,::?=>Z5OOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__TMW3
MXS?\R[W#_P")P^2/_P`$!V5[]U[I%9KY'9O`9;?23XC9N5QNWGWM08R@QVX<
MG29^@RVV:V/#X+^^]5D\1#M?`8O=V=J:>EAG:M5HFJXF"2J)C#[KW4FC^2E5
ME.K^Q>PL/MK&9:JV1M?:>7I,5CL^E;29C.9[`TE;D\"F5I:66G_W$YZ2:@6>
M(2I,8M8X(]^Z]USW;\ECB&[(DP6V35XW9'4FV^Q:+*YM\CC(\CE<_6SI/A*B
MBAQU56QT^$QL]%-4R0K-/YYI*<1>2(@^Z]TFL-\F-P9_,X'`T)ZYAJZFK2AR
M51(O9M7%D:A\[_#`,/1T^RTR&!:.`#4F;2BU2.KQ&6E(G/NO=+7:GR&7?N-W
M3%L^DVOD=S4O84^RMI4B[G2MP]=BZNGRM;MS=>XJW$4U=58:FR>-P%?4-1B)
MZI33B(A6?4ONO=2Z/OR2@SJ[$WEAZ/#]B)N_:&U7P^,DSF7PM=3[B&*,VX,?
MN"/!QXZGHW@K)9Z:FK)*>K\<:I*B2,H;W7NI6Z>W]X[>_CNZ*;9&+R?7&%S-
M=LYZS^\1H]U/N:FR+X.#*R8R6@?'+M*?=!CQC>.HER*&3[H0-$I7W[KW6.E[
MAW;C-PY#9>\-L[?AW)AMH;ZW96U.W<UD*S"5E-MJBV;7X?[`Y'%4-=#_`!(;
MFJ(*A)4+0246I#(LHT^Z]TV8CO/=.Z\33P8#;6`QF[,CD\6F+AW%E,JV`J\#
M6[&GW=49G[O&8J6L\E+7X^KQKP*C/'*D4KD1S)?W7NHVW.]-[U&&ZZ7<6S<&
M=T]Q8'!9SKFFVYDLQ5X*9\C3P97/X[<-?68B.HQ+[.VS4KDYYV01UT220TZF
M9`K^Z]T:CW[KW7__T]W3XS?\R[W#_P")P^2/_P`$!V5[]U[H3JOK_;E=BI,'
M605%3B9]U2[PK*"HF$]-7Y27.R;E>GK(IXY$GQ?\9<2_;D!#H53=;@^Z]T'B
M_';8D$N\(L=6;DP^"WW5I7[CVIBLA0TFW*BKC]:2T5,,6];BE6H_=\=+411F
M2Y*V)!]U[J;/\?\`KR:BW/0QP9FDCW;CLUC<I+39BI\\<.<WAD-[U$E#).)Q
M2RT>:R)6E%FCIZ2**G51%&J^_=>ZY4'2&*Q.3S>>Q.]>PL=N'=!C;=>>@R^&
MER6Y)*5#3XN3(?>;>JJ.F;"X^U+2"CAI4CIU`(9O5[]U[J4O1FP**D2EV_15
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M:`:GY\GJ^OOW7NE][]U[K__4W=/C-_S+O</_`(G#Y(__``0'97OW7NG.7O7"
MT>XA@\MMC<V(HJW=5=L[;^Y*R;:SXC<.:Q.5CQ.82CIZ3<M3G:"EQTK/(TU=
M1TL;QQ-I)=HT?W7NE'%VOMN;<.,VY#!DIJO+9S.8&EJHHZ.2A^[P"P-62O.E
M:S_;2><"-E5F)!NJV]^Z]TU[T[KVSLC,[KP61Q>XZZLVCUADNTZZ7&T%,]!5
MXK&5%5!)@J"OJZZCI9-SRK2&5::1HT6!ED>15-_?NO=,.0[[3'5.+P<_6N^U
MWIDLO-BVV=/5;#HJVCCCP-7N.'+/G:_>=+M&LQ=7CJ*18WI<A/)]PCPLBO&X
M7W7NGZ+N&DJ-H5^YZ3:&Z*K(8_>4.P9-HI+M>/-R[GDS5#@7I(:V;<<>V6IH
M*VN!:<UZQ-&C%2WI#>Z]TU0?(+:#4>X)JS&Y[&U^UH]L+G<-5#!R5]+D=R[S
MSVQ!B:=Z+-U5!D:K$Y[;E0*IX)I*?Q%&BDD)*CW7NG/;_>&T]Q[CVCMBBH=P
MQ5V\L7N_)X^IJ,;'_#:+^Z&;J<)+09:MIZJ>*BR&<?&5]1CX_4)Z?'U#,49`
MK>Z]T,GOW7NO>_=>Z][]U[KWOW7NO__5W=/C-_S+O</_`(G#Y(__``0'97OW
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M_P`:\'@\CCMQ/N'*5NZ\'N?&9G`9D'(4=)CL-09+<=;+MZ;`4^9_A.0%;3;W
MSD+54B"1?XD6"_M@-[KW1E??NO=>]^Z]U[W[KW7O?NO=?__6W=/C-_S+O</_
M`(G#Y(__``0'97OW7NA*7LW8#9BJP!W9ATS%'52T4U!-4^"5JRGK*7'U-+3F
M94CK*BDKJV**9(6=H7D`<*3[]U[J1FNPMC[<#?QS=.%Q92OJ,8ZU==%&\=;2
M45-DJV*2.Y=%H,=613U$A`CIX9%>1E4@^_=>ZAY/M'K[#5.:I<KNK&4#[<I*
MJOS\U2TT=#AJ.AQ"Y^LJ<GDC#_#J**EPKK4N9)5TQ,&/U'OW7NG2??.SZ:HK
MZ6?<N'CJ,73+69&(UT)>BI'IZ"L6JJ+,1'3?:9.GE+GTB.96)TF_OW7NGJ@R
MV,RIKAC:ZEKOX9D*C$UYI9DF6DR=(L355#,T9*I54WF42)>Z,=+68$#W7NG#
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__7W=/C-_S+O</_`(G#Y(__``0'
M97OW7NF7-]'93.8O/2U>=W&,M4;[SF8V]04FXX<=B]N8W/;_`*3*5V;PDE#C
MJ>JIMQG;,<WBDJ):IJ::>41:"_'NO=18.L]];*R.3K]O8Q.PXLC6[UPP7>V\
M7DS1Q.\L9UZD&:R&9K<=6-5X_'U^U)X*ND"FH^R,1A$AC$;>Z]T&4G1O8N)P
MF_>O\?C]U9S'9C8,VT<+GJGL3&T6P<A)%U%@=G05.6Z^FDGK8*NLS&(=7>TP
M4N)22M_?NO=+.EZ=[!P6Z>PJO'4F`S&&R]%5;9V:^8J5R2P[?RNUMB[:IFW7
MC<D?]R\&VOL:\30&5WR%%1Q*6\D[!?=>Z'/J/9E;UUM&/8D[+5XS;%=4T.W,
MR[H^3SV#G$60@R>X2I+3;D^[K)H:ZI:QKJB%JHA3,57W7NA/]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=?_0W=/C-_S+O</_`(G#Y(__``0'97OW7NA^2H@D
MED@2>%YH;&6%)$:6+5RODC#%TU`\7`O[]U[KE'+%*H>*2.1&+*KQNKJS(S*X
M#*2"492#_0@^_=>ZQ2UE'`R)/54T+R'3&LL\4;.UPNE%=@6.HVL/S[]U[J3[
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]'=T^,W_,N]P_\`
MB</DC_\`!`=E>_=>Z`?=?5/9\V=W;FL1BL2(LZ.^*7"383:Z;?WM%D<S7Z\9
M2[EWBV5J7SVW-U[=AKEH'\%`M%7BAU/(!&Z>Z]TY9#`9".J_OWUKUMOG#8+:
MV]<7OC`;+@P;[0R&8R^U>K=V83<U-C]L96FICAZ+=F-K*;"()8J=*ZOC,L9T
MNE1)[KW09[#V!NK:G9V9J]Z8/.T,.4S3Y'[D=)Y3MFARV5R?9F^=R9O^';I@
MQM6-G0)5;@25*IHXXYH94FTA8`![KW1^-@[:WEMFBKJ?>78U=V/55,M#)25]
M?MO;VVY,>E/BZ2DK88X-O4U-!41Y#(P2U=Y`6B:8QJ="J![KW2^]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__TMW3XS?\R[W#_P")P^2/_P`$!V5[
M]U[HPGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z__]/=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z!#>78F;QN[^Q-L;=W%N
M7/[MWFF7V]MI=M;L(R&TYY-P;<P%-09#KC=R8G"[$W%CZ*NKI\#EXJF.AST5
M*]14,3XV]^Z]UDH=]Y*LQVW:?M?=O8'6D^V=D4]+A(J#,I_>S=/:FU-T[MVW
MN.FKH,`N0QO8VXZC$87#U\.#6.LI*U<J[K!4(5>+W7NF2JW7V-MA]T9.D;=S
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M\1@.K<32[NCV9G8-K3U34>"DG7$[>FBRB`S9"7(U*N\QD(@]U[HWGOW7NO>_
M=>Z][]U[KWOW7NO_U-W3XS?\R[W#_P")P^2/_P`$!V5[]U[HP/CCUF30FM@H
M+Z5UD)JT`M:Y":VM_2Y_K[]U[KLHC%2R*2K:U)4$J^DKK4D<-I8B_P!;'W[K
MW7BB'22BDHQ9+J#I8A@67CTL0Q%Q_4^_=>Z[L+DV%S:YL+FWTN?S;W[KW6#[
M2E\HF^VI_,!I$OAC\H73ITB33J`T\6O]/?NO=9R`;7`-B"+@&Q'T(_H1?W[K
MW76E0Q<*H=E56:PU,J%BJEOJ54N2!^+G^OOW7NN7OW7NO>_=>Z][]U[KWOW7
MNO_5W=/C-_S+O</_`(G#Y(__``0'97OW7ND/O+N'=VV:W?E`,O##G<E0[CIN
MJ:*?;`S6S<G646X,+M7'9'%[AVS49'*9#*;<R.8!SV&K(EKWE1_M8D@@>23W
M7ND+7?(SL"GP%1F%JL(E-1=0;*DR5558'(XRHHNX:[?F]-FY=3B\G'3U,&#S
M%9LRIIJ>FJA!/!4&G`#F8A?=>Z&O>>]-YTG:><V]B:O-P8';_6.!W?IQ6'VQ
M5XM<IDLGV'35#[JR&9F_C,&.DAVO3+"F.C,E_*6(NOOW7N@6?O7LJ+K_`'C4
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MR5$LTF+RD7GIWQ]/41LLE33R2K[KW4_;V_\`?N5U9V7=FW:^AVSOO8G7N3H,
M)AH3M_>Z;BH=K-E-UX7(5%3/EZ%WJ=X(U+%'-+3QG'RQ-YO)Y4]U[HTGOW7N
MO>_=>Z][]U[K_];=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z$>/J[KJ'<E5O"+9
MFWH]SUM73Y"IS:8Z!:Z2NI6\D=:)`MHZMY0KR2*%>9T1I"S(A7W7NI=?UYL;
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M\[/BOX;$8&S$,8@@R*N;U$5734H\$3HZF.G_`&5M$='OW7NGH=9=?+GL'N=-
MF[>BSVV<;3XC;^1AQE-#)AL;1T\U)14F.BB1*>ECH*.IDAIRJ!H(9'2,JC,#
M[KW2Y]^Z]U[W[KW7O?NO=?_7W=/C-_S+O</_`(G#Y(__``0'97OW7NF?='=^
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M`(G#Y(__``0'97OW7NGW)=&[5R>7.;FS&\(ZZEK,ID=O%,\9H=H9+.9W$;CS
M-;MR*MI*M8'R.5PD#F*I^YIX$UQP1Q)(ZM[KW4O,].8'<*Q'-[@WC754N(J=
MN9RO3,4V-K-U;8J<A_$CMS<38?'8Z&IQD$[2+"T"4]3%%43QK*%GF#^Z]U"K
MNB-FUM9758KMS4HGR.8S>*I*7+I]CM?/[@R]%GLYG-N4]31U`I*_)Y6B$KB8
MU%/'YIEBC1)I5;W7NA7Q&/EQ>/IZ&?*Y+-2P>35DLNU$^0J?)*\H^X;'T6.I
M#X@^A=$*>A1>YN3[KW3E[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_
MT=W3XS?\R[W#_P")P^2/_P`$!V5[]U[I6CMS#?Q7-T+87<"8W"YRCVU)N7QX
ME\)/G9L_BMNUN.=HLN^1Q$V.K,U3R?[D*>C%93:Y:3[B-"WOW7NL.4[LV5A\
MCMK&5CY$U&ZNPJGK?%M2TL57#_&*:`,V2JI*>ID%/@6KIZ:C^X-RM76P(R`/
MJ'NO=88>\=FR45;724^?I8L=6;ZQ]9#/BB:R.LV'G<=M^IAAHJ>>>IK6W%5Y
M>EDQ/A63[R&HC;T,VGW[KW4O#]L4=94+CMQ;4W7L7,Z<^\N,W7'@X@(L#1X/
M(23T>6Q&<RV"R]/74FX(3$]'53JDL<T4WBEB9/?NO=,D'R`V949'-XQ,?N99
M\'UMANSY99,7$E'78;+0P5,^*QU::S[:IW!@Z7(X^6N@U*D*9*F(D?6VGW7N
MAS]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]+=T^,W_,N]P_\`B</DC_\`
M!`=E>_=>ZXYSH*EW-OA=X9[.8^M6-I89:2/:.*IZO<.)?<^V]QTN`WO7)4-2
M;LQ6!&W%IL:):2*6G24L[RL&,GNO=1<S\;-L9F;(,,I5X>"*#/R;.IMN0/MZ
M/9F<W#G,1N"JS5(F&KJ*#*&+([:Q;I35$?VY>C+,I,K>_=>Z<LAT+0Y"=:H;
MKS..JCAMVXZ>?%P4M*S9/.[[QV_\!N"`.9Q3Y#:.3H6AA7UQU5/+HE!"(![K
MW47#_'O#QYW.[@W35XC<]1N'(Y_,5F'GVS$^V:/+9_%8#&561P^)SF4W%)CJ
MF=\(]3.1,PEFJG"B-`%/NO=-J?&K&+20O_>_-_Q[[7+X>LRJ_=+CZW;61V90
M[*I\$VV3E6PL"T%%@\74"H1!/+4T"NS>MA[]U[HS7OW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[K__T]W3XS?\R[W#_P")P^2/_P`$!V5[]U[H3W[%V3'E*[#2
M;AHX\CCY%AJ8I$J8XC.<A0XF6"EJW@6CKYZ/*9*GIZE())'I9IXTF",Z@^Z]
MUG&_=F?:8"O;<F)CH=T82KW+@*V:J6"ER6`H<?2Y:LR\-1-XXDH:7&UL4[R.
M5"QN"??NO=,2=P];R4<E9'N>!_%DDP\F/2@RS9U<C+CGS$5/_=P4!SY\N&C:
ML5Q3&-J-3.&,0+^_=>Z<:7LWK^NEDAHMW82L>++;;P3_`&M8E0HRV\,;1YC:
M]&LD.N-WSF+R$,].5)22.0$'W[KW3G#O3:D[P1Q9_&M+4[@R^U8(O.%EDW%@
M:?(UF9Q(C<*XJ\=1XFIFE!`"PQ%[Z;$^Z]U%PG8.R]R+0/@]QX[)KE,!4;IH
M#32.?NMOTM:N-J<K&&13]M!7L(FO9@_%O?NO=8,OV1LS!P;<GK\PS+N^FEK-
MM1XW&9?-569I(*.#(355'1X:@KZMJ:&CJHY'D*!%$BW-R/?NO=2<5OW9^:;$
MQXS/4=349NJS%%C:(B>#(S5>WN,[3S8VIAAKZ*7#L56I$\<?A:2-6L9(PWNO
M=*_W[KW7O?NO=>]^Z]U__]3=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z8LIU5V-
MD=ZY*OH:_!X':-=DVR>7Q%/N'.Y/%[FK(-X[=SV$S--MG(XN6FV/N&BQV/K%
MR4N/JV@RU3,KR1ZG,D/NO=)JIZ.W_NC8?7>SLZNV=OS;$ZSS>P9JRASE?G(<
MK5U6V-L8S'92.)]O8EHL>^3V^WW$#_N?;2>EBW`]U[H3),)V[59W%;ZK,'UT
M,UB'R&*I]J4N>S/A;!9;#T25U=-O.7;2S5.6CW)CT:GC.+CACQ;R*29W-O=>
MZ"':_P`9=U[3DV\^/S^!E^P[,Z\W)G1(:^*++;5VGM;;4%12TT"4;)1Y?$[K
MQ=4V-4ZHCCJITD=7?]OW7NEOOOIO>VZ-R;_FQV1VS1;<W%M;+4.VI'-:F?PN
MZ]^XK`[)WMN-F_AU31128/96">3%V,HJJS(2I.L<:!W]U[INVAT]V-U]NLRT
ME?A=[[97`;JVMBZ_+5])MC<&*Q&Z<_AMSD56*V]LZ';U6,5E!D$B2G6FU4YA
M!]6HK[KW4;-=5=C;@H^GQD,-24;]88G*X&J@VOV_N[9]?EHZ[;.&P\&2I=Q[
M;VYC,E#`E3C7\E')9'5T<L60+[]U[H7]H=88_;_86ZNQ/X=2TN4W3M;9^'G9
M<KDLI515F(AJXL[+-)6!*>6HR<5/C(YZU$6IKQCH34?YF*WNO="Y[]U[KWOW
M7NO>_=>Z_]7=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z'I*ZBD=HXZNEDD0.7C2
MHB9T$9TR%E5RRB,\-?Z'Z^_=>ZD%E&J[*-/+7(]/%_5_3CW[KW798`@$@%B0
MH)`+$`D@#\D`7_UO?NO==:TM?6MM):^H6TK^IKWMI7\G\>_=>ZXF6)7CC:2-
M9)0YBC+J'E$8!<QJ3J<("";7L#[]U[K&]72QI)+)4TZ1Q2&*61YHU2.46O'(
M[,%207'!Y]^Z]UP%?0L\4:UM(TDZAX(Q4PEYD:^EHE#ZI%;2;$7!M[]U[J7[
M]U[KWOW7NO>_=>Z][]U[K__6W=/C-_S+O</_`(G#Y(__``0'97OW7ND'VCU8
M^:3M'`;;Z]Q3U79^2V3M:7+)0/@:&3;M;3R9+?LV9W'M^"/.46+K\;CIZ2>6
M$M))65,*$$O<>Z]T%>+I]_8[8'?&PMU[,WU/OK-]9TFW<768G:N[<]M[=-?L
MKK>MVM+D<5NR+%MC9)=Q2X99Z>*IE@JYI:E$\?D=5/NO="7V%4=@]@[PV#OK
M86VLS2[4ZIFQ^XJ\[CPN\MI;QS\^3W%!C]V8+:^U,MC<;)E*E-BXJLBO5K%#
M*^3B$3OZP/=>Z"^GZ\[GCVWL'`18?^,MG>MMZ;"FH<GA<EMO';2QVY>S>O*_
M,0[OS5)E,A73_=[-Q5?X6CIX)'=``A,A"^Z]TI=NXWL/"9CK5,WLO.;BWMMN
MCVIU]7RY+:N0RNSLKC=H[LRF+KM];0W^*@5'764@VW-)DIVR:+%N2!Z:F6(R
MJWB]U[I'?W;RU)2[?I*?8&XFVQMK?NTJK)9_<'1^?SFZJPQ[([>Q533[VVAC
MY9(>SJS!566QR2;IQR+#53URR,96I]?OW7NACV53T%/V@E7)M>LHZ7*G:51@
M*B?XZ;JH$C@@V5CL?-+3[LEI4I>MX(LM1U&K'5BH](;W/^4!C[KW1PO?NO=>
M]^Z]U[W[KW7O?NO=?__7W=/C-_S+O</_`(G#Y(__``0'97OW7NC">_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__T-W3
MXS?\R[W#_P")P^2/_P`$!V5[]U[H,>P\7DMOU':]-M?<_:S[GW17[0V5M&DQ
M_8&;RE7C:O?H^[W'6[.Q.\=R0[0QV9Q&&IJRNI)96@CHEICXVC4:3[KW2(KN
MT.S\C@:V:&MW5B,_N[JK%=<UL4<=))7=?]M8J7L.'/;IAQM/55>%Q\\--M?,
MU4]3%)/#>AHA>5?&#[KW2?V)F>X8^JY>S:#/;CR63S-/N_:%#3YCL'+Y^MWE
MNS<&Y?[F]?4F&VKGQ1;9V3/M_(S).U7#51-5+!:8JDTDD/NO='+Z,S^<SO7&
M)AW4,N-V;8J\OLO<YW`F-3.5&5VIDZG##*948:NR>):LSV/IH,@S4U1-`XJ@
MR,5(]^Z]T+WOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_1W=/C-_S+
MO</_`(G#Y(__``0'97OW7NC!Z5O>PN#<&PN#8K>_]=)(_P!8^_=>Z]I7GTCU
M?7@<_CG^O!]^Z]UT$0``(H"G4H"BP;GD"W!Y]^Z]URL!>P^IN?\`$V`N?ZFP
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__2W=/C-_S+O</_
M`(G#Y(__``0'97OW7ND5N[*]OX+*;Z6A[*R62@I-R;`PN#Q&/V%LN;)4,.^,
M[CEG-')6S4-/DJO&XZ22&'[J6.,JQD?4ZB_NO="+T]N7>65S'8&WMX9"MR4N
MU*K:T-%49;"X7!YH+F]OQYBJBRE+MZJJ\/YHI9P$\+D",+<EB??NO=!34=Y[
MR_OIVO\`;U%(VQ]G5M%D<(%VMFDR/\"Z[W'A=N=TP5.0K::FQ>9\KY*>:AGH
M9IFIA2D.K$E??NO=/=)W)NR>KCW)]UAJG9)W!A*__)($6%NN-Q]@;TZ]QFXS
ME)6:4QI2X[&YN1PJ@1/)'8)ZA[KW2IZRW/W)N7<&#S>Y,+0T77.X-CG*4Z1I
M0#+T>Y,SEI]P8D5#K7+4C$8S9]53XQ@8/--D(GE8*C7'NO=&&]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=?_T]W3XS?\R[W#_P")P^2/_P`$!V5[]U[H6=P[
M&VCNN@RV,W%@,=E:'.R8R;+05$1'WTV&FBJ,3+-+$T<WEQT\"-"P8,A46/OW
M7NDSM_I7JS:V<HMR[>V7BL5GL?3FEI<I2FK%6L!BJX/'*[U+BJTP5TJ*90Y5
M7L"`!;W7NE=)M#;$T-'3RX+&/!00Y>GHX6I8S'!!GXY(LW"J6L8\JDS?<`W$
MI-VN>??NO=1:C8>RZK#5>W:C:^$EP5=MF'9E7B&Q]/\`P^?:=/#4P4^WGI0@
MB.*@AJY52&VE0YM]??NO=*J*..&..&&-(HHD2.**-52...-0J1QHH"HB*``!
MP`/?NO=<_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__U-W3XS?\R[W#_P")
MP^2/_P`$!V5[]U[J!ENTNR=I97>^3W9A=B'K[K^HQ];N3(8&MW?7;FI-IY-9
M*E\\F*7;\\%3)M[&#[JNAB9RT,4OB-PH/NO=<Z#N[.5NY=AT-5MS"[<PN]L;
M+FZ"/<^9R&)W+E\/6562.*.W**?#IBZS/X_"4M)7Y3$2U,=?!'7B-$=H'+^Z
M]TP9#O\`WEA]N8K=E7L7#93%;WAV7GNO:/![@KGS%=MC<^]-G;>JZ;/4];AH
M(*3<]+@MYT]=314[ST]14+)2L\>E9I?=>Z<4[]R-5NC$X>#'[1QN+K=^YS:$
M61W'N.OQ0W&F.S:8JFIMI5JX>HP\^YVHG%<:"KGIVJDDBAIC([N\7NO=+S.[
M^W>^\\CMG8NU\3N*'9\6VZS?`RF<?"9*6EW2]9]E3[25J*HQU77XZAH):NH^
M]GI(77QPQL7=WB]U[H)<Y\BMU87:D.\ZO;>T<=MO>6+Q.X.N<UE-QU]/146#
MR6\ME;8^Y['48L/AY!BM[094?8FJC2*":"1E=$DE]U[J5MGY(Y'*8P5F0V[@
MZFF?`;^KJ#=&VLY5Y#:&X\GM&LD7#';]95XREJJK`[NH:6J\%65*I6T4L"F9
M6AED]U[I/4OR9SM9#OJN%7U)CJ?:V?SN!2@RV;W;2UV'3%]GP]=0YK=U<^!3
M#TN,"R"KG^VEE9/(B*3ZF'NO=&'ZDWS5=B;+IMRU:X"5I<EF<?#D]IY&KR^U
M,]38O)5%%!F]N9.NHJ"HK,77)#<,8R@E5U225%65_=>Z$SW[KW7O?NO=?__5
MW=/C-_S+O</_`(G#Y(__``0'97OW7NA;K-GX:N&[A.M5_O\`;')B\X8ZJ1"U
M+'C9\2HI"/\`@)**2I;U+SJL?J/?NO=)O,=3[9SF<QV:KZK<#14%=MC+28%,
MS4+M[)9C9<[56U\K7XYE=OO<55^.2\$D"5+4\(J5F6)%'NO=-M+TIM&G>F\M
M9N2OIL75[=GV]CZ[-/)0;8I-K[KQV\L5B,%310PB#&#,X>D$HE,TTE-310&3
MQ(J#W7NFRD^/FP\;'-1X>HW-AL)6[BJ]RY;;>-SLL.W\Q5U>ZWWG]I68Z2&9
M*?&T^;D;QQTK4S"E/VQ8P`1CW7NE+NGJ?:^[LX<YDI\[2O5TN'H<_C<3EY\;
MB=V46WLJ<U@Z7<E)`NNMBQM>\FDQO"\L$LE/,9*=VB/NO=,\?1>R5D0RS;AJ
M:6BJ,?)M_&3YF7^&;4IL=O/"[]3&[=HXHHDI<?/N';U$767S2+2TZ4T;I`HC
M]^Z]U*KND=@9'';EP]505IQ>Z%RPK*&'(U-+!0/F<\NZJR;"_;&&3%S#=&O(
M1M&UXZJ5V'#6]^Z]U(Q/4V(PZSTD.X-V5.#EW'5[KAVY65^-DQ%%F:S>+;ZD
MGI'CP\.6$*;A=W2*2JD01N8[%;6]U[I;;?VWB=KTM90X6G^SHJW,9?.M1HW^
M305^=KILIEFI(K!:>&LRE3-4,B\>:9R/K;W[KW3[[]U[KWOW7NO_UMW3XS?\
MR[W#_P")P^2/_P`$!V5[]U[KG'\CMF2[C?:28C=7\?&&RF8CHFH*",3_`,*[
M1EZDGQT51)E%@_B,NY(_/&C,JMCV$^H<J/=>ZG#OK;^03<$.UMN;HW9F-O\`
M8\W6,F#QR8'&U>1SE/CZK)3Y#&UNX\[A</-@4@Q]2@J'J4+S4TD:H66Q]U[J
M;A^Z\-GLEMS%8O;.[JJMS./I,EEX8Z/$M-LVFK=PY;:<+Y^!<RT]7#%N/`UE
M/438M<C!2)!YYG2G>.5_=>Z89/DGL:-=TZL7NP2[5SF_=OSPOBJ:%\M6[!V]
M/N6HFPK3Y"**LQ^X\?1U"XJH+)'534\BDQA;^_=>Z%;:V],1NZ">IQ@J(X83
MBU5ZO[:/[ELKMO#[HB%.(:B<R&GQV;A$OTTR!@+J`Q]U[I7>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO__7W=/C-_S+O</_`(G#Y(__``0'97OW7NHS_'BA
M_O97[NCW57FNJ>UJ?LNBBJ:"*H3%TD6"@I9]G4LOW<3C#5FZH3F)&&F\SE-%
M[RGW7NF^A^+&Q*>+%T.0EDS^$%)MQMT[?S]/)F<-NO.[>_O;/_>)Z#)UU93X
M:KR62WI654T5*H@$HC*J#&#[]U[IVK^AY*FAV%AZ?<U##B.NI]OS;7>IVC05
M>XL`VV<S-6T,FWMRK7TU;C)LKA5I\5D_*E5'64<+$)$\TA/NO=-=/\8=K8VF
MVW18;+Y"CI,%7;#R=6M:U?FILK7;-J,\N0E\N3R\RXZ/=F)W17TM7%"HA03:
MU4V*M[KW3OLSXV=>[=V=_<W<]#3=C4L.=W1E,?7;MQU)55F,QNX,O35E'@*)
M_6::@P^'Q>/QP\9034]$BE5C/B'NO=&#5550J@*J@*JJ`%50+``#@`#W[KW7
M?OW7NO>_=>Z][]U[KWOW7NO>_=>Z_]#=T^,W_,N]P_\`B</DC_\`!`=E>_=>
MZ$T]E;`$\U+_`'OP)JJ>AJ\G-3#(0&HCH*#<4FT:RJ:`,9?%2[HA;'OQ=:M3
M$?7Q[]U[KV3[*V#AL+D]QY+=N#I\)ALS4[=RN2^^BFIZ'.T=3]I6XB<TYE=<
MA13W$T5B\05BX"JQ'NO=2JG?NRJ/%2YVIW3@XL+"XCDRK9&F./5SA5W&H%4K
MF%@V!85@()!IR''IY]^Z]U[^_NR_L:G)C=.#./HQN9JNL7(TS4U-_<NN;&;M
M6>59"D3[<R*F"L5B&@E&E@&X]^Z]TAA\ANE&EPD"=C[<EFW'*M/A889YYI:^
MK:HGIC0QQQ4[O'D(Y:63R4[A9HT0NZA!J]^Z]TIH>UNMJBMS6.BWOMLUNW<M
MB\%FH'RE-$V/R^:R\.WL503-*Z(T]?GZA*"/26!K6\%_+Z/?NO=/.7WIM3`X
M#+[IS&?QN/V[@):N#,Y>HJ%6BQT]#6''5<%3(-6F>"O'A*`%O+Z0+\>_=>ZB
M8WL/8^7VK5;WQVZ<-5;3H8JR6NSJ5L:T%`,??[Y*YY"CT<]*19XI0DBD@%>1
M?W7NG3;.Z-O;SPM)N':V7HLYA:[S"FR%!*)8'>FFDIJF%N%>&HIJB)HY(W"O
M&ZE6`(M[]U[I^]^Z]U[W[KW7_]'=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z"6I
MZ'[`I>P\KOC'TF"J)*3M"8[=C2LI*`5/4E;)!VG78O(K]DY%3+W)Y(Q%]?$W
MW!N0I]^Z]U%PG0_9FP=M9K$P555O:IRM5M3>YRNT\[A^K]RXGL1<7DL#N^LV
MS40XY\3-_$H_M9JF7*+,F0IYZR.9'8HDGNO=<-T?'?LO/[/S4M?G9Z_?&6FJ
M&K<-1;GFQ_7%745/2_\`<FIR=+MW["FHJ6HEW*25(@BTH?*$06C'NO=*O(]+
M[[%7BJK%IC%I:&MW5O&OH#FZB,Y3<])VMM;>6"P'B>GEHJ7"[XVU@/MLA.I'
MVM5$DC0SF20^_=>Z6.W-G]EUV2V)N#=<<4<V-[7W)O*NHZZMVU+FL7MK*=4;
MDVCCJ'*5>TL!@L)F\K19S*)$CHDTBX_Q>2HE:-O?NO=(:CZ7WAD*386U<[M[
M"PX7JO'8[9U-N*+-*<GOK!S;IV3D<CEX(*2&*KVX$Q6TEJ9HY)VJ6RQ7Q'3$
MM1)[KW3SDMG]CU?4V_=A2;>AK]WIN'^]F,JH,NL&%W/%4=IU^X*.F@S.0IX/
MM,Y-@,)!45BRH8Z>IK536ZCR-[KW2E7:^_LEBMSYVJVMC<3N'/;UVQV#2;5&
MXJ66!&V2-G4E)@<OG*:CEICF=P4VWI9#40Q34M-^S&SOI+^_=>Z%79+[EEHZ
MZJW/MG#;6KLE6G*+08>MAR!C2J00K!F:Z&.&.OW!3PTL9JIXU-.2ZQQ/*L7D
M;W7NEK[]U[KWOW7NO__2W=/C-_S+O</_`(G#Y(__``0'97OW7NC`^2,`DR)8
M`L3J6P4&Q8F_`!_/OW7NNRZ*+LZJ+$W+`"P^IN3:P]^Z]U#_`(GC=#2?Q"A\
M:Z`S_=P:%\@+1ZF\FD>102O]0./?NO=9C5TJ^`M4TZBJ*BFO-&/N"UBH@NW[
MI;4+:;WO[]U[K-J73JU+I_U5QI^MOK]/K[]U[KO4MR-0N+@BXN+`$W'^`(_V
M_OW7NN(EC9S&LB&0(LAC#J7$;E@DA4'4$<J0#]"0??NO=<_?NO=>]^Z]U[W[
MKW7O?NO=?__3W=/C-_S+O</_`(G#Y(__``0'97OW7N@!AZRWM3]M5.93:^<C
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M!G.PN@=L=$':&]:7)3Y*GPF]9]V8C>FR,=C\;AZ_-;F^^7=YPW^Y`5E?A*6&
M*7'BJCFEJ8P]HG8^_=>ZZVUMOM.KJ:G>F7VEN#&;LPV5W=G*C&2/5O29^NIN
MINDMHYO&130M!'E:+==1@\PN+D90C5D,,Q`\9'OW7NE-T_@\Q@NR<(AV;G_)
M6;5C?<^9W5L[)8ZNVNR;,V914M)M_L"*L.$W!MW+5.)BC;`RI)7XNL29[QQQ
ME??NO='0]^Z]U[W[KW7O?NO=>]^Z]U__U-W3XS?\R[W#_P")P^2/_P`$!V5[
M]U[H8*;=^W*NHW52Q9.,2[)FCI]T&>&JI8,3)+BJ?.+Y:JJ@AIIHQBJJ.9GB
M>1$5K,000/=>Z!S*_*CI+"4T55EMRY?'PRTAK&^ZV/OF&:ECDJUHL7#D:9]N
M+4XNMW'-)&<5!4I%-DXYHWIEE21"WNO=.+_)+J*GFR,%?G<OB)L3C$RE='F=
MG;QQ31HV/QN6./C^^P4`J,['C,Q2U#8^,O6K#,K&*U[>Z]UPG^2?5%-NS(;+
MJ*_=,.<Q,]9%DO+U[OU,31P8^+#U-;E)L^VW!A!A*:AW#05+5HJ#2BFJXI=>
MAPWOW7NG^F[RZQGQFV,O+N&;&T.\<EE\7MY\W@MP8*:NJ,'@LCN?(3/29?%T
M551XY<!BY*J.KG2.FGC:+QR,9H@_NO=<J3NWKFMQ&#SE/E\DU!N">KBQX?:^
MZ8:U(*`TPK<KDL9+ADR6(P%**ZG+Y"JBAHE6JA8RVEC+>Z]TF:3Y-=15M3-1
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MW=/C-_S+O</_`(G#Y(__``0'97OW7NAFW-!03;;W%#D<?6Y/'U.%RD.2QN+I
MY:G)9*CEH)HJJCH:>G*U%36U5.3'$B$.SD`<V]^Z]U7#6)\8L[%O3+[RJ^UJ
MO<E5UO,,OOS>VP:`[GH\4V)7-X6IQD9VA]G_`'GJ=H8BGIZ1$H67(4U.BRK+
M42N9/=>Z5&YL?\9<=2;?R&X,YO+=#;KWI7T\LVV<!0XR3>DG76T=O_<XFO39
M&WMO1TNT<*FV\?FX4H32*U?`6B+1RS02>Z]TYS4?1=)N.+>=+O[L8S;.V_GL
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MZS'XJ3#M4[..R(-CYO;#04"55`LF,>$RRU#%;S2JWNO="5@OBML+"4!PYRF:
MR6&@FDK,11UF-V33UF&R,F)R>+CR=+G<5M+&YZIKZ!\H]11/45,WV$R1BG$<
M2"/W[KW0C=>]28+KK*Y_,X[)YK*Y#<%!@,/++ECB46CPFV%R(PF+IXL/BL3%
M.E"V7J`L]2)ZLPM'"93%#$J^Z]T*OOW7NO_6W=/C-_S+O</_`(G#Y(__``0'
M97OW7NC">_=>Z+_E_C)U)GH4I\MAJVLB^ZVE-4ZLG41S5])LN@I,?B<)7U4/
MBJZG`3K04\M71F3PU,\".XNOOW7NHE#\6>HJ`X.!<7D:G#;8;-2;;VW6Y#[G
M!82;<6WY-MYN>BIWIQ5--74#(^J6:4P5$220^-M6KW7NILOQLZVGGJYIEW#,
M*^DW+%6Q29N5TJ<CN[;N1VGGL])(T1J5S%?MW)O32%9%IY/'#(\+30QR+[KW
M2`QWP;^/6+K,GD:7;V<.0R+T[Q5E5N;*ULN)6#+2Y-X<2M7+-#3055.T6/E1
MTD!QM-#3C2J<^Z]T)$/QUZV@W%EMP1454$SF0Q^3RV`<8N?;]75XK,5.<H?\
MDGQ4M534D5=5N6IH9XZ:53:2-R+^_=>ZY9/H+:V0RF"R\&X-ZXBKV]2;0I*'
M^&9BA,<G]Q6W-_=>HJUR6(R+3U..@W=6Q$W"S1NOD5V16'NO="=M/:.W]D86
MEP&VL;38W'TRK=8(((IJRH\:1R5V0E@BB-;D*D1@RSN#)(1=B3[]U[I2^_=>
MZ][]U[KWOW7NO__7W=/C-_S+O</_`(G#Y(__``0'97OW7NA7S+;GQD.Z,SCY
MX,RD&`J*C;VV%QIBJ'S-%254T<+Y*.K,E4F3J`D>CQ(5XL?K?W7NB`UG=GR0
MECW_`)+;60@SFSMD;"ILU2;XJ]B18*FW#D,PF>&0GBVQ60S;CBR.S]PT)QD=
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M^Z]U[W[KW7O?NO=>]^Z]U__0W=/C-_S+O</_`(G#Y(__``0'97OW7NANS]7D
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M+L?#XW9F9KJ=*A,/B<G0YK*9YEHQD9<F:NNEHX:!ZNER$5`U(/M:V)S/[KW0
M]]7;EEW+M.@J:S.)N/(1*_ES*[=K-JME<=-45#X',R8.LEF>C?,X58:FZ%(I
M?)Y(XXD=8D]U[H1O?NO=?__1W=/C-_S+O</_`(G#Y(__``0'97OW7NA$Q'9.
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M8^#(T],]?B,FT<-0-<7^Y#`9'+8:K#QV8/35,T1!X8^_=>Z47OW7NNB`000"
M""""+@@\$$'@@CW[KW7@``````+`#@`#Z`#\`>_=>Z[]^Z]U[W[KW7__TMW3
MXS?\R[W#_P")P^2/_P`$!V5[]U[H8-XKA6VCN@;D2:3;O]WLT<]'325,4\F&
M&.J3E(X9*.6&K61Z(.`8G5[GTD'W[KW5=>\NU.AURF3VMGNC]T4-7USA=S[G
MW%M+:N[\32TF&@SN(AW%68W)X+8^[EP]9C*NFV705F3@F!IL55K'/)&3JF;W
M7NN59W-\>9=ZPY#<O4\]'D)MS=<97);II-STN5?;V1DS,M3B,ICX:"OCJX]L
M8^:2:NSWVBQTU2KU+U4-23)J]U[ICV=W/\;*G=6SJ/:_369QU?%N+%4NU!-O
M*GHL#BZF@EDS`S<F+7<=114>7A+BGIW^UDGK:%$I_**>-(1[KW2IPO870.]J
M?:9?J+=U-CL-2[)PM.)-Y+0;:IMIT&=Q6$V-ELC))N_'8C=NX]L[AW"E/'1,
MM9E\>TLVDG7$LWNO=#QEOE(N"[.7K3(]8[D6>;=M=M6AR=%F]LY!LH<?_<BH
MJ:_&82EKVRU2D&)["QU;)`46=*=:DZ2U.RM[KW45_F-L!MO;CW#18;-9"+;-
M9C,?7T]/4X@E:O,C?<^-C>H^^:"%9L=LC[IF)]$.0@X+"14]U[IVV_\`*;;^
M>K,3C1M'.4%;59/!T69-=E=LTN/Q-)N;*4V!V[E*'(5>6IH]ST^?S-24HHJ!
M9:BH@ADE"#]M9/=>Z?<K\CMK83L/L#864Q60IUZZVMD=TYO/I6XB>DAI,5MO
M;^Z*K[[&Q5AR^(I*FAW'#%1U=3$E/65<,\,;:HN?=>Z&'9>Z:+>^T]O[MQT4
MM/29_%TN12EG>&2>BDFC'W%#424TDM-)44-2'AD:-VC+H2I(L??NO=*?W[KW
M7__3W=/C-_S+O</_`(G#Y(__``0'97OW7NACW=DJ7#;3W/EZZA3*46*V]FLE
M68R31HR-+0XVIJJBA?R1RQZ*N*(QG4C+9N01Q[]U[HE>V3UMN/;VZ\10]!XF
MER6<RVSL%EL3G\SN3;G\=AI-C;@W7AWR^3W-MO';IQZ[>VU!5T5''-1V\,L<
M4;)2,I7W7N@QV]W]UMN+=.SIL'TAF:VNWQN3#TF`RFZM];NAI:C*T6XSM3;>
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M<577S-45;4E*\CP4$,T[LYB@6.(.S$*"23[KW3W[]U[K_]3=T^,W_,N]P_\`
MB</DC_\`!`=E>_=>Z'.HEQ%?2Y2DJI<=644<4]'F::>2FJ*:."6F)JJ7)Q2%
MXDBDI);NDH`,;<BQ]^Z]T7#+[P^)&Y9YLSF\CU'FZC)X1\I4Y'(TF'KGK,+M
MAZF&.IJ)YZ:3R1X]<;**;6=;0Q,80T8)]^Z]U.J<_P#%G<J)C<A_HLKTVWB*
M[<T-)D\-BHOX%B\U4XW-Y3(TL==00G&M7U4M)65(CT2LS132#E&]^Z]URH.Q
M/C*N=PN+Q6<V+09O`Y3+XW$T.-I/X6^.K)Z.@PN<I&BIJ.F@BH11ST<=2);4
MJ**9GMIA(]U[J?BJ?XS9?'[/R^,Q_5%7CY<SD\?LJM.,P'C&;P\55NC)4^(:
MIIE:&KQM/MV2O.D+XHZ59ELJHWOW7NA8V;N#:&Z,%#FMCY'$97;]759!XJS"
M-":*2M:MGDR3$0J@6IEKY)))=0#.[ES?5<^Z]TJ??NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U__]7=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z&C<.,QN4V_N#%Y-_ML9
MEL/E*'*U$12&2.BK:":EK)Q*4=5DCII&(9@UK?0^_=>Z()DNO^H,AD.SVW7O
MK>&9W_O?$;7VYE<C)L+<&-@QF3VQAY:+%Y#'[7I((<1-EJ79^9I35%KR003&
M:)J<5#(/=>Z]DMC=&[]QE;G*[L3=<?W>?P.7W-%MK;F?P>7JL3'LK:46)H,5
M2Y*+,9W`XFJ3;E%DY:Z&22HG@-122RF)BD?NO=+R#;VRLWD]OYJ+>6X\E68?
M;F>6>/-==YK(-N/&YO'==X*LGQU$YIH*O,S1=915"0S19"&6.IE>6E>$"WNO
M=)_-=9['J<EM7:FX>U>Q8,ML7^\.\L!6T6T<A2[,I:7+3;.RD\:)78[,;>K-
MMT6#I8\6F*,\E.JYBIIUC5'CIXO=>Z&O:.[]@].[5Q6(S?8&2W!2YD;CW/C<
MDV"R;8S%[?QU9B:"JI\?2XVCKH\#MG#U65HZ>""65@DM2$B"QZ8HO=>Z$JJ[
M6V51T=572U]<T-(&GD6'"9F>IDQJ4T=7+G*:CBH7JJO`0TTJL];&C4ZZ@"UV
M4'W7NF].Y=EM5TM%(-RTLU7]H8C6[0W+20JE4:Y?)-//C$AACI7QE0)BS#QF
M!P?TFWNO=.L/:>Q)M`;/14LKTAK?MZZDKZ&H2%2599(JJEB9:D2CQ^+_`#C2
M$*%)9;^Z]T[#?6S6_B(CW-A)7P\LD&7AAR--+48J6&LBQ\ZY&GCD::B^VK)E
MCD,BJ(V/JM8V]U[I5:AIU7&FVJ_XM:][_P!+>_=>Z__6W=/C-_S+O</_`(G#
MY(__``0'97OW7NA_G@BJ8)J:>-98*B*2":)Q=)(I4,<D;#\JZ,0?\#[]U[H*
M(>C>N*6:NK*+$5V/R^4RLF8R>X,?G<W1;BR-5+204#Q5^<IZ^/(U=`U%3)']
MM)(T'I+Z/(SNWNO=>I.C^O*+'+C:>@S""-!#'7G=&Y),PE&,=C,/_#UR\F4:
MO&..(P]/3&'R>,PH1:[,3[KW3C'U'L=*1J9L?73S-CY<0N5J<SEJG.PX>2.I
MB3#PYR:L?*)B:9:N3Q4WE,,>HV7Z^_=>ZEY#JS864J*"LKMO4U158NABQN.J
M3/5I/0T$9P^NEI)8ZA'IX:N'!4T-0$(^XIU:&35%)(K>Z]U"KNF^M,E`U+6[
M4H)Z=:+)8^AB+U2KA*7,3QU647;A2H5MN25]3"DDLE"8'9D7GCW[KW4:MZ3Z
MVR%+F*.KP!D@SS4Z94?Q#(J]5CZ6E@H8\(TJU0E7`&DIDC:C4B!E1;KZ$T^Z
M]U+INIMGT%5]QC4SN*IUR$&2@P^+W/G\?M^BF@IIZ0P8[`TN1BQ6.Q]33U,B
MRTT$4=/(9&)34Q)]U[KJFZ>ZXIG25MLTM9/'5/6K49*HK<E.*J7&/BIY1)6U
M,[+]S!(TLBBRO5M]R1Y[2#W7NNHNHMCI)N%YJ&OKX]TJHS5-D<UEJZGJR)XZ
MAW,=16.$>2:&-B1_:2XL2Q;W7NA'\*_;_;ZYM'A\/D\TOW&G1HU_<:_-YK<Z
M]6K5S>_OW7NO_]?=T^,W_,N]P_\`B</DC_\`!`=E>_=>Z7F:V/X*_<.\]MU>
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MACH8<5FJ9B_BEW)D,]28JKJPD38>)?O9*1H`_NO=&+Z$.\O]'5#'OI-UC.09
M')P?<[SEI&S>0I(ZC3%D7I8$^ZQE)5R^1H:6JEJ9X$](GEA\3'W7NAG]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7_T-W3XS?\R[W#_P")P^2/_P`$!V5[]U[H;=PO
MEXL!G)-OQ13YZ/#Y)\)#/H$,V72BF;&Q3&1XXQ%)6!`VIE%CR0.??NO=5ZYO
M=ORLJ:??.2VE_I.I\#M[`X5=J5>Y-BX3^]&Z,SD,'NN7.,NSH-D4=5^QN:FH
MZ0.61<:OCGABR5++J;W7NG%]Z_):IW3#2;37>E1$^;V')@XMU[,W)1[<R&`U
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M]?,.:CS6#S6UMS87<U36X:?;=708#!Y;$G;_`/#=\YK<<U?N#'8C(X3&9&FE
MR>$Q\5/+JJ9'HQX8I7^Y+>Z]TM]O[B^1F.W;38C=<.\\AA:?><6)QE3B=O8>
MHIJ^.3<V)CR$>Y,]!M-5FVKA]F5#STF3,&'7)3&<2205,45/[]U[KE_I&[JK
MLWN/:D>&[%AKB^;Q6)R+=>9+$8,5L7=V=AHZBGWG/L[)X""D;J$49BK66JIR
MMI`LM3J5O=>Z-WM.DW!0;;PU'NK)0Y?<-/0Q19;)4Z1I%5U:WU2+XJ/'Q2,%
ML&=:>G61@7$48.A?=>Z4/OW7NO_1W=/C-_S+O</_`(G#Y(__``0'97OW7NA?
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M*W`;>&,HLON:APN-Q<%+0;IS66J*J:K@!4_8P%XJ>Q$GNO=3-R?Z<#N'.Z/]
M,(IUW?FQ6C;IQ/\``GKFERAZA;9@=#6?W$CPZT8W;Y&$/W[+K!7[LCW7N@\H
MHOF'_>?&P;CJ=\SXL4\G\'DVU#AJ+'5>4S.].PVHHMW9"::>HQ;[,P1I4<O1
MU&,RF+^T,CT^0\3CW7NG:6K^1.9I=^4&0I>YL7_>3J7'?Z/:C%Q4V/J\+V1L
MW;..I\X<G6TK3#"ON3=F,JGIQ.6@R4,P9"(Y5O[KW7/=\/S"H<KO"/9\&;EV
MW'M[>TNTX:G,T.3RV3I,&<?U_BJ*HK*VDBJ,-O3)X^2+=>,D:6>.LJX*J.=D
M$WA7W7NA3_T=]B?Z//X?_?#N+^/?Z>+_`'G]\I?XY_HU_P!*_P#`O^!7CM_`
MO]&?^5:;>75^_P#YWCW[KW7_TMW3XS?\R[W#_P")P^2/_P`$!V5[]U[H;=PT
M^4K,!G*3!U24.:JL/DJ?$5TA(CH\I/1318^JD(24A*>K9'-E;@?0_3W[KW1(
ML)U#WID\EN_(5F4W-M3;U7B=AX[8^U=P=@9S=F<P,\>6>'L6KK\[B.P*>"M;
M)K'+7#7+/+44E5'3Q244D9BC]U[KV2ZS[ZH6W)1PKO#<$+9'(3[5R6)[2K,7
M08[;M/N.>IK<%4;9R>[J2IRU7NK%SPFB2HR<7V:4YC?(4I4"H]U[HZ&SH*RF
MVM@(,C25=!718JD2KHJ^2.6MI9UB42054D.>W1$\\;<,5R-:"?\`=S_7W[KW
M2D]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__3W=/C-_S+O</_`(G#
MY(__``0'97OW7NA0K:O>&+3=V4JYMIS8FAQ5;7;;@*Y3'5"3TE)+/IW)E)9Z
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M+4T=/2Y/+1245'DVFBIIS*LE33HDKQ0.[0Q^Z]T.OOW7NH\/VGBC^W^W\/\`
MNGP^/Q?K_P!UZ/3_`)S^GY]^Z]US'@LNGPVUMHMHMY-9UZ;?V_)>]N=7^/OW
M7NH<'\)TK]K_``[1YYM'@^VT_<^%O/I\?'G^WOKMZM%[\>_=>ZF+X-1T^+7Y
M3?3HU>?Q^J]N?+XOK^=/^'OW7NFX_P`#\O/\)\_F-[_9^7[C3S_M?FT?\A6]
M^Z]TX'[>\FKPZN/-?1?]!T^2_/\`F[VO^/\`#W[KW6!/X;]RGB^Q^\^V7QZ/
@!]S]IQHT:?W?MOZ6]/OW7NIOOW7NO>_=>Z][]U[K_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g611784g27z39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g611784g27z39.jpg
M_]C_X0M[17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``+<;````G$``MQL```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q,SHQ,#HQ,B`Q,CHP-#HR-P```Z`!
M``,````!``$``*`"``0````!````[J`#``0````!````)P`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```I%`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`&@"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`X^C%S<W+=C85-N5>2YWI
M4M<]VW=MWN#?H5[G?SC_`&(MW1NN49->)=@95>3=N]&DUO+K-@WV>AMW>MZ3
M?=9Z?\VK_4+'87U8Z?7B.=6WJMV;;U`UNAUS\>W[/C8MA9ML]&G'=ZOV??Z6
M^WUE5RNDY6)TJK.KZA1EX+<C[.QF+=<[TKK*SD/_`$=U5#*M]-7Z9U*T1(GL
M!=#Z-(P`O<D#B-,3T#ZQ@2>EYP`Y)HMC_J5[)]3/_$GTC_PG3_U#5Y%U2RW]
M@_5W](_7'S).]VOZT_GW+N['V/\`J+]6<#<YF-U.S!PLUS=P/H6MFVKU*RUU
M?VEU;,5SO^'4&>Y1C=?,1_BLV$")E5[`ZO4-^LWU<=D_96]4PSD%VP5"^O<7
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MV7U5[/3_`,$H])ZSU_\`:6)7D6V]0;F.+<N@=.R,2O%AEEGK8^7F5T^KCLL:
MRA[<IWVBW?ZE7^A2X3NJWKE7S>H]/Z>QMF?E4XC'G:QU]C:P3&[:UUKF[G;5
MQ_3^O_6BSZL/^LV1?0^KTW,KQF4.(;%[:+.J9+JWON<S&H;??9AX[/YG_#*U
MT*RSK'4\C&S,['^L73,&ICF90QJO3^TVEV^L7L?92^W&QV-_HS/YO,_6/TM?
MZ4\%$V=E7>SOU?6#H-]S,>GJ6);?:0*ZF7UN>XG4;&-?N<KZX7$;1TSH-_4<
M'`Q;<ZKK%M-&^MC#%F><3TV7M9NH_16^G79_@?\`1_X-:?5^H=6Z9BXK<_K.
M'B960]_T,.VYSR/3+:,/#9DOOLKJ_2>O?[_IT_S*!B+T4">KTZ2Y/I?ULZAG
MO^K9=72QO5SF,S`T//NQ&O:VS&]0UOJ9;;3ZGIWUOL97^B^FFZM]:NJX5_7V
M4557?LIW3AB5D%I?]K>VN^NVS?M]V[]%9M_1?\(EP2NOY?-P*XA_+_&>I?D4
M5VUTV6,9;>2*:W.`<\M'J/%;3[K-C&[W;41<U;?U3&ZST*CJ8P\K(S+LG]+7
M26FAK<9UOI8EMMMC]V]CV6Y'L]>G_`U+-L^M'6[,ZNJG,PZ<F_/^PGHCZ'V9
M550L>QV<[T\AKW?JK/MCWOJKPOLO^&_TRX56_P#_T.6Q>J78C,C#LHJS<"^T
MV6X>0';!8T[6Y6/92ZN_%RO3_0^M2_WU?SB?-ZO]HPF].Q<.G`P6W_:C54ZV
MU[KMGH-LMR<NRRQS65>UE;-B=WTG?\C_`$G?E*;_`-PZT?3?C?TXO^^:9X^$
MZFO+7A_QD&1FVY&'@X;F-:SIS+:ZGB=SA=8<E_J?F^UYVLV+V/ZN=/P^I?4;
MIN#G5-OQ<C"I;;4[@C8T]O<U[7>^NQGOK?\`I*UY'_[AU[/]4_\`Q,]+^A_1
M:OYKZ'T1_-_R5#S/RQK]X_:R8+N5]ANT[?JIF7X[NGY'7<Z[IME?I68[QCFQ
M["-KF69WV;[2]KV^U_\`AO\`A5IXG2,?$ZGF]1K>]UF>RBNQCB"UHQQ8ROT]
M-_N];W[WO5])5CQ?[S/HX>)]6\C!MJKPNJY5/3*7!S>GQ4]H`=O;CUY-M+\I
MF)_@_1]7^:_1UVUI[_JW8W,NR>E=1OZ4,QXLS*:64OKLLC:_(K9E57?9\FYO
M\];5_._SEE7J_I%MI)>K^7[5:-*CI55/4[>I"Q[[KL>K&<UQ!;MI=;8Q_P!'
M=ZCG9#]ZH6?56GTJQC9E^-DT9>1G49+16XMLRO6]=AJNJLILIVY5C?H>I_PJ
MW$DA:M'%QOJOB`9=G4[K.JY6?3]FR<B\-:?0@_JN/7C-I9C4;G>I^B_2/M_2
MOL_FU/I_1>H8>16ZSK&7EXE(BK&N;22?::_UC*90S)R-L[_=9O\`4_G?56ND
MEZM?Y?XJM'DNL]%'2/J=5T3&;;E=/]5M.=:6"V^O%ML=9E9----?Z2ZCU/9L
MH?Z#/UGT[/11/JOU&W(ZD_'P<_(ZQT9E!)R\FK:ZN\.8&8]>8*\;[;ZM+[7W
M?H;+,?TJ]^1^EV+J4D3=&][/^,C2Q3C#ZM5?LY^!Z[]K\[]H;]HG=]I'4O1C
M]W>WT]R?JW0;\S/IZIT_.?T[/JJ=C/M%;+FOH>YMKZO1O]C+66ULLIO;_P!>
MKOK6PDAZK3H\S5]2_LV!BT8G4;J\OIM]]_3\U[&6.8W(W_:*,BMXV9;+?5?Z
MEGZ.[?\`X2M/_P`S?4KSSE]1NR<GJCL-^3>YE;8?A/%S/0JK:UM=-FW9Z;O4
MV?Z6VQ=*DG>O7^S][_OT>EH9O2:\SJ?3NH.L<QW3'VO96`(?ZU3L8[_SO8U^
MY</@=2NP',R,/--GUBS<O?U#ZN/I'NLM+?M5-+G-?FX56/1^F9G6Y=V`_P!#
MUO3]*STUZ.DA&ZUVI1KZO__9_^T38E!H;W1O<VAO<"`S+C``.$))300$````
M```/'`%:``,;)4<<`@```OC;`#A"24T$)0``````$*!866B0-<4GG0XH9N[Q
MH;@X0DE-!#H``````.4````0`````0``````"W!R:6YT3W5T<'5T````!0``
M``!0<W138F]O;`$`````26YT965N=6T`````26YT90````!#;')M````#W!R
M:6YT4VEX=&5E;D)I=&)O;VP`````"W!R:6YT97).86UE5$585`````$`````
M``]P<FEN=%!R;V]F4V5T=7!/8FIC````#`!0`'(`;P!O`&8`(`!3`&4`=`!U
M`'````````IP<F]O9E-E='5P`````0````!";'1N96YU;0````QB=6EL=&EN
M4')O;V8````)<')O;V9#35E+`#A"24T$.P`````"+0```!`````!```````2
M<')I;G1/=71P=71/<'1I;VYS````%P````!#<'1N8F]O;```````0VQB<F)O
M;VP``````%)G<TUB;V]L``````!#<FY#8F]O;```````0VYT0V)O;VP`````
M`$QB;'-B;V]L``````!.9W1V8F]O;```````16UL1&)O;VP``````$EN=')B
M;V]L``````!"8VMG3V)J8P````$```````!21T)#`````P````!29"`@9&]U
M8D!OX````````````$=R;B!D;W5B0&_@````````````0FP@(&1O=6)`;^``
M``````````!"<F1456YT1B-2;'0```````````````!";&0@56YT1B-2;'0`
M``````````````!2<VQT56YT1B-0>&Q`<L````````````IV96-T;W)$871A
M8F]O;`$`````4&=0<V5N=6T`````4&=0<P````!09U!#`````$QE9G15;G1&
M(U)L=````````````````%1O<"!5;G1&(U)L=````````````````%-C;"!5
M;G1&(U!R8T!9````````````$&-R;W!7:&5N4')I;G1I;F=B;V]L``````YC
M<F]P4F5C=$)O='1O;6QO;F<`````````#&-R;W!296-T3&5F=&QO;F<`````
M````#6-R;W!296-T4FEG:'1L;VYG``````````MC<F]P4F5C=%1O<&QO;F<`
M`````#A"24T#[0``````$`$L`````0`"`2P````!``(X0DE-!"8```````X`
M````````````/X```#A"24T$#0``````!````'@X0DE-!!D```````0````>
M.$))30/S```````)```````````!`#A"24TG$```````"@`!``````````(X
M0DE-`_4``````$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8`````
M``$`,@````$`6@````8```````$`-0````$`+0````8```````$X0DE-`_@`
M`````'```/____________________________\#Z`````#_____________
M________________`^@`````_____________________________P/H````
M`/____________________________\#Z```.$))300(```````0`````0``
M`D````)``````#A"24T$'@``````!``````X0DE-!!H``````U<````&````
M```````````G````[@```!$`-@`Q`#$`-P`X`#0`(`!%`%@`(`!,`&4`9P!A
M`&P`+0`Q`````0`````````````````````````!``````````````#N````
M)P`````````````````````!`````````````````````````!`````!````
M````;G5L;`````(````&8F]U;F1S3V)J8P````$```````!28W0Q````!```
M``!4;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````
M)P````!29VAT;&]N9P```.X````&<VQI8V5S5FQ,<P````%/8FIC`````0``
M````!7-L:6-E````$@````=S;&EC94E$;&]N9P`````````'9W)O=7!)1&QO
M;F<`````````!F]R:6=I;F5N=6T````,15-L:6-E3W)I9VEN````#6%U=&]'
M96YE<F%T960`````5'EP965N=6T````*15-L:6-E5'EP90````!);6<@````
M!F)O=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO;F<`````
M`````$QE9G1L;VYG``````````!"=&]M;&]N9P```"<`````4F=H=&QO;F<`
M``#N`````W5R;%1%6%0````!````````;G5L;%1%6%0````!````````37-G
M951%6%0````!```````&86QT5&%G5$585`````$```````YC96QL5&5X=$ES
M2%1-3&)O;VP!````"&-E;&Q497AT5$585`````$```````EH;W)Z06QI9VYE
M;G5M````#T53;&EC94AO<GI!;&EG;@````=D969A=6QT````"79E<G1!;&EG
M;F5N=6T````/15-L:6-E5F5R=$%L:6=N````!V1E9F%U;'0````+8F=#;VQO
M<E1Y<&5E;G5M````$453;&EC94)'0V]L;W)4>7!E`````$YO;F4````)=&]P
M3W5T<V5T;&]N9P`````````*;&5F=$]U='-E=&QO;F<`````````#&)O='1O
M;4]U='-E=&QO;F<`````````"W)I9VAT3W5T<V5T;&]N9P``````.$))300H
M```````,`````C_P````````.$))3004```````$`````CA"24T$#``````*
M80````$```"@````&@```>```##````*10`8``'_V/_M``Q!9&]B95]#30`!
M_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3
M%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-
M#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`&@"@`P$B``(1`0,1`?_=``0`"O_$`3\`
M``$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`````````
M`0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:``P#`0`"$0,1`#\`X^C%S<W+=C85-N5>2YWI4M<]VW=MWN#?H5[G?SC_
M`&(MW1NN49->)=@95>3=N]&DUO+K-@WV>AMW>MZ3?=9Z?\VK_4+'87U8Z?7B
M.=6WJMV;;U`UNAUS\>W[/C8MA9ML]&G'=ZOV??Z6^WUE5RNDY6)TJK.KZA1E
MX+<C[.QF+=<[TKK*SD/_`$=U5#*M]-7Z9U*T1(GL!=#Z-(P`O<D#B-,3T#ZQ
M@2>EYP`Y)HMC_J5[)]3/_$GTC_PG3_U#5Y%U2RW]@_5W](_7'S).]VOZT_GW
M+N['V/\`J+]6<#<YF-U.S!PLUS=P/H6MFVKU*RUU?VEU;,5SO^'4&>Y1C=?,
M1_BLV$")E5[`ZO4-^LWU<=D_96]4PSD%VP5"^O<7D[/3V[_YS=[=BTUS_7,K
MI/0^GMHLZ+9E=,I8Z][,6BEU%0J(LWV5VV4M8YO\ZS8S\Q5[.I];R?K!U#$H
MRJL3IO3:\7*N<:?4N+;!9;=C,]WI_IJZ7_I_\!_@J;/YQ5^&]0S6]0DN$Q/K
M1]8<BO&ZI6;;SENJ+>BU=/R/3%%SV;2SK%U5-3\FK&?ZUF4ZS[!9_@Z_3_3(
MN;]9>L963FOP+WX;,"^['QL;]G9&6S)?0?3L.5FXM=C*JK+V65,9B_IZ6?I;
M?]"EP%5O;*MD]0Q\;*Q,6W=ZN<]]=$"1N96_)?O=^;^BI>N>.;]9>K=3&%B9
M+.C,/3\7-N8^D7WUW7.O:_&_2FJK:ST?TSK*]_L_1>GO5._-ZKU1W0HMJQNI
MU=0SL1V0*S95NQZ<[&??7CNLK=^D95OK8^W]'9_I&)"/BJWMDER>1]8>J?5P
MYN-UA[>I_9\%^?BY+&"AUGIO;0_%R:VNLK8_U,C'V7U5[/3_`,$H])ZSU_\`
M:6)7D6V]0;F.+<N@=.R,2O%AEEGK8^7F5T^KCLL:RA[<IWVBW?ZE7^A2X3NJ
MWKE7S>H]/Z>QMF?E4XC'G:QU]C:P3&[:UUKF[G;5Q_3^O_6BSZL/^LV1?0^K
MTW,KQF4.(;%[:+.J9+JWON<S&H;??9AX[/YG_#*UT*RSK'4\C&S,['^L73,&
MICF90QJO3^TVEV^L7L?92^W&QV-_HS/YO,_6/TM?Z4\%$V=E7>SOU?6#H-]S
M,>GJ6);?:0*ZF7UN>XG4;&-?N<KZX7$;1TSH-_4<'`Q;<ZKK%M-&^MC#%F><
M3TV7M9NH_16^G79_@?\`1_X-:?5^H=6Z9BXK<_K.'B960]_T,.VYSR/3+:,/
M#9DOOLKJ_2>O?[_IT_S*!B+T4">KTZ2Y/I?ULZAGO^K9=72QO5SF,S`T//NQ
M&O:VS&]0UOJ9;;3ZGIWUOL97^B^FFZM]:NJX5_7V4557?LIW3AB5D%I?]K>V
MN^NVS?M]V[]%9M_1?\(EP2NOY?-P*XA_+_&>I?D45VUTV6,9;>2*:W.`<\M'
MJ/%;3[K-C&[W;41<U;?U3&ZST*CJ8P\K(S+LG]+726FAK<9UOI8EMMMC]V]C
MV6Y'L]>G_`U+-L^M'6[,ZNJG,PZ<F_/^PGHCZ'V9550L>QV<[T\AKW?JK/MC
MWOJKPOLO^&_TRX56_P#_T.6Q>J78C,C#LHJS<"^TV6X>0';!8T[6Y6/92ZN_
M%RO3_0^M2_WU?SB?-ZO]HPF].Q<.G`P6W_:C54ZVU[KMGH-LMR<NRRQS65>U
ME;-B=WTG?\C_`$G?E*;_`-PZT?3?C?TXO^^:9X^$ZFO+7A_QD&1FVY&'@X;F
M-:SIS+:ZGB=SA=8<E_J?F^UYVLV+V/ZN=/P^I?4;IN#G5-OQ<C"I;;4[@C8T
M]O<U[7>^NQGOK?\`I*UY'_[AU[/]4_\`Q,]+^A_1:OYKZ'T1_-_R5#S/RQK]
MX_:R8+N5]ANT[?JIF7X[NGY'7<Z[IME?I68[QCFQ["-KF69WV;[2]KV^U_\`
MAO\`A5IXG2,?$ZGF]1K>]UF>RBNQCB"UHQQ8ROT]-_N];W[WO5])5CQ?[S/H
MX>)]6\C!MJKPNJY5/3*7!S>GQ4]H`=O;CUY-M+\IF)_@_1]7^:_1UVUI[_JW
M8W,NR>E=1OZ4,QXLS*:64OKLLC:_(K9E57?9\FYO\];5_._SEE7J_I%MI)>K
M^7[5:-*CI55/4[>I"Q[[KL>K&<UQ!;MI=;8Q_P!'=ZCG9#]ZH6?56GTJQC9E
M^-DT9>1G49+16XMLRO6]=AJNJLILIVY5C?H>I_PJW$DA:M'%QOJOB`9=G4[K
M.JY6?3]FR<B\-:?0@_JN/7C-I9C4;G>I^B_2/M_2OL_FU/I_1>H8>16ZSK&7
MEXE(BK&N;22?::_UC*90S)R-L[_=9O\`4_G?56NDEZM?Y?XJM'DNL]%'2/J=
M5T3&;;E=/]5M.=:6"V^O%ML=9E9----?Z2ZCU/9LH?Z#/UGT[/11/JOU&W(Z
MD_'P<_(ZQT9E!)R\FK:ZN\.8&8]>8*\;[;ZM+[7W?H;+,?TJ]^1^EV+J4D3=
M&][/^,C2Q3C#ZM5?LY^!Z[]K\[]H;]HG=]I'4O1C]W>WT]R?JW0;\S/IZIT_
M.?T[/JJ=C/M%;+FOH>YMKZO1O]C+66ULLIO;_P!>KOK6PDAZK3H\S5]2_LV!
MBT8G4;J\OIM]]_3\U[&6.8W(W_:*,BMXV9;+?5?ZEGZ.[?\`X2M/_P`S?4KS
MSE]1NR<GJCL-^3>YE;8?A/%S/0JK:UM=-FW9Z;O4V?Z6VQ=*DG>O7^S][_OT
M>EH9O2:\SJ?3NH.L<QW3'VO96`(?ZU3L8[_SO8U^Y</@=2NP',R,/--GUBS<
MO?U#ZN/I'NLM+?M5-+G-?FX56/1^F9G6Y=V`_P!#UO3]*STUZ.DA&ZUVI1KZ
MO__9`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``
M(`!#`%,`-@````$`.$))300&```````'``@````!`0#_X1#]:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM;&YS
M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U
M+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@("`@("`@
M("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY
M.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+R(@>&UL;G,Z>&UP34T](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]M;2\B('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C`O<U1Y<&4O4F5S;W5R8V5%=F5N=",B('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S;W5R8V52968C(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS
M.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(@>&UL;G,Z<&1F
M>#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B('AM;&YS.G!H;W1O
M<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W`O,2XP+R(@>&UP
M.DUO9&EF>41A=&4](C(P,3,M,3`M,3)4,3(Z,#0Z,C<K,#4Z,S`B('AM<#I#
M<F5A=&5$871E/2(R,#$S+3$P+3$R5#$R.C`R.C4P*S`U.C,P(B!X;7`Z365T
M861A=&%$871E/2(R,#$S+3$P+3$R5#$R.C`T.C(W*S`U.C,P(B!X;7`Z0W)E
M871O<E1O;VP](D%C<F]B870@4$1&36%K97(@,3`N,"!F;W(@5V]R9"(@>&UP
M34TZ1&]C=6UE;G1)1#TB=75I9#HQ838U9F%C9"TS8F)A+30X-C@M.#<V9BUF
M,S$U-CED,S%F9#`B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z1$,Y0S=%
M-3<P.#,S13,Q,3A#0D9&,SA"-T)&0T4P,#@B('AM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#TB=75I9#HQ838U9F%C9"TS8F)A+30X-C@M.#<V9BUF,S$U-CED
M,S%F9#`B(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&1F.E!R;V1U8V5R/2)!
M9&]B92!01$8@3&EB<F%R>2`Q,"XP(B!P9&9X.E-O=7)C94UO9&EF:65D/2)$
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M=ST](B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W`Z24-#4')O
M9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B/B`\>&UP34TZ<W5B:F5C=#X@/')D
M9CI397$^(#QR9&8Z;&D^,CPO<F1F.FQI/B`\+W)D9CI397$^(#PO>&UP34TZ
M<W5B:F5C=#X@/'AM<$U-.DAI<W1O<GD^(#QR9&8Z4V5Q/B`\<F1F.FQI('-T
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M=#IA8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.D1#
M.4,W134W,#@S,T4S,3$X0T)&1C,X0C="1D-%,#`X(B!S=$5V=#IW:&5N/2(R
M,#$S+3$P+3$R5#$R.C`T.C(W*S`U.C,P(B!S=$5V=#IS;V9T=V%R94%G96YT
M/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E
M9#TB+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM<$U-.D1E
M<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](G5U:60Z.#$U935E.34M8C@X
M."TT.64V+6$U,3DM-30P,6)F,V%A-SDV(B!S=%)E9CID;V-U;65N=$E$/2)U
M=6ED.C%A-C5F86-D+3-B8F$M-#@V."TX-S9F+68S,34V.60S,69D,"(@<W12
M968Z;W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C%A-C5F86-D+3-B8F$M-#@V
M."TX-S9F+68S,34V.60S,69D,"(O/B`\+W)D9CI$97-C<FEP=&EO;CX@/"]R
M9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`\
M/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI;F\"
M$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#('-2
M1T(```````````````$``/;6``$`````TRU(4"`@````````````````````
M```````````````````````````````````````````18W!R=````5`````S
M9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@```A@`
M```49UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD9```
M`L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4;65A
M<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P```@,
M8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T
M="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y-C8M
M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````````
M`````````````````````````````````````````````````%A96B``````
M``#S40`!`````1;,6%E:(`````````````````````!865H@````````;Z(`
M`#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/A```
MML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````
M`!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````````
M````````````````````````````````9&5S8P`````````N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````````
M```N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="`````````````````````````````&1E<V,`````````+%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````````
M`"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M``````````````````````````````````!V:65W```````3I/X`%%\N`!#/
M%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`````
M`````0````````````````````````*/`````G-I9R``````0U)4(&-U<G8`
M```````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`5`!9
M`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!`,8`
MRP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!10%,
M`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I`?(!
M^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"P0++
M`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z`\<#
MTP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$\`3^
M!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(!ED&
M:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('Y0?X
M"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD";H)
MSPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+L`O(
M"^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>#?@.
M$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,081!^
M$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#$R,3
M0Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6`Q8F
M%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@&449
M:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<HQS,
M'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!(&P@
MF"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D321\
M)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ**(H
MU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!
M+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z,?(R
M*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXVZ3<D
M-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG/&4\
MI#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q![D(P
M0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`2`5(
M2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.)4YN
M3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/5-M5
M*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;E5OE
M7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<8O!C
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MC&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*E/25
M7Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>0)ZN
MGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*H
MQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R2[+"
MLSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]
MC[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''O\@]
MR+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!TT33
MQM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>HM\I
MWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;ZN7K
M<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*
M^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E`&1`````
M`?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M_\``$0@`)P#N`P$1``(1`0,1`?_=``0`'O_$`:(````&`@,!````````````
M``<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+$``"
M`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,74G&!
M&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R9(-T
MDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8F9JD
MI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1``(!
M`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B%C,)
ML23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756-X2%
MH[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>WQ]?G
M]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:``P#
M`0`"$0,1`#\`UA]U9#)C>&]@,KE@!OG>MA_%<A_SU67_`.FGWT`M43Z:W[!\
M`_P=8-;G/*M[(`PII3R'\"_+IC_B.3_YVV7_`//KD/\`ZI]J/#3^`=%_U$W\
M0_8/\W7OXCD_^=ME_P#SZY#_`.J??O#3^`=>^HF_B'[!_FZ]_$<G_P`[;+_^
M?7(?_5/OWAI_`.O?43?Q#]@_S=7M_P#":^LK9_YNO3J3U^0J(_\`0Y\@28ZB
MOK)XB1L^BL3%-.\9(/TN.#[B_P!WU4<EW=%']K%_Q\=2O[22/)S`-1&#Z#_?
M4_R_U8].OI8^\1^LGNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_T*C/@U\"A\UNWOD7NGLCM+'_
M`!X^(WQB?>G9_P`J/D5F*2.NBV3M=]T[DEQ&T-I4,Z34N2[#WA#B:QZ598YH
MJ2EI9)?!55,E'156:?,?-)Y=V[;+>RM#<[W=D)!"#34U!5F/DB5!8XX@5`)9
M<3]@Y27F#=+JZOI#'M<*1ESDDC2H``7N)<U6-5R[AJ5*:',?6_*/^0WLYY]@
M;-_E5_(SNS9=+4RT,7?W9?RTW7L'N;/T.H1_WEH=C8/*KMK&U,NDRT]'/)B@
MJ$"6&%KQJ3Q[+[F7"B[GYNMK>X(KX*6R/&/Z)=^_'`G)]">CBXWCVXM9Q91[
M.TL`:C2>/*M-.*^'"A@>M*]M5;SK4]%4QN]OY6&R_E#V]EYN@?E;WS\-<MM?
M;"=&;)S':^-ZH[LV9O*HH<)7[VGWON'$5@I,_@,;EGR.-Q<9J:B5Z5(9Y9)G
M;R`\DM>=[C9;",;G9V^^*[>*RQL\;*"P72&(()&AC@9J``.B**]Y'@WN^D;;
MY6V]EJH=DH-2Q$`+%'*@*MXH-,%2M3J#=6@9'K;^2AC_`.7EMC^8.WP/^6TN
MVMS?*C*_%N'K!/E]E5W)29;%;5R^Z7WG+G&RPP\F(ECQ#0"F`^X$C@\J+D%1
MWGN')S--RR.8;43I:>/K^G%*>((]-*\<ZJUX>5<=#B6UY%AV6+>VVG_%WF$8
MR*5,'CUJ("W#MH4'<":TH2H/Y)V\/BEO;^=KT%E?AYT=V?T!UK3?&WOG'[AV
M=VSVA_I9W%EM[IAIZBJW)C]P^:H..PT^#GHZ841<VGIY);#R6]M^X5OOEMR!
MN";_`+A%<W9N8RK(GA@)J2BD5-374:^A`\NM\CW6Q77-D;[':^'!H4'-1J$=
MUJXQQY(*>1I0YS0;@W\RS^8GMO\`E]=6[&K<9UUN/O?Y%]^;YINH_B[\=-F2
M)%NCMWL_(1Q,E.]08ZB3$[2V^M5!)E*Y89FA^X@A5#)41D03RMRS+S)=W`>Y
M6WVRW3Q)YF^&-,_8"Q`-`2!16-<4ZF7=MV3;$B55#7<M0B_856I`JQ&IT0!0
MS%W1:#5J!(-N](_\*)^UL4>Q-[_.+X9?%+<>7A;(X_X\;#^,4/=FV-JB=3+!
MM_<_9VZMQKFZ_(4A"Q5$^-EJZ<$LT4DHT^S^2_\`;6S9K6#8+R\C&/&>9HV/
MJ512H(KD:E0TH"!T5"UYIN0D\FXBW;/Z:^%0^E=4,Q0C\06245X,>K0?A?/\
MTJ'I6NIOY@,G0S=U[<WGNO&1[LZ!EW#2=>[QZWQ8HCM??5=C=V%:W;&X,Q']
MU)6T(/@ID2,C2695"6^#8VO4/+HN/HFC4E9:%E<DU4$<1333B:DBK``D[VX[
MB(9OWKX8D5SI*G!32IJQH!4-K%=*ZE"L50DJ#-S;RVA3U6!H9]U;;@KMU*S;
M7HYLYBXZK<BI&)G;`T[U2S9A4B8,33B2RF_T]E0@G*R,(7*I\1H:+]OI^?2T
MRQ!E4RJ&/`5%3]GKU!SG8O7VV,WB=M;EWWLW;VX\^T:X+`9S<^$Q.;S32R-#
M$N)Q5?74]=D6DF4HHAC>[`@<^[QVEU-&\T-M(T2\6"D@?:0*#\^JO<V\3I%)
M<(LK<`6`)^P$U/Y=++VGZ>Z1V,[%Z^S6Y<ELS#[ZV=EMX899&S&U,9N?"5^Y
M<2L+B.5LE@J6NERE"L4A"L98DTL;'GVH>UNHX4N)+:18&X,5(4_82*'\CTRM
MS;O(T*3H9EXJ&!(^T5J.G^JS&(H9I*>NRN-HYX<?4Y>6"JKJ6GFBQ5$56LR<
MD<TJ.F/I&=1+,0(XR1J87]LJCL`50D$TP//T^WY=.EE%:L!05_+IDVEO[8F_
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M%5U()1R`1;W'$L4L#M'-&R2#B&!!'V@YZ&\<D<J"2*16C/`@@@_F.H&Z][;,
MV'C5S.^-W;8V9B&G2F7*[KSV*V[C6J9`3'3K79>KHZ4SN%-DU:C;@>[06]Q<
MOX=M`\DGHJEC^P`GJLT\%NGB7$R)'ZL0H_::=.]-EL768R'-T>2Q]5AJBB3)
M4^7IJRGGQD^.DA%2F0AKXI&I):)Z<^02JYC*>J]N?;91U<QLA$@-*4S7TIQK
MU<.A76&&BE:UQ3[>FN7>6T(*G`44VZMMPUFZA(=KTDN<QD=3N011B:4X"!ZH
M2Y@1PL';[<264W/'NX@G*R,(7TI\1H:+]OI^?53+$&53(NH\!45/V>O39DNS
M.N,-N2#9N8[`V1BMWU5.M73;4R6Z\#0[DJ*5QJ6I@P=57Q92:G91<.L14C\^
M[I9W<D1N([61H`:%@I*_M`IU1[JVCD$,EPBRG@I8`_LK7JI;O^L_G=U'87:V
M\_BYV7_+!G^--!69+(]91=D8;OW-=EKMW`X:!<S0;LR>SZ@[/J,_%N6@R$-Z
M6188D"+(5=9`!KM:>WXMK2#>;;=QNIH'\/P0E6."H8AJ4(.17H+[C+S<7FFV
MEMO:Q4,07>34:%O)8F&``#W'N!X#`(=\)OE)_P`*`/GY\8MB_*GI;=/\K?:F
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M,D44:_DL0![)U5F(502Q\AT8$A068T`ZXFNH12K7&LI11-3&L6L-1"*5J-8O
M.:I:C7X33"#UE[Z='-[>]Z6KITG56E/GZ=:U+2NH4I7\O7[.O__1*+U>E=G?
MY"W\T;#[`U2[AVA_,?ZUWOWO28]O\N'24N7V1'@LGF8(P)I=M46YL++.[/KA
M04-1(=*Q2,N65X4B]R>49;K$3[;(L1/#Q1J+T/KX9`/V@>?6/-HLL_(^]00=
M\WB1G2N6TM$4B%!FIN@63T/=Y5ZJR^,>T/A_N[/;TA^9/?7<'0&TL5@,=7;)
MSG3G3\?<>6W+N!ZZKCSF(SF*D<'!4..Q<<,]/.%(J)))$+*44..M^N>8+:*!
MMAVV&YD+'6))/#TBF".TUSU''*EAR]?RR1[S>^&YPH([<E0I#>-%DU:HJ:!0
M?/HQ'\ROX1]8?"/=_P`9:3IWN'>_=G7OR;^+FS?E!MC=/8.S,7L+<5!@-^92
MOBV]BY]O8N1_M7EPD$%3,E0%J()Y&B8>G@KY.YCON88=W_>%DD%U:7CV[*C:
MQJC"ZC6@KDD8\A7I;SIR[M^RG;I]MGU6UQ;12KVL*B7Q2"=4DAK1!P-,_*I-
M%N3_`+AL^J?_`!K9O#_WU.]O9);_`/3V+[_I3+_VD+T(=P_Z=MM__/<O_:!T
M^?\`":O_`+>[]._^(<^07_O'T7MOW@_Y4N[_`.:L7_'UZI[0_P#*P?F/^K5Q
MUM%_,@8;#_\`"BC^5#G>SQ!3[(S'Q@^4NU^GJ_/,(]OCOOPUTM91XR2L/\/_
M`+V5>S\E3Q4Z+:H>66`)=_&/<*;'XLGMIS='9YF6YB:4#CX58Z5\Z55R?*@:
MN*]3AN15.:]I:X/Z1":,XJ%NU8GY:Y(%]/$:$?$4ZN`^86__`)<=<]9X;.?#
M+X^;"^27:%3O7%XS-;&[#[?I>EL+C-CSXG.5&5W13;IK,)G8J[)4&8I:"G2A
M\2M+%5R2AOV=+`C9;;9[JZDCWK<GM;4)4,L9D);4HTT&1VEC7U`&*U`CW":]
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M;7?-:F^'N2SVYLMM3$TZ+G&IL?\`);=NP\"-NXF.HR"5$<,T1:HBF*3(BL-L
MY;W;GG=MQM'M&L[2Q-PPS]+XZT!)-*F(`ZW8`C74T(!!5;AN>Z[5R]8QSV\I
M::Y2,!5/B:611I$9(('U+:5CJ`8!H4A2I`7]\_&/HC'?'RGQ?\OG^29_--^+
M_P`W>L'P6YOCA\K8.K-N[?W]3=K83(TM3!D^XNS3WQN#*;LVUO(F>'/+DJ:M
MI3#5.ZQ1HBA%%C?;A^\)9M^YZV2[VB9666#Q*J4(P%7PE(TD*1W`M3N)J>O2
M2VL\5K:VNP;M%(DBE7>.72@KWD`,50A"WAF-1X3:?#"@`='C^8GQZA^6_P#.
M4_E@],?+6BR-.F]OY;W;.2^2/7FP=VY7;^V]_P":P&7P^?W;U/N#-;9R%%7Y
MGJ;(;\C$E;00U"P96GH8H92T#NK$&S[FNS<F<U7FS!6";C2"210S(IT*K@,"
M`^@\2,'/ETONK26^WO9H]S++<&"#Q51B!K$=X[4*D<'7M8'`)*T:C!5?(;X@
M="_RSOYGO\IWL7X)[)H_C72?*?N;L?XT_(?K7KJIR&,ZN[6Z^/753NC#U.X=
MEM6388;BVYF:43TM7'$K^98I#ZX@S)MLWF^YEY4YLL]\<7'TT:S1.P`>-^ZM
M"`..D#/X2PX-3I9?VB;;O>U7%H[AI!1@7=ZCQ8(Z59B0NF9R4^$N$>FI`>F7
MK3X)_%3YN?SPOYNG^S5]4T?=&&ZCQGPMKMD[(W5FLZ.N8\MN_HT0Y;/[DV/C
MLA0X7>.>I*7`PP8Z;)I4Q8Z*:I\40DF\B+;_`'_=]C]NN1TVJZ\'Q_J@Y"J6
M(6<D`%@=(J:FE":#-!0D^U[98W_.W-TMS#6:&6!D8,RL";=5^)2&I0D::Z34
MZ@2%TKO(_'38W\H3^:C\%,?\-),UUW\7/YC>=[9Z.[P^)F/S>9RW6>$['V'L
M`[ZV)W?UQA,WDLJ=J92*>-J3,)2B*!:,L%LM05B0)N<W./*&^G>U$FZ;8L;P
MSZ0&T,Q#1N5`%**=/\3,I.5R<26_[EW[;ULF/T]R&,@9F9C1HXN+$L_=-$P9
MRQA2)HTHLM%KBZZ["Z[^=/R@^7ORF^<?\N?YT?S(,;M3Y&=L?'GXS["ZMZTV
MYV;\5OCMU/U/F(ML-A*/:^<[4V1CJ[NW<N0IY,AN&NJ\;4:1/`T#J78(*[S;
MYMCV?9=HV+F?;-M\2VCFG:60I/-(U<U\-_TP:A*$'BIPHJ';;>!=;EN-U?;+
MN$\L<FA&@1RH1E60*61@P_3>,-'70S()](>0Z39?$+K3N7JOI+^=/M;:/QM^
M3WQ9_EP9[XK;ZW?\:^COEG346(W9UCVMFND^Q5[KVOU+M^'>6^*O&=/9*=:>
MNBA-:U+35+JD(61J@>RC=KFRN=TY!>;<[.[YD2]B6:6V-5=!*GAESI4:E%`*
M"I[JX"]*U%P=FYM9;.X@VU[*<JDRE6!\-LG5EI&8R:W)-46`L2Y=F%S^2S_+
M"Z.R'PP^%/SXWYC<OW3\V(?CEMO,=$=@=F[RW56[1Z#VZNR<]MSJCJ[K#8./
MRM)L_;^R=H[6S$<529Z*MK*O)S560:4321B$MYXYKO!O6[<O0)';["+BDB1H
MFJ0D@RNSD%M3&H&DJ-&E""*U.-EV%8K9[^2YEGW(M)I9W;3VLRQZD!"L!0/1
M@P1RS1A:]4@8]?Y251_+^^076_SAZ_[!W?\`ST<A7]R8;LS"9G;?96]OFCN3
MYAY7/9L=<5G5^X<+2Y?#-L&HJZK#O11TU0N)_@Z2+40RNQ$X^T\WQ\S;7?;'
M-"O(Z+$593&L*VU`9*AN\'+Z:BJU6A51VABFU3;%?V5V)CN<KR@>+XWA%PS>
M&)B/T20%47*DZI)!)B1W4ON*_!#X_P!;\8?Y872?36>ZYVKU1OC;GQFI*WM'
M8^S8I(<'B^VMP[*ES_9]2(WK<BG\5RN]\C7560:*9X'KYIFB]!7W"O,.XKNO
M-U_?17)FMWO#H8^:!Z)3`QIIIJ*TI7/0]VVV^CY?@@,;HRVV0YU..RE'-2"X
M``:ATZ@=.*=5-?RD7>/_`(3+;E>.:>GD3XW_`#W=*BEGFI:J!US?>96:FJ:=
MXZBGGB8:DDC971@"I!`/L;<Y9]V[:H!'U=EQX<(>@CLE1[=;J0:'P+W_``R]
M.G\DS^6=UOO_`.-/\OG^8+\D.P.VN[_D5M?IK96:Z*I\]V-N>AZNZ(ZV@VIE
M=L]?]?[2ZZQ>0I,!FI,/M?+255?D\O'75M=FZJ6I9UTQJJ/GGFFXMMSY@Y>V
MJUBMML>0K+05>5ZAG=G).2V!2G:`"304/-BV-/#BOK^X:>[61])8)10LA"Z:
M*"@.E6T*50'@"2S/67\Q]N_R//[E_+&M^+?7WSM[W^7>QCVSN7&_.GX^)\J.
MSJ?K#OG"4N:W'19+,?(Z;<--U?1;#V1N+Q19>2D%104^'BD*N[HLP%_+TG/C
M7.SV^[7EC;;)*R`VLWA*7B9Z,J)I+ZR0=,98:6HA4+V=!/=UY9M++<-RVRVF
MN;^&,N'634NI8NQI8S(H9&0@F41L[(?%1R^F3HYORP[K['[U^$7_``G`[G["
MW)6UG8G:'S@^">>[`S>)KJK%)NG.Y':&6&>R-?#C):2GJ8<]71/53P%/MC)*
M;1A;`$^Q[?:V','NC8VT0%M#MUX$7CI`.`*YHO`>=!GI=O5Y/)M')TSR%I7O
M;=69U74?U$4L12BN:5)4`@D@4!IT?'_A2E5UM%_*@[5J,?D,CC*E>WOC4BU>
M*R-;BZQ$D[TV/'(J5F/GIJI%D1B&`<`@\^PW[4(K\Z6"NH*^%+Q_YIG_`%?R
MZ.N?G:/EC<76FH(WD#^!_(XQQ'H:$9`Z*U_,'Z1WG\G/YXWP_P#CUA>Y>Q.F
MMA=D_P`N'MFF[QR_6FX:O`[RW'T[C^U9*K=6P-JY97DCVKD^P<JN,Q]=F*:,
M9&GQ!J4@=792#3EV^MMK]O\`>=PEL$GN8]R'A!ZZ5D*1@.0""=`JR^C#%*D]
M)MTM+B]YGMH8[MXX#;PAPM,BMVWF#4'3I9?A8-5PZKH;%_,6^)O3/P2V1_)G
M^/\`\:\=NK9G6U!_.&Z0SLE#7[]WEN;,9;);QK-VYC<$N>W%GLU79C-P5U7-
M;PU,TD"Q(J!`J@>W>4]WO>8;CGG<=U=9+G]QSBH4``*N*`8'2?F>UAVF#EZ"
MR0*C;G;@]J^<L2X&FBG2`*J`:>>35[_FX'HW/_S*OBKL;^9]N?=&T_Y6V2^.
MN],ELA:[<>Z-F?''>7S9I]]!?[N_(W=.UZW%B&/']21BKV]39.I@H9*L2:'*
MM6QLQR;]=%RINUWRHBMS<MT`^%:1;4H!6)6!J3(2"`#6M2-2QD*=^B6YYALK
M?=M7[D,*E-)<,9P[.:>'W:55$+N-+)2-5;PY9QU71\9OC?\`RAMQ_('^99VS
M6U%;F?Y/G6FUOB_UCM;O#=O:G>%!TKL_M;??<VRZ[LCIKJ/=:;GA_O%TGF=]
MX;:-/G*Q_/38Y9?MUK(\74&5Q+NF]\ZQ[;RQ;!T7FV1II#&JQ&1T6*2DDBD:
M5=8R?#"X9M0*EU*@IL]CV![_`'8FSD.W)I7X)`RDM'HII7Q&9I/%9W8F54$4
MU55HY6__TJ2?B1\XNU?@?\ANU-_;!P>TNQMC=D5'8G6/?70O95*V2ZM[TZNR
MNZ<^E;M3=M#X*L4F0H!6U#XW(I!.U,:BH@FAJ:.JJJ:7-[>^6;/F;:;.">5X
M;N'3)#,F)(I`,,I_PCSP<,%9<0=IYJGY<W6Y5XA+MTJ*LD9R&5HT#`J2`0P`
M!K0@@$&FI'-Q/N7_`(3P[Z>LWKGNH/YHO1.0R)K:RM^/'5>\NG=[=9X^HG5I
M(L%L_L7=U15;PH-M([>&/SU5--!"!XUCL`"!;;W3M4%G%?;3<1C`FD699*>K
M(G97[*CH1R[C[<W=X-VDM[Q)U8,43Z4QLW'_`$8+*]3\3.NIB//S+1_,?^;N
MT_F]V7TMD.L^G<CT?TW\:?CULGXP],;.W%O&3?6]:CKO84M2^'RN]\_XQ2MG
M&BF6%8H9:LK%&&EJ9Y79@>\H<N7/+UKN'UU\+C<+NZ>XE95"+KDIJ"CTQ7RX
M\`,=!;G+F.QWN6QM]LMC'86T$<25))TQ:PF2`3ASJJ!D`"OQ&9EOE_UM7_RD
M]D_`6+`[V7N#;?SASOR;KMSR4.(7KB38F3V3N+;<&'I<FN7?/2[K-=F8F:%J
M!*9(HW/F8E5%(N7[U.>+GF4RQ_0OMX@"U;7K$H>M*:=-!_%6OETY=<RV,_)]
MKL:0RBZ2Z#DG1IH+7P?XM5=6?AII\ZXZ.1_PFK_[>[]._P#B'/D%_P"\?1>P
M_P"\'_*EW?\`S5B_X^O1][0_\K!^8_ZM7'6^A_,!^`/3O\PWI>DZO[+R&Y=C
M;QV5N;'=C=&]Y==UHPW:G17:^!O)@-^[%S::9(Y89+1UM$[""NI^+Q3QT]33
MXS<N<QWO+=ZUU:JKP2(4EB?*2H>*L,C[#0TR""I96R.W7:K?=8%BE.F1356'
M$<*@T()4T!(!!#!71ED1'6OO`;,_X48=.8=.N</V?_+0^5>)H*48O;W>/<.$
M[VZJ[.DHZ:):2BR>_-G=?1UNT,IFVBC$LYHI;33$L[DDW$S3^U]ZQNI[3=;2
M4L2T41B>/)K1&>K?+.D>@'1$\7.]O6*TN+&6(*`K2B0N6\RVDQA5_A%)6'%G
M8]//QE_E=?)'KSIS^9[G._\`Y`=9]F_+3^9ILW,X[>=?L78N4V/T3UQN.CZ>
MWMU1LF/`4L\F1WEE</'3;IADR53-%'.\=*OC@,QEEFKN7-^USW_*";?MLL6S
M;3,&74P:61?$C=JYT@T3`J14G(%`-KR[>O9\QB:[0WU_:F(#BB&DQ!+!4+=\
M[9"+1%44+!F8]WP\^(K],_R\NCOA%WH=I]BQ[-^-N%Z`[43;[99]F[RQW]T'
MVCNNEQSY.EQ&:;"9G'5,T0:6&GG,;WTHW`#6[[TUWS'=[]8%XY&N?&C)`#*P
M8,IH"P!!%:5/VGH^BV^-ML?;;Q%>%T='7)!5]55K0$U5J$T'Y=5J]._$G^<G
M_+ZVRGQQ^'':WPW^4WQ.VS.^,Z"7YDU';VR>Z^A]D---/C.O\YG^J<5E</VC
MM/:<50*6AG?[2O--"B(E-`L=/&*KK>.1>89/WCOMI?VN[-3Q?IO#:.4TRP\0
MU5C_`-%%WJY(EL>:-N1X-LNK:6'N(,P8G43480QA%)J7HSC4WZ:11@1@[?R!
M^!6[OG)\%=L?'CYC=IXJ'Y'8BNVWVCC/D)\?]OUVSZ+JGY$[+S5=N#8G8G5&
MW\WDJG(KC=E2U:X\0UM4E3D\=YO)+33U`EA#^W<PQ;#OLNX;-;-^[64QM%(:
MF2(A=:N14#4PU@=RJ:`AU!#&=UM,FY;=';[A,OUBLS*ZC"DZUH*:21X3F)F7
M0Q!9D,;E2I;]G;<_X4+8V';O5.Z^P?Y9>:PN.KL50Y_Y6K@.]1V5F]JT^2IV
MR66BZ(I:7%[`@[&K,.DB!1DHL(M2P8)I')M/+[:N'O(K;=%G(J(*Q>$&\U$A
M)D">0-6<<37@4`BYP!\`7-GX.0'(9I`--`Q("(SZZ,RB%%*]H8-W]&,[1^$G
M96^?YK?Q:^>6,W9L>DZNZ+^,W<W2FYMH5[9[^_\`E]Q]D945^)RF"2GQ4NW6
MPM&BJ*AJBLAG4J0D<@8%"FUWVW@Y4W/8&B?ZB>X60$`:0%\/B=51\+8TFM1D
M4()A/MD\N]6VY*Z>`BH",ZNU;E33%,F93Q_"V,CJ5\X?A7V1\G?DI_+;[HV5
MNK9&`VY\,OD;N7N/L3%;I;/+F]T;?S6PZG:E/C=EC$XNOH),Q%5SEW6NEI(!
M&=0D)70U-CWNWVO;>8;*:-VDO(`BD`$`@/\`%5@1E@:@-@$4R"-[EMT]Y>;=
M<1.@2(]U:U_MH),4!\HF&:9(/"O15>ROA=_,<^/_`,Z_E/\`-GX%[Q^(G96'
M^7^#Z<HNS^D/E)C.S=F9/;65Z7V:^R]N5VPNS.M?[PB>EJ::6:IJ8*['P)*U
M3H-S!%+[/[7?^5]SY=V?8.9(+V)[$R^'+;F-@WBOK;6CTIZ"E3BM0"1T42[-
MO%CN^X[KLTEN6O'0R"4,:*D80!%4K5M0!U&1%TD@HQ`;I;_&?X"_++>_R]VO
M\_?YE_<?5'8/<?4>S]V[(^,/Q]^.N%W/B_C[\=Z'L&%:/?F\J?+[W9-W[_[-
MW3A5&.EKZR&*.FI`54S!:7[1)NO,>SV^SW'+O*MG/'83NK32S%?&FT4*J0A*
M!585%*>@"UD+JK+:-PFOK?=-\FB:[B!T+'JT*2"M1JH0-)/8=1+&KR/X<(C1
M6[O@3\Z_B)\D.\?D-_*U[.Z#K>M_E%O2H[7[[^&GRKI=ZX_K=.YZ^C2BW!VK
MTQV+UU29+<.R<SO4)'-EL=44CT,]1"'+O&M-!2OP<Q<O[UMUAMW-UM<BXM(_
M#BN+<J7\,4TI(KG2548J*GS`5C(SMOM&Z[==75QL4\(BFDU,DH)4$DLY`%"Q
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MW^E)C6^NA0L/A#$58J&/`5.D,?2I.>EX,FU[8[&,/,FHA0:!F9R4741BI8*6
M(H.-*=4U_"/X:?SA?CET=0_*+X@[X^&F1P'R'RNX?E;#\".W]N;FW2VSZ;O"
M&GWM2;&VM\T*RL_TJ[CW?)A,G#!-4YZK?#15A<+*T)>:4=[_`+WR9N5\VS[W
M;WJW%J/`:ZC8`,\=59C!30L8DJ1HC+::`*M`H!^RV&^6UDFY;;)`\$^F1$(S
MX1IH^+N:0P:$"M<(H<%G>1F=C>U\'OE]B?YC_P`&=K_(7:NTJKKO-=E;;[!V
M9N?KW.9./)S;#[-VEE=P]?;PVQ49RDI88LKCL?N?$2M3UB01M/1/'(T4<A:)
M8_W_`&5^5N89=MFF\2.)T8.!34A`8&E31J&C"I`8$`D4)%>V;A^^]G6[1`K2
MH12M0:CM8&@.AU*NE0&T,-2JU5!3?@?_`"_N_?CA_)CS?P*[$J^NYN]\AT]\
MI=BTU5MO<66R?7PSG<60[-JMGM+N&KV[C<JN/CCW=2?>R#'EX2)-"2:1J.N8
M.9MMW/GR#F2W67]W+/;.05`>D0C#4&HBO::9SCAT4V.PW=KRG?[)5?JI(KA5
MJ<5EUZ:D#'Q"M`:?/HW7P-^+N\^A/Y<OQT^(?;]=C(M[=??''`]-[]R6PLQ5
M5F-ARD&VI<!EJS:V<K,=C*N581.STU0]-$P<!M`M[(=^W:*_YDO]YM%K$]QX
MBAA\P:$5X5'"O#H_M[-AM[6<Q(U"0&AR`[,>/J`?V\.J8.H_@3_.%ZJ^(>0_
ME%[67X;[1^*O]V>Q^J*;YWXK,;JK>UZKHS?]9N.ORM%)\<SBJ+&R=T9[&[DF
MQ59DI,LF.@$TE4DD]3&D\HYN>8N2[C?(><9!?2;FK1O]*2-(EC"A3XI!JBZ0
M?XF(J5`)0!?]T;\VUW>R$VXBF,FI]!*,)69I!_;:Z,6:BZ`5C(B$A9?'Z%;+
M?RKOF%V9_*?^&'QUR^[NE^E_F]_+][+ZV[0^/>Y]NY#/[]Z=S&=^/^2S&%Z_
MBWY)D=OT.2@I-_;1G2IR*T]%5+0UC1@))&)H/::+G#9;/G#?=RCAGFV'<HGC
MF!`60++0OHHP':105(P30U`8WEY?OKS9-NM[@H-PM9?$0:J`L`VG4VE\HY#J
MP4AFC0LJAF0!K\W/C'_/+_F:_&7._'[MOK3X.?&#;^'W'UWN_*X_:G;N_NQ\
MQWWN79N]<+FL?BZ',R;0:AZ?Z[Q)I),O4^>/+9JOJZ*DHD:*":JE]K.6]XY`
MY3WB/<[>XO[J0JP4E%41*RFM0=)D<X44H@#,2*A:I.8MMYKWW;);"(6R`JP;
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MG[.D_,FT7&[C:1;E1X%Y#*:FF(Y$<_R4T^=/M%:7\P3K_OK^9-_,LQ_1_P`/
MWZYV1NG^5]M+;^\.WNROE!3S=L?'?<>\/E)LRMK=D]98[XN56#S&W]U[F396
M/FK9-YU$M/58@%X*4+/'!(XGY;N+'E7E=MRWDS-%NQ98E@[)0L+@.YF$B$`.
M`-'`@BA(>0`FW:,\P;X]E9QH[[>5,@D(TZG34F&AF%&#TPIU%6+%&AA+KC$?
M+W^81AZC<W\KKMSX=_"[8OS6WGU`.P_B9N7'Y+-Y_P#E^]Y["VKV5M#!]OSY
MW8]/BDWSL+<W7NULID-PQX*:.:/(5,,*_L+)":E,^S\M.\7-5IOE\^QI,5G4
MT%Y&2IT$/\+`L40G@`PHS48HI%_NRQMLLVVVZ[@T0T8'@%C4Z=.HG0524A\,
M/#8M`M8EE__3UQMS]/\`8$F[=YR"/K51)O;>4@63Y%_&5)%$FZ,LX$D;=RAH
MY`#ZE8!E/!`((]YYVVY0+;P#PK@T4<()O3_2=87;ALWB73.=ULE)1,-+D'0M
M0:*14<,$@\02*'IE_P!#G8'^IZR_]*.^,G_VYO;W[S@_WQ<?\X)O^@.D7[B_
MZ3-A_P`Y?^A>O?Z'.P/]3UE_Z4=\9/\`[<WOW[S@_P!\7'_.";_H#KW[B_Z3
M-A_SE_Z%Z]_H<[`_U/67_I1WQD_^W-[]^\X/]\7'_.";_H#KW[B_Z3-A_P`Y
M?^A>KR?^$XW7.[MN?S9NH<MEEV1]C%U%WY!)_`^Y>D-Y9$/4;0I%C:/`;)[)
MW'N&HA#K9Y(J1TBN&D*K=A&GNS>Q3\G7<:QS`^+'EHI%'QKBK*!7_-ZT!D[V
MMV[Z/?5<7UM+5N$;ZB/T9\G`^7"I\Z4!(^D%[Q1ZR0Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#KMZCZMR/
M5/96/[P?9\?3-=L/=M'VQ)V#78W%[$3KBJP5=!O1]Y9/,5%)B<=MA=NO4&NG
MJ98H(:;6[NJ@D*K%KQ+VT?;O$_>`E4QZ`2_B!AHT@5);52@`))Z2WJVCV=TE
M^4^A,;"360%T$'5J)(`%*U-10>?5$FQ?Y0N!;I;&;<^-G\XGYL;5_EZYK:]3
M7[8Z]ZW[@Z>WGLW&]15L4]568+K'Y*U.T<UNS"]8QXLS14LL&2JEI:&ZBH8`
MM['\_.4O[P\7<N3+)N8E8`L\;JQD&`9(>)<FA.0:TH!T0C98V@D$>\2?0MJ)
M(8XR:TTNL(4'XE,11J'Q`Q+5MO\`@YL+XG]6_%GJ3KOX0YWK[<_QGV;A:W`=
M=[CZRWUA^S-KYTT&9R46Z,L^_L'E,U0[JW%7[M%=)EJO[J65\FTXDTN"B@_?
M[C>+O=KNYWZ.5-T<@NLBE&`TC2-+`$*%TZ?Z-#GCT<[9%8PV<<>W2(UL&;*D
M$%BQ+FJ]M=9-0*`'````!L?9-TOZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>ZI=^0WP?V!W=\UM^=W_``L_F`9'X;_/S`]<;'VE\E,#U54=4=SC>/734YJN
MJ<A\A?C3O6LJ6IZZCQ;F/;V:G7'2RT!"1M,BH5'6V;_<6&R6ECOW+GUW+AD9
MH2_B14:K!UBG4<-52RKG4#4\1T&;_;%N[JZDVC=UM=UX.0%D(;3'5FCU+5O#
M$0I)J4+X;!02"0>PO\MZOVKW-N_<._?YM6[M[?S8^T>I:7"]#]R;\VWT4FY^
ME^B=M]E[9W=V&O0_PQ^]IMN3;2WE)@Y\+N/+%:I5IZYPLT$OD,RU^:(I;6&.
MWY-1.3XIBTL2M)220II4276G552RNHXDA:D@)I2C99U+^)S`#O[1!5D*CM/<
3?$$)D-6*K(%`81J/%*H`\H?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
